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GENERAL REMARKS 
 
1. Nuclear Magnetic Resonance spectra were recorded on Varian-200 MHz (Gemini), 
AVANCE-300 MHz (Bruker), and Unity-400 MHz spectrometers using 
tetramethylsilane (TMS) as the internal standard. Chemical shifts have been 
expressed in () ppm units downfield from TMS. Selected data are reported as 
follows. Chemical shifts, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, br = broadened, dd = doublet by doublet, dt = doublet by 
triplet and td = triplet by doublet), coupling constants (J in Hz) and assignments. 
2. Mass spectra were recorded on CEC-21-11013 or Finningan Mat 1210 double 
focusing mass spectrometers operating at 70 eV using a direct inlet system. 
3. FABMS and HRMS were measured using VG AUTOSPEC mass spectrometers at 
5 or 7 K resolution using perfluorokerosene as an internal reference compound. 
4. Optical rotations were measured with a Jasco Dip 300 digital polarimeter at 25 °C. 
5. Melting points were recorded on Büchi 535 melting point apparatus and are 
uncorrected. 
6. All evaporations were carried out under reduced pressure on Büchi rotary 
evaporator at below 40 °C. 
7. All solvents and reagents were purified and dried by standard techniques. 
8. All the reactions monitored by analytical thin layer chromatography (TLC) using 
E-Merck silicagel plates (60G-254). Visualization was accomplished with UV light 
(256 mm), iodine and by dipping in 2% phosphomolybdic acid in 15% aq. H2SO4 
or 2.75% p-anisaldehyde in 3% H2SO4 or -naphthol in 5% H2SO4 in EtOH 
followed by heating. 
9. All non-aqueous reactions were carried out under nitrogen (N2) atmosphere using 
dry, freshly distilled solvents unless otherwise noted. Yields refer to 
chromatographically and spectroscopically homogeneous materials isolated unless 
otherwise stated. 
10. Nomenclature mentioned in the experimental section was adopted from chem. 
Draw ultra version 6.0.1, @1985-2005, CambridgeSoft.com. 
11. Room temperature = 25-27 °C. 
12. Petroleum ether boiling point is 65-70 °C. 
13. ‘Brine’ means saturated aqueous NaCl solution. 
14. 60-120 & 100-200 Mesh silica gel is generally denoted as ‘Silica gel’ (Acme’s 
Laboratory Chemicals for Chromatography). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS 
 
Ac  : acetyl 
   aq.  : aqueous 
 Ar  : aryl 
 n-Bu  : n-butyl  
 c  : concentration (%) 
 CHCl3  : chloroform 
            CH2Cl2 : dichloromethane  
 DDQ  :            2,3-dichloro-5,6-dicyanobenzoquinone 
 DIBAL-H : diisobutylaluminium hydride 
 DIPT  : diisopropyl tartarate 
 DMAP  : 4-dimethylaminopyridine 
                                    DMF  :  N,N-dimethylformamide 
 2,2-DMP : 2,2-dimethoxypropane 
 DMS  : dimethyl sulphide  
 DMSO  : dimethyl sulphoxide 
 EtOAc  : ethyl acetate 
 EIMS  : electron impact mass spectrum 
 ESIMS : electrospray ionization mass spectrum 
 EtOH  : ethanol 
 t-BuOH  : tert-butanol 
 Et3N  : triethyl amine  
 eq.  : equivalent(s) 
 Et  : ethyl 
 FABMS : fast atom bombardment spectrum 
 g  : gram(s) 
 h  : hour(s) 
 HRMS  : high-resolution mass spectrum 
 IBX  : 2-iodylbenzoic acid (or) 2-iodoxybenzoic acid  
 IR  : infrared 
 LAH  : lithium aluminium hydride 
 M+  : molecular ion 
                                    Me  : methyl 
 MHz  : megahertz 
 min  : minute(s) 
 mL  : milliliter(s) 
 mmol  : millimole(s) 
 m. p  : melting point 
   NaBH4  : sodium borohydride 
 m/z  : mass to charge ratio (in mass spectrometry) 
 NCE  : new chemical entity 
 NMR  : nuclear magnetic resonance 
 nOe  : nuclear Overhauser effect 
  
 Ph  : phenyl 
 PMB  : para-methoxybenzyl 
 iPr  : isopropyl 
 Py  : pyridine 
 Ac2O   : acetic anhydride 
 PTSA  : para-toluenesulphonic acid 
 CSA   : camphor sulphonicacid 
 Rf  : retention factor (in chromatography) 
 rt  : room temperature 
 s  : second (s) 
 sat.  : saturated 
 sol.  : solution 
 DIPEA : diisopropylethylamine 
 n-BuLi  : n-butyl lithium 
 LDA   : lithiumdiisopropylamide 
 LiHMDS  : lithium bis(trimethylsilyl)amide 
 TBAF  : tetra-n-butylammonium fluoride 
 TBDMS : tert-butyldimethylsilyl 
 TBDPS :           tert-butyldiphenylsilyl                               
            THF  : tetrahydrofuran 
 TLC  : thin layer chromatography 
 TPP  : triphenylphosphine 
 PTSA  : para-toluenesuphonic acid 
 UV  : ultraviolet 
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 1
The thesis entitled “STEREOSELECTIVE TOTAL SYNTHESIS OF FUNGAL 
METABOLITE HERBARUMIN-I, PLANT NATURAL PRODUCT 
LEIOCARPIN A AND DEVELOPMENT OF SYNTHETIC 
METHODOLOGIES” is divided into three chapters. 
Chapter I: Describes stereo chemical total synthesis fungal metabolite of Herbarumin-I 
by using L-Ascorbic acid involving the barbier type reaction, swern oxidation, grigard 
reaction, and macrocyclization reactions. 
Chapter II: Divided into two sections i.e Section A and Section B. 
Section A: Deal the stereoselective synthesis of leiocarpin A by using D-mannitol 
involving barbier type reaction, grigard reaction, ring closing metethesis, oxamicheal 
addition reactions. 
Section B: Deals the phospomolybdicacid-catalyzed synthesis of tetrhydro pyrano and 
furano quinolines. 
Chapter III: Divided into two sections i.e Section A and Section B 
Section A: Deals with ring opening of epoxide with amines with NbCl5 as a Lewis acid. 
Section B: Deals the Niobium (V) chloride catalyzed tetrahydropyranylation of 
alcohols. 
Chapter I:  
Stereoselective total synthesis of fungal metabolite Herbarumin I a ten membered 
lactone: 
        Bioassay guided fractionation of a culture broth and mycelium of the fungus 
Phoma herbarum Westend (Sphaeropsidaceae) led to the discovery of three novel 
nonenolides named herbarumin-I (1), II (2) and III (3) (Figure 1) These lactones 
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 2
exhibited significant phytotoxic effects when tested against the seedlings of Amaranthus 
hypochondriacus at very low concentrations using a Petri dish bioassay. Amongst these 
lactones herbarumin-I (1) shows promising phytotoxic effects with IC50 values as low as 
5.43 X 10-5. Enzyme-inhibition studies of compounds 1–3 also suggested an interesting 
behaviour superior to chlorpromazine, as calmodulin-dependent enzyme cyclic 
nucleotide (cAMP) phosphodiesterase calmodulin inhibitors without interfering with the 
basal activity or the independent form of the enzyme. 
        In our strategy, the synthesis of the Herbarumin I started with readily available L-
ascorbic acid (4), which converted into (S)- 2,3-O-isopropylidene glyceraldehyde 9 by 
known procedures in the literature (scheme1).  
 
 
 
 
 
 
 
 
Scheme 1 
        The treatment of (S)- 2,3-O-isopropylidene glyceraldehyde with allyl bromide, 
activated Zn and sat. NH4Cl, which give mixture of homo allylic alcohol 10 and 11 in 
the ratio 95:5 (anti:syn) (scheme 2).  
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Scheme 2 
        The required anti isomer 10 was reduced with PD/C and hydrogen gas followed by 
alcohol 12 was protected with 4-methoxy benyl bromide in presence of NaH at 0 oC to 
rt for 4h afforded compound 13, then the acetonide group was deprotected in presence 
of 1N HCl in THF at room temperature provided diol 14 (scheme 3). 
 
 
 
 
Scheme 3 
        Thus the diol 14 was protected with as TES ether by using TESCl, in the presence 
of imidazol, in DCM afforded TES ether compound 15. The compound 15 was oxidized 
under swern conditions furnished aldehyde 16, via domino deprotection of the primary 
O-TES group and subsequent oxidation of the primary alcohol to aldehyde moved for 
next step without further purification it was subjected to vinylation reaction with vinyl 
magnesium bromide, which was insitu generation of grignard reagent by activated 
magnesium turnings and vinyl bromide in THF at room temperature afforded to the 
corresponding allylic alcohols as mixture of 17 and 18 anti : syn ( 9 : 1 ). 
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Scheme 4 
        The subsequent deprotection of  17 was the presence of 1N HCl in THF gave diol 
19, which on subsequent protection of acetonide in the presence of 2,2 dimethoxy 
propane and catalytic amount of PPTS provided compound 20. 
 
 
 
 
 
Scheme 5 
        
        The oxidative cleavage of PMB ether of compound 20 in the presence of DDQ in 
DCM at 0 oC afforded alcohol 21. The alcohol 21 was esterification with hexenoic acid 
in the presence of 2,4,6 tri chloro benzoyl chloride afforded di olefinic ester 22.  
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 5
        The cyclization of 22 in the presence of Grubbs’ second-generation catalyst led to 
the exclusive formation of the undesired (Z)-isomer 23 in 85% yield. In the 1H NMR 
spectrum of 24 and 23, whose spectral data compared well with that reported in the 
 
 
 
 
Scheme 6 
literature. However, compound 22, in the presence of Grubbs’ first generation catalyst 
yielded an E/Z mixture of cyclic olefins (24:23 = E:Z = 80:20) in 82% yield. The  
 
 
 
 
 
 
Scheme 7 
diastereomers were separated by chromatography using an AgNO3–silica gel column. 
These compounds are conformed by comparising the reported compounds. 
        Finally the deprotection of acetonide group of compound 24 with 1N HCl in THF 
under reflux conditions for 6h gave target compound 1 in 85% yield as white solid. The 
optical rotation is [α]D25 +12.0o (c 0.5, EtOH) were in good accordance previously 
reported [α]D25 +10.8o (c 0.51, EtOH), with those of natural product isolated [α]D25 
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+28.0o (c 0.1, EtOH). The IR, 1H NMR, 13C NMR and mass data of the synthetic 
herbarumin I 1 was in good accordance with those of the natural product. 
 
 
 
 
Scheme 8 
Chapter II: 
Section-A: Stereoselective synthesis of Leocarpin-A a plant natural product: 
        The Leiocarpin A, leiocarpin B, leiocarpin C and 7-epi-goniodiol are four new 
styryllactones, recently isolated by Chaoming Li et al. from the ethanolic extract of 
stem bark of Goniothalamus leiocarpus (Annonaceae). Apart from interesting 
biological profile of these styryllactoes are attractive synthetic targets with structural 
complexity and biological activity. The leiocarpin A have the same structural 
relationship with 2,5-deoxygoniopypyrone except for the configurations at C6 (figure1).   
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        Owing to the importance of these styrylactones regarding cytotoxic activity and 
basic structural features, we encouraged to stereoselective synthesis of leiocarpin A 
starting from commercially available D-mannitol.      
        In direct reciprocation of retrosynthetic analysis, we commanced our synthesis 
from D-mannitol 3. The cheap and commercially easy availability high enantiomeric 
purity and equivalence of double unit of C3-chiral building block because of C2 
symmetry were the strong incentives to start from D-mannitol. The foremost step was 
the conversion of D-mannitol into 1,2:5,6-di-O-isopropylidine-D-mannitol 4 using 2,2-
dimethoxy propane and cat. PTSA in dry DMSO for 8h as shown in scheme 1. The 
treatment of diacetonide D-mannitol 4 with NaIO4, and sat. NaHCO3 in DCM at 0 oC 
for 8h afforded the (R)-2,3-O-isopropylidineglyceraldehyde 5 in quantitative yield 
 
 
 
 
Scheme 1 
        The next endeavor was the stereoselective allyl addition to the aldehyde 5. 
Accordingly, the compound 5 was treated with allyl bromide, in presence of activated 
zinc dust and saturated NH4Cl for 4h, which gave the mixture of diastereomers 6a and 
6b in the ratio of the 95:5 (anti : syn) The required isomer of homo allylic alcohol 6a 
was protection with 4-methoxy benzyl bromide in presence of NaH at 0oC to room 
temperature for 4h afforded the product 7. Acetonide deprotection of 7 was in 1N HCl 
in THF provided diol 8 in quantitative yield. 
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Scheme 2 
        The diol 8 was silylated with tri ethyl silyl chloride in presence of imidazole in di 
chlromethane at 0 oC to room temperature furnish di TES compound 9. The compound 
9 was oxidized under swern conditions furnished aldehyde 10, via domino  
 
 
 
 
 
 
 
 
Scheme 3 
deprotection of the primary O-TES group and subsequent oxidation of the primary 
alcohol to aldehyde, and which on subsequent phenylation with phenyl magnesium 
bromide in THF at 0 oC to room temperature afforded to the corresponding benzylic 
alcohols as mixture of 11a and 11b ( 9: 1 anti: syn). 
        The required anti isomer of benzylic alcohol 11a was protected with TESCl in the 
presence of imidazole in dry dichloromethane afforded the compound 12,  
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Scheme 4 
which on sub sequent DDQ mediated  oxidative cleavage of PMB group in DCM:warer 
19:1 ratio provided homoallylic alcohol 13. 
 
 
 
 
Scheme 5 
         The homo allylic alcohol 13 was acryloylated with acryloyl chloride afforded 
compound 14, the dien was cyclized by ring closing metathesis in the presence of 
Grubbs, first generation catalyst provided lactone 15, finally deprotection of TES group 
target as colorless solid leiocarpin A with [α]D25 +94.9 (c = 0.4, CHCl3) were in good  
 
 
 
 
Scheme 6 
 
with TBAF in dry THF, followed by cyclization through oxamicheal addition afforded 
accordance with those of natural product. Pleasingly, the IR, 1H NMR, 13C NMR and 
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 10 
mass data of the synthetic leiocarpin A 1 was in good accordance with those of the 
natural product. 
Section B:  
           Development of new synthetic methodologies is an important subject in organic 
chemistry. Synthesis involves expensive reagents and catalysts, which are not easily 
available. To replace all such reagents and catalysts different improved processes have 
now been discovered to carry out the reactions efficiently and conveniently with readily 
available inexpensive materials. Modern methodologies are also concerned with the 
yield and selectivity of the product. In this chapter we describe phospomolybdic acid 
catalyzed synthesis of tetrhydro pyrano and furano quinolines. 
Phospomolybdicacid (PMA, H3PMo12O40) catalyzed synthesis of tetrhydro pyrano 
and furano quinolines: 
        Pyrano- and furanoquinoline derivatives belongs to an important class of natural 
products and exhibit a wide spectrum of biological activities such as antiallergic, antib 
inflammatory, antipyretic, analgesic, antiplatelet, psychotropic and estrogenic activity. 
Many biologically active alkaloids contain pyranoquinoline and furanoquinoline 
moiety. Hence, the synthesis of pyranoquinoline and furanoquinoline derivatives is of 
much current importance. Generally the pyranoquinoline and furanoquinoline 
derivatives are prepared by aza-Diels-Alder. The treatment of anilines 1 and 
benzaldehydes 2 with 2,3-dihydrofuran (DHF) in the presence of 1 mol% of 
phosphomolybdic acid in acetonitrile afforded the corresponding furanoquinolines 3 
and 4 in high yields (scheme 1). 
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Scheme 1 
 
 
 
 
Scheme 2 
        In a similar manner, treatment of anilines 1 and benzaldehydes 2 with 3,4-dihydro-
2H-pyran (DHP) in the presence of 1 mol% of phosphomolybdic acid in acetonitrile 
afforded the corresponding pyranoquinolines 5 and 6 in high yield (Scheme 2). 
Proposed mechanism for the synthesis of pyrano- and furanoquinoline: 
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Chapter III:  
Niobium (V) chloride: A new and efficient reagent for development of new 
synthetic methodologies: 
In this chapter we described Niobium penta chloride catalyzed synthetic methods. In the 
view of the recent surge in the activity of Niobium reagents as mild and vater-tolerent 
Lewis acid. We wish to disclose a new protocol for the rapid synthesis of variety of 
methodologies. 
Section A: Niobium (V) chloride is a new catalyst for the synthesis of amino 
alcohol: 
        In this chapter synthesis of variety of biologically significant amino alcohols using 
catalytic amount of Niobium (V) chloride under mild conditions were described. The 
treatment of styrene oxide 1 with aromatic amine 2 in DCM in the presence of 10% of 
Niobium penta chloride for appropriate time s at room temperature afforded amino 
alcohols (4 & 5).  
 
 
 
Scheme 1 
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        Similarly, various epoxides like cyclohexane oxide, epi chlorohydrin with aromatic 
amine under similar conditions to gave corresponding amino alcohols in high yields.  
Section B: Niobium (V) Chloride as a acid catalyzed tetrahydropyranylation of 
alcohols: 
        During endeavors of the total synthesis of biologically active natural products, 
which involves the protection and deprotection of a variety of functional groups were 
involved. Among the various functional groups, hydroxy is very familiar and its 
protection as  
  
 
 
Scheme 1 
Proposed mechanism for tetrahydropyranylation of alcohols: 
 
 
 
 
 
 
 
 
 
Scheme 2 
OH
O
O ONbCl5
DCM, rt+
1 2 3
NbCl5
ROH
O NbCl5R
H
_
O
O NbCl5R
_ H
O
ORO
+
+ +
..
 
                                                                                                                            Abstract 
 14 
tetrahydropyranyl ether (THP) is a common and widely used transformation in organic 
synthesis. The tetrahydropyran derivatives are attractive for the reason that they are less 
expensive, easily deprotected and stable under variety of reaction conditions that they 
are less expensive, easily deprotected and stable under variety of reaction conditions 
such as strongly basic media, metal hydrides, metal triflates, Grignard reagents, 
acylating agents, oxidative reagents and alkylating agents. THP groups are also the 
protective groups of choice in peptide, nucleotide, carbohydrate and steroid chemistry. 
        According to scheme 1, treatment of benzyl alcohol 1 with dihydropyran 2 in the 
presence of Niobium (V) chloride in DCM at room temperature afforded corresponding 
THP ethers 3 in high yields. The reactions were clean and products were high yields in 
shorter times. The crude products were purified by column chromatography. 
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Stereochemical total synthesis of fungal metabolite Herbarumin-I a ten 
membered lactone: 
Introduction:   
        Bioassay guided fractionation of a culture broth and mycelium of the fungus 
Phoma herbarum Westend (Sphaeropsidaceae) led to the discovery of three novel 
nonenolides named herbarumin-I (1), II (2) and III (3) (Figure 1).1 These lactones 
exhibited significant phytotoxic effects when tested against the seedlings of Amaranthus 
hypochondriacus at very low concentrations using a Petri dish bioassay.2 Amongst these 
lactones herbarumin-I (1) shows promising phytotoxic effects with IC50 values as low as 
5.43 X 10-5. Enzyme-inhibition studies of compounds 1–3 also suggested an interesting 
behaviour superior to chlorpromazine, as calmodulin-dependent enzyme cyclic 
nucleotide (cAMP) phosphodiesterase calmodulin inhibitors without interfering with the 
basal activity or the independent form of the enzyme.3 
 
 
 
 
 
Figure 1 
        In this chapter the stereochemical synthesis of herbarumin-I is reported. Therefore 
in the past work of this chapter ten membered macrolides is presented. Macrolides in 
general and several synthetic methodologies for the synthesis of herbarumin is also 
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presented. In this chapter the various methods for the synthesis of key intermediate 32 is 
presented. 
 
Past Work: Review of literature: 
Natural bioactive molecules containing nonenolide skeletons:    
        Mata, and coworkers4 reported the isolation of Pinolidoxin (4) and lethaloxin (5) 
also exert significant phytotoxicity, makes this class of compounds promising new lead 
structures in the search for novel herbicidal agents (figure 2). 
 
 
 
 
 
 
Figure 2 
        Peter Proksch and co-workers5 isolated from Fungal isolates of Penicillium cf. 
montanense were obtained from the marine sponge Xestospongia exigua collected from 
the Bali Sea, Indonesia. Culture filtrates of the fungi yielded three novel decalactone 
metabolites 8, 9, 10. Xestodecalactones A, B, and C (6 & 7) (figure 3), consisting of 
10-membered macrolides with a fused 1, 3-dihydroxybenzene ring. These compounds, 
of which 6a and 6b, due to the additional stereocenter at C-9, are diastereomeric 
compounds, are structurally related to a number of biologically active metabolites found 
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in terrestrial fungal strains. Compound 6a was found to be active against the yeast 
Candida albicans. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
        Antonio Evidente 6 and co-workers reported new phytotoxic metabolites from 
pycnidial fungal Stagonospora cirsii, a fungal pathogen isolated from Cirsium arvense 
and proposed as a potential mycoherbicide of this perennial noxious weed, produces 
phytotoxic metabolites in liquid and solid cultures. Recently, the main metabolite, 
stagonolide, with interesting phytotoxic properties, was isolated from a liquid culture 
and characterized as a new nonenolide. In this same fungus, grown in solid culture, 
exhibited an increased capacity to produce five new nonenolides, named stagonolides 
B-F. (11 – 13)(Figure 4) 
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Figure 4 
 
         Arlene 7 group isolated four new decarestrictine analogues (botryolides A-D; 14-
18), a biosynthetically related γ-lactone (botryolide E; 18), and the known compounds 
decarestrictine D (19) and sterigmatocystin from cultures of a fungicolous isolate of 
Botryotrichum sp. (NRRL 38180). Like botryolides A-D (14-18) (figure 5), most of the 
decarestrictines contain 10-membered ring lactone (decanolide) units.  
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        Other decanolide derivatives have also been described as fungal metabolites, and 
those with similar pentaketide origins include cephalosporolides,8 aspinolides,9 
diplodialides,10 humicolactone,11 pyrenolides, 12 multiplolide,13 and modiolides.14 Some 
of the known decarestrictines are inhibitors of cholesterol biosynthesis,15  but wide 
range of other bioactivities have also been described for members of this general class. 
Microcarpalide16 24 was isolated from an as yet unidentified endophytic fungus 
growing on the bark of the tropical tree Ficus microcarpa L. While weakly cytotoxic to 
mammalian cells, the compound acts as a strong microfilament disrupting agent.17 
These properties make 24 a potential lead structure for the development of new 
anticancer drugs and, consequently, an attractive target for synthetic studies. 
 
 
 
 
 
 
 
 
 
 
Figure 6 
        Rolf Jansen and coworkers 18 reported a novel highly cytotoxic metabolite, 
apicularen A (25), was isolated in a screening of the myxobacterial genus 
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Chondromyces. The structure of apicularen A is characterized by a salicylic acid residue 
as part of a 10-membered lactone, which bears an acylenamine side chain. Compound 
25 is an inhibitor of the proliferation of human cancer cell lines and induces apoptosis. 
Apicularen A (25) is present in nearly every strain of C. apiculatus, C. pediculatus, C. 
lanuginosus and C. ro- bustus. Habitually 25 is accompanied by different amounts of a 
more polar variant, 
 
 
 
 
 
 
 
 
Figure 7 
apicularen B (26), which was identified as 11-O-(2-N-acetamido-2-deoxy-a-D- 
glucopyranosyl) apicularen (figure 7).. 
Earlier approaches to the total synthesis of herbarumin I (1): 
        Novel structure and phytotoxic activity of Herbarumins have an attractive synthetic 
targets with in the chemistry community. Alois Fürstner  et al. published the first total 
synthesis of Herbarumin-I in 2001, and this was followed by various groups presented 
herein. 
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Alois Fürstner  approach for the synthesis of herbarumin I: 19 
        The first total synthesis of herbarumine I (1) was completed by Alois Fürstner and 
co-workers in early 2001. The synthesis of herbarumine I (1) was started with the 
perception that the stereochemistry of its three contiguous chiral centers is matched by 
the pattern displayed by D-ribose and Therefore, the D-ribonolactone acetonide 27  
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derivative was chosen as a well accessible starting material which is converted into 
tosylate 28, and subsequent treatment with sodium methoxide in THF leads to product   
29 via transesterification followed by spontaneous closure of the epoxide ring once the 
alkoxide at O-4 is liberated. The given epoxide 29 was opening with ethyl grignard 
reagent in the presence of cuprous bromide dimethyl sulfide provided lactone and the 
lactone reduced to lactol with DIABAL-H fallowed by the resulting lactol treatment 
with one carbon wittig ylide provide key fragment 32 (scheme 1). 
        Which was esterification with hexenoic acid using DCC, DMAP to provided di 
olifinic compound 33, the macrocyclization by ring closing metathesis using Grubb’s 
catalyst provided compound 34 was finally deprotected with 1N HCl to afford 
herbarumine I (1). 
Ronaldo A. Pilli,s approach for the synthesis of herbarumin I: 20 
Ronaldo A. Pilli,s approach the stereoselective total synthesis of herbarumin I (1) by 
involving the key steps like Felkin-type intermolecular NHK reaction between alkoxy 
aldehyde and vinylic iodide, followed by macrolactonization Starting from L- 
arabinoselactol  was prepared according to the procedure by Ballou and Wightman.21 
Wittig olefination afforded the corresponding olefin as a mixture (Z/E) that was 
subsequently hydrogenated on Pd/C to give acetonide 37. Removal of the acid labile 
acetonide group and recentralization of the corresponding triol with 3-pentanone  
provided 28. This one was transformed in the corresponding benzylic ether and then 
converted to the corresponding bis-silyl ether 39. Selective deprotection of the primary 
silyl group with HF·Pyridine in buffered THF, followed by mild oxidation of the 
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corresponding alcohol with Dess–Martin periodinane provided aldehyde 40 (scheme 3).  
Hydrostannylation of 5-hexyn-1-ol 41 catalyzed by Pd(PPh3)2Cl2 stereo selectively 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2 
         
provided vinylic stannane 42. Tin–iodine exchange was accomplished the required 
vinylic iodide 43. Which was Jones oxidation followed by esterification with SOCl2 in 
methanol afforded ester 44. The intermolecular Nozaki–Hiyama–Kishi reaction of 
vinylic iodide 44 and aldehyde 40 was successfully carried out and provided allylic 
alcohol 45. The provided secondary alcohol was protected to TBS ether 46. Alcohol 
was prepared by the reduction with Pd(OAc)2 in cyclohexane without disturbing the  
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Scheme 3 
olifinic bond. Ester hydrolysis fallowed by macrolactonisation under modified 
yamaguchi conditions and simultaneously removal of both TBS with TBAF in THF 
afforded hebarumin I (1)  (scheme 4). 
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Earlier approaches for the synthesis of key fragment 32: 
        The herbarumins, as well as two close relatives, pinolidoxin 5 and lethaloxin 6. 
These large family of ten membered lactones that have recently attracted the interest of 
many synthetic chemists. The key moiety of these closely relative ten membered 
lactones are same as herbarumine I (1) with opposite hydroxyl centers at C-7 and C-8 of 
pinolodoxin and C-7 and C-9 of lethoxin 5. Because of Several approaches towards the 
synthesis of these ten-membered lactones have appeared in the literature during the past 
years. 
Leys approach for the synthesis of key fragment (32):22 
        Leys group to apply a method developed by the synthesis of herbarumin II to 
highlight the synthetic utility of butane diacetal-desymmetrised glycolic acid. Glycolic 
acid as a primary building block for the stereoselective synthesis of functionalized  
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hydroxy acid polyol motifs. In this report key aldehyde afforded by the reaction 
between the (R,R) glycolate 48 and acroline and fallowed by deprotection of hindered 
butane diacetal 49, then TBS protected aldehyde 51 was treated with non chelation 
controlled metal propane halide provided key fragment 32 (scheme 5). 
Fortanet approach for the synthesis of fragment (32):23 
        Jorge Garcıa-Fortanet group was synthesized key fragment for the total synthesis 
of lethaloxin 5. A stereoselective synthesis from D-ribose, which was treated with 
acetone in presence of conc.H2SO4 provided acetonide compound 54 then lactal one 
carbon wittig reaction gave olefinic diol 55, which was converted to epoxide by reaction 
in the presence of  tri phenyl phosphine, DIAD. The epoxide 56 was treated with ethyl 
magnesium bromide provided key fragment 32 (scheme 6). 
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Present work:  
        Bioactivity-directed fractionation of extracts from the fungus Phoma herbarum1 
led to the isolation of two new phytotoxic nonenolides: (7S,8S,9R)-7,8-dihydroxy-9 
propyl-5-nonen-9-olide (1) and (2R,7S,8S,9R)-2,7,8-trihydroxy-9-propyl-5-nonen-9-
olide (2), which were named herbarumin I and II respectively, and also isolated 
herbarumin-III.  
        Herbarumin I (1) was shown to have the molecular formula of C12H20O4 (three 
unsaturations) from HREIMS, based on a molecular ion peak at m/z 228.1364. IR 
spectroscopy indicated the presence of hydroxyl (3390 cm-1) and olefin functionalities 
(1670 cm-1), in addition to the lactone group (1721 cm-1). The NMR data coupled with 
the IR and MS indicated that herbarumin I (1) has a structure similar to those of 
pinolidoxin and related nonenolides. Which could be assigned to the NOESY and 1H-1H 
coupling constant data, which revealed that in CDCl3 solution, also in agreement with 
the calculated conformation.  
        The NMR spectra showed the existence of a ten-membered macrolide core, a 
vicinal diol, a trans disubstituted double bond, and an n-propyl unit. COSY and HMBC 
experiments indicated the position of the hydroxyl, n-propyl and olefin functionalities 
on the macrolactone core. Thus, the HMBC correlations C-5/H-7 and H-4b, C-7/H-6, C-
8/H 6 and H-7, and C-9/H-7 and H-8 were consistent with the placement of the double 
bond and the diol grouping at C-5/C-6 and C7/C-8, respectively. In addition, the 
correlations C-9/H-10a and H-10b, and C-1/H-9 revealed that the n-propyl moiety and 
the lactone closure were located at C-9. The stereochemistry and the solution 
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conformation of the ten-membered ring lactone of herbarumin I (1) was determined by 
molecular mechanics modeling, NOESY data.  
Our synthetic plan of herbarumin – I: 
 
 
         
 
Retrosynthetic analysis of Herbarumin-I: 
        As per our synthetic view and retrosynthetic analysis of herbarumin-I, which was 
starting from L-Ascorbiacid. 
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        Generally the cyclization of medium size ring lactones with n = 10 (n = no. of 
aoms in the macrolides) appear to be more difficult due to both enthalpic and entropic 
factors.23a notwithstanding the difficulty, to date, only two total synthesis of herbarumin 
I (1) has been reported through ring closing metatheses and Nozaki-Hiyama-Kishi 
reaction as the key step  in low stereoselectivity. As part of our interest in the 
synthesizing natural product here we decided to synthesis of herbarumin I (1) by the 
derived from common in expensive starting material (S)-2,3-O-isopropylidene 
glyceraldehyde 37 which derived from L-ascorbic acid 38. 
        The key steps involving the Barbier type allylation, swern oxidation fallowed by 
grignard reaction on the chiron derived (S)- 2,3-O-isopropylidene glyceraldehyde (37), 
yamaguchi esterification followed by marocyclization by ring closing metathesis. 
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        The synthetic approach of our reterosynthetic analysis revealed that the target, 
compound 1 (sheme 7), obtained from 33 by yamaguchi esterification macrocyclization 
through ring closing metathesis followed by deprotection of isopropylidine group. The 
compound 36, in turn, could be chiral building block 36a. While homoallylic alcohol 
could be realized from (S) - 2,3-O-isopropylidene glyceraldehyde (37). 
        Accordingly, the known aldehyde (37), prepared from a literature procedure from 
L-ascorbic acid (38).24 The foremost step was the conversion of L-ascorbic acid into 
3,4-O-isopropylidene ascorbic acid (39) using anhydrous CuSO4 in dry acetone for 24h. 
The isopropylidene derivative was treatment with K2CO3 and 30% H2O2 to afforded 
potassium salt of compound (40) then which was treated with ethyl bromide in the 
presence of Bu4NI gave ethyl ester compound (41). Then the ester was reduction with 
LAH gave diol compound (42).  
        The treatment of diol (42) with NaIO4 and Sat. NaHCO3 in DCM at 0oC for 8h 
afforded the (S)-2,3-O-isoprpylideneglyceraldehyde (37) in quantitative yield. In the 1H 
NMR spectrum of 37, showed resonances characteristic of aldehyde proton at δ 9.65 
ppm and two methyl protons appeared as twp singlets at δ 1.40 and 1.45 ppm. 
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        The next endeavor was the stereoselective allyl addition to the aldehyde 37. 
Accordingly, the compound 37 was treated with allyl bromide, in the presence of 
activated zinc dust and saturated NH4Cl for 4h, which gave the mixture of 
diastereomers 36a and 36b in the ratio of the 95:5 (anti : syn) (scheme 9). The 
diastereomers were separated by column chromatography and the required anti isomer 
was obtained in 74% yield. The reaction was called as barbier type reaction; this 
stereoselective Barbier reaction installed the single chiral centre of the target compound 
with appropriate stereochemistry. 
        A brief discussion on Barbier reaction and the rational for the stereochemical 
Proposed Reaction Mechanism:  
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outcome is discussed herein. The nucliophilic addition of allyl and propargyl halides in 
the presence of metals like Zn, In and Sn to a carbonyl elctrophile is called Barbier 
reaction. The advantage of Barbier reaction is two fold: 1) Unlike reagent which have to 
be generated from alkyl or propargyl halides and Zinc powder mediated. Before hand 
there is no necessity to the prior generation of the organometal in the Barbier protocol. 
2) Use of water (salt) as co solvent makes a metal together with a two - phase system, 
this reaction as attractive green protocol. Under such conditions,25 intermediate radical 
ion formed by a one –electron transfer mechanism [CH2=CHRX].-Zn.+, are through to 
interact with the carbonyl compound. The proposed transition state for this Barbier type 
reaction, with geometric characteristics similar to those of the corresponding structure 
in the SN2 displacement. 26  
        In the transition state, the substituted carbon atom ( carbon) of the allylic moiety 
interacts with an aldehyde molecule adsorbed on the Zinc metal surface. The rigid 
arrangement of transition state, having a cyclic structure, favors the Thro-form due to 
minor interactions between the methyl group linked to the allyl ( carbon) atom and the 
bulky R groups of the aldehyde. Adsorbed carbonyl compounds can interact with the 
Zinc metal to give radical anion and then, by diorbtion radical species.26,27 the  
hypothesis of a transition state with a cyclic structure might explained the moderate 
threo-selectively allylation on aldehyde. The observed anti-diastereoselectivity may 
probably be explained by Felkin-Ann model (figure 8) with the addition of allyl metal 
expected at the less hindered side of the carbonyl group in the staggered model of 
Newman projection. The moderate diastereoselectivity (95:5, anti:syn) can be explained 
by the steric size difference between RL and RM, which moderate. In addition, the steric 
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differentiation of two groups is limited due to the formation of 1, 3-dioxalane ring. 
Since the syn isomer is formed as minor product and also the reaction was performed in 
aqueous medium. The chelation control model is ruled out.  
        In the 1H NMR spectrum of 36a showed a multiplet at δ 5.69-5.75 ppm for olefinic 
single proton and another multiplet at δ 5.16-5.06 ppm for olefinic two protons, 
attributed to vinylic group and a broad singlet at δ 1.93 ppm indicate the presence of 
exchangeable of hydroxyl proton. The 13C NMR of 36a showed peaks characteristic 
allylic olefin carbons at δ 133.9 and 118.0 ppm. The absolute stereochemistry at newly 
formed secondary center at C-4 was essentially assigned based on literature precedence. 
The reduction of olefinic double bond in compound 36a reaction with 10% Pd/C in 
ethanol under hydrogen atmosphere at room temperature for 4h. The required 
compound 43 in 100% yields. The 1H NMR of 43, the expected disappearance of 
olefinic proton was observed gave further proof of the structure. 
        The alcohol of 43, protected as benzyl ether with 4-methoxy benzyl bromide and 
NaH in dry THF at 0 oC to room temperature for 4h afforded 35 in 85% yield (Scheme 
10).the newly introduced protons corresponding to PMB group in 1H NMR of 35 
resonated at   δ 3.70 as singlet for methoxy group, δ 4.54 as doublet for two protons and  
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 two doublets at, δ 7.25 and δ 6.88 for aromatic protons, while rest of the protons 
appeared at the expected chemical shifts, thus conforming the product.        
        Acetonide deprotection in compound 35 on reaction with 1N HCl in THF at room 
temperature for 6h (scheme 11) afforded diol 44 in 95% yield. In the 1H NMR of 44, 
the expected disappearance of isopropylide protecting group was observed. The diol  
 
 
 
 
 
Scheme 11 
compound 44 was silylated using TESCl in the presence of imidazole in DCM at 0 oC to 
room temperature for 3h provided di TES compound 45 in 85% yield (scheme 11). The 
newly introduced protons corresponding to TES group in 1H NMR of 45 resonated at δ 
0.67 – 0.57 as multiplet and δ 0.88 – 1.01 as multiplet, and also ESIMS of 45, (M++23 ) 
peak was observed at 505.5 giving further conformation of the product. 
        Selective oxidation of terminal TES protected alcohol under swern conditions28 
furnished aldehyde 46 via domino deprotection of the primary O-TES group and 
subsequent oxidation of the primary alcohol to aldehyde moved for next step without 
further purification which on sub sequent vinylation reaction, which was insitu 
generation of Grignard reagent by activated magnesium turnings and vinyl bromide in 
THF at 0 oC to room temperature afforded to the corresponding allylic alcohols as  
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Scheme 12 
mixture of 34a and 34b anti: syn ( 9: 1 ) in 74% overall yield. These diastereomers were 
separated by column chromatography. The major diastereoisomer 34a had the required 
stereochemistry at C-3, which was conformed by 1H NMR. The 1H NMR of 34a 
characteristic allylic proton resonated at δ 4.58 (J = 7.2 Hz) as triplet, and olefinic 
protons at δ 6.00 (ddd, J = 17.0, 10.2, 7.2 Hz, 1H), 5.34 (dd, J = 17.0, 10.2 Hz, 2H), 
thus, conformed the product. Further HRMS spectrum shows (M++23 ) peak at 
417.2437 calculated for C22H38O4NaSi and the appearance of strong absorption peak at 
3292 cm-1 in IR spectrum gave further proof for the formation of allylic alcohol. 
        Selective deprotection of O-TES group in the presence of 1N HCl in THF at 0 oC 
provided diol 47 in quantitative yield. The proton NMR of 47 indicated the 
disappearance of protons corresponding to TES group confirming the desilylation. In 
the ESIMS of 47, the (M++Na) peak observed at 303.3 gave further conformation of 
product. Our aim to the synthesis of known key intermediate 32, comparison for data. 
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Accordingly Acetonide protection of diol 47 in the presence of 2,2-di methoxy propane 
and catalytic amount of PPTS in DCM at room temperature for 6h furnished acetonide 
compound 48 in 95% yield (scheme 13). The 1H NMR of 48 indicated appearance of 
characteristic acetonide peaks at δ 1.33 and 1.44 gave evidence of the product. 
        To make the intermediate 32, acetonide compound 48 was subjected to oxidative 
deprotection of PMB group using DDQ in DCM: H2O (19:1) at 0oC to room 
temperature gave alcohol 32 in 92% yield. The 1H NMR of 32 indicated the 
disappearance of protons corresponding to PMB group confirmed the deprotection. The 
 
 
 
 
Scheme 13 
(M++23) peak observed at 220 in LCMS of 34a further confirmed the proposed 
structure.   
        Having prepared the key intermediate 32, it was next aimed at esterification and 
further transformations to herbarumin I 1, under Yamaguchi conditions.29 Accordingly, 
acid 49 on reaction with 2,4,6-trichlorobenzoyl chloride in the presence of Et3N in dry 
THF for 4h at room temperature furnished anhydride. Reaction of anhydride in toluene 
with alcohol 32 and DMAP for 12h at 0oC to room temperature gave ester or dien 
compound 33 in 85% yield (scheme 14). The 1H NMR spectrum of 33 revealed that  
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Scheme 14 
esterification has taken place as evidenced by the down field shift to δ 4.83 - 4.89 as a 
multiplat compared to the same proton in the alcohol compound 32. The remaining 
protons resonated at the expected regions. The (M++23) peak observed at 309.3 in 
LCMS of 33.  
      Now with the required dien in hand, our next endeavor was the macrocyclization by 
ring closing metathesis on dien 33. The RCM was a smooth with Grubbs catalyst to 
obtained as a mixture of olefinic compounds.  
 
 
 
 
 
Scheme 15 
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        A brief explanation of ring closing metathesis (RCM), which has received an 
unprecedented attention of synthetic organic chemists in recent years for the C = C bond 
formation, the construction of complex cyclic organic compounds. The popularity stems 
out of the following reasons:  
      (i)        Mild reaction conditions.  
      (ii)       Very high functional group tolerance.  
(iii) Availability of wide variety of catalysts, which are, in general, inexpensive 
and not sensitive to air and moisture.  
(iv)  High productivity. 
(v) High TON. 
RCM is a transition metal catalyzed reaction in which formally a mutual exchange of 
alkylidene groups between two substituted alkenes occurs with the evolution of 
ethylene. In other words, the metathesis reaction offers a catalytic method for both 
leaving and forming C-C double bonds. The olefin metathesis reaction was reported as 
early as 1955. 30a,b Various types of catalysts are known to effect the metathesis, 
molybdenum and ruthenium complexes. 
Molybdenum-based catalyst developed by Schrock, R. R.30c Schrock’s alkoxy 
imidomolydenum complex (figure 9) is highly reactive toward a broad range of 
substrates. However, drawbacks of this Molybdenum based catalyst has moderate to a 
large number of different desymmetrizations, work well for a wide variety of substrates, 
poor functional, group tolerance, high sensitivity to air, moisture or even to trace 
impurities present in solvents and exhibits thermal instability. 
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Figure 9 
       The widely-accepted mechanism for ring closing metathesis reaction (Figure 10) is 
delineated below.30e,f Ru-carbene systems are interesting because they not only exhibit 
high reactivity in a variety of RCM processes under mild conditions, but also show 
remarkable tolerance towards many different organic functional groups. Catalytic 
activity is not reduced significantly in the presence of air, moisture, or minor solvent 
impurities. They can be conveniently stored with out severe decomposition for several 
weeks. Although the Ru-carbene system (Figure 10) 30d often exhibits relatively lower 
propagation rates, especially with sterically bulky substrates when compared to the Mo 
catalyst system, their availability cases of use have resulted in the catalyst of choice. 
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Proposed mechanism for ring closing metathesis: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 
 
        The RCM of 33 in the presence of Grubbs’ second generation catalyst led to the 
exclusive formation of the undesired (Z)-isomer 34b in 85% yield. In the 1H NMR 
spectrum of 34a and 34b, the signals pertinent to four terminal olefinic protons were 
absent and only the signals due to two olefinic protons, whose spectral data matched 
well with that reported in the literature.19 However, compound 33, in the presence of 
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Grubbs’ first generation catalyst yielded an E/Z mixture of cyclic olefins (34a:342b = 
E:Z = 80:20) in 82% yield.23 (scheme 15) The diastereomers were separated by 
chromatography using an AgNO3–silica gel column. These conformed by according to 
the given literature .19  
        Finally the deprotection of acetonide group of compound 34a with 1N HCl in THF 
under reflux conditions for 6h gave target compound 1 in 85% yield as white solid.  
 
 
 
 
 
Scheme 15 
         
 
 
 
 
 
 
 
         
 
 
S.No. Ref. Optical rotation
1. Tetrahedron, 2000,pp 5337-5344 +28.0o
(c = 1.0 mg/ml, EtOH)
2. J.Am.Chem.Soc. 2002, 7061- 7069 +10.8
o
(c = 0.51, EtOH)
3 Tetrahedron Lett. 2002, 2819-2822 +18.0
o
(c = 0.10, EtOH)
4 Tetrahedron Lett. 2007, 7173-7176 +12.0
o
(c = 0.51, EtOH)
(we report)
Table 1: Comparision of optical rotation
O
O
O
O
O
O
OH
OH
1N HCl
THF, 50 oC
34a 1
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        The optical rotation were in good accordance previously reported19,20, with those of 
natural product isolated 1. Pleasingly, the IR, 1H NMR, 13C NMR and mass data of the 
synthetic herbarumin I 1 was in good accordance with those of the natural product. 
        In summary, we have developed a simple, convenient and efficient approach for 
the synthesis of herbarumin- I involving a sequence of reactions starting from (S)-2,3-
O-isopropylidene glyceraldehyde (37). This approach offers a high overall yield, useful 
stereoselectivity and readily available starting materials at low cost and involves simple 
experimental conditions, which makes it a useful and attractive process for the total 
synthesis of herbarumin-I (1) 
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Experimental section: 
5-(2,2-Dimethyl-(1,3)dioxolan-4-yl)-3,4-dihydroxy-5H-furan-2-one (39): 
 
 
 
 
        Procedure: To a stirred solution of 100gr L-ascorbic acid 38 in 500 ml of dry 
acetone and 5 ml of acetyl chloride at room temperature equipped with CaCl2 guard 
tube. The reaction mixture was stirr for 6h, then the round bottom flask was settled for 
12 at 0 oC (in freeze). The reaction mixture was filtered with buckner funnel and wash 
with 100ml of cold acetone. The product was white solid 39 in 94%(115.3gr) in yield. 
EIMS (relative intensity) m/z (%): 216 (M+, 5), 156 (55), 142 (5), 92 (100), 65 (10), 
43 (10). 
1H NMR (CDCl3, 300 MHz): δ 10.80-11.00 (br, s, 1H), 4.40-4.48 (m, 1H), 4.20-3.80 
(m, 3H), 3.00-3.40 (br, s, 1H), 1.20-1.35 (m, 6H).  
 
(2,2-Dimethyl-(1,3)dioxolan-4-yl)-hydroxy-acetic acid ethyl ester (41): 
 
 
 
 
O O
O
O
OH OH
OH
O
O
O
OEt
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        Procedure: To a stirred solution of 39 (90g, 416.6mmol) in 500ml water was 
added K2CO3 (114.4 g, 833.3mmol) at 0oC portions wise. To this added 2 equivalents of 
30%H2O2 in water at 0 oC over 3 h periods. Then the reaction mixture was allowed to 
room temperature and stir for 12 h. after completion of reaction water was removed by 
vaccum distillation and the mixture was extracted with hot ethanol. The reaction 
mixture was concentrated and the crude was go next reaction. The crude was taken in 
400 ml of acetonitrile and added 0.05% of TBAI. The reaction mixture reflux for 24h, 
after completion of reaction monitored by TLC, solvent was evaporated. The crude 
product was extracted with ethyl acetate; product was purified by column 
chromatographed on silica gel using ethyl acetate and hexane (2:8ratio). Product (41) 
was yellowish oil 72 %(61.2gr) in yield. 
EIMS (relative intensity) m/z (%): 204 (M+, 5), 189 (45), 131 (10), 101 (90), 73 (18) 
59 (46), 43 (100). 
1H NMR (CDCl3, 300 MHz): δ 4.38-4.25 (m, 2H), 4.10-3.95 (m, 3H), 3.92-3.89 (d, J = 
4.2 Hz 1H), 1.70-1.65 (br, s, -OH), 1.40-1.25 (m, 9H). 
 
1-(2,2-Dimethyl-(1,3)dioxolan-4-yl)-ethane-1,2-diol (42): 
 
 
 
 
        Procedure: To a stirred solution of ethyl ester (10.1g, 49.7 mmol) in 50ml of dry 
THF, was added LAH (2.8g, 74.55) by portion wise at 0 oC. The reaction mixture was 
OH
O
O
OH
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stirr for 6h. After completion of reaction quenched with saturated ammonium chloride 
solution at 0 oC. Then filtered, filtrate was concentrated. The crude product was 
partitioned between water and ethyl acetate. The organic layer was washed with brine, 
dried over anhydrous sodium sulphate and evaporated. The residue was chrmatographed 
on silica gel using ethyl acetate and hexane (4: 6 ratio) to afford the pure compound diol 
42 (7.4 g, 92%) as yellowish oil. 
1H NMR (CDCl3, 300 MHz): δ 4.12-3.90 (m, 2H), 3.85-3.60 (m, 2H), 3.60-3.45 (m, 
2H), 1.4. (s, 3H),  1.25 (s, 3H). 
 
2,2-Dimethyl-(1,3)dioxolan-4-carbaldehyde (37):  
 
 
 
        Procedure: To a stirred solution of diol 42 (5.0g, 30.8mmol) in 10ml of DCM, 
was added 1.0 ml of saturated sodium bicarbonate solution at 0 oC and then added 
sodium meta periodate (9.6g, 46.3mmol) portion wise over 15 min. The reaction 
mixture was stirred for 8 h at ambient temperature. After completion of reaction, the 
reaction mixture was filtered the product 37 (3.6g, 90%) was used for next step. 
1H NMR (CDCl3, 300 MHz): δ 9.70 (s, 1H), 4.35 (m, 1H), 4.10 (m, 2H), 1.45 (s, 3H), 
1.40 (s, 3H). 
 
 
 
O
O
CHO
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Synthesis of ( R )-1-(2,2-dimethyl-1,3-dioxolan-4-yl)but-3-en-1-ol (36a): 
 
 
 
 
        Procedure: to a mixture of activated zinc dust (5,5 g, 84.6 mmol) in 30 ml of 
freshly distilled THF under nitrogen atmosphere, was added a solution of (S)- 
glyceraldehyde 37 (5.5 g, 42.3 mmol) in 25 ml of THF via syringe at 0 oC followed by 
ally bromide (7.15 ml, 84.6 mmol) drop wise over 10 min. The reaction mixture was 
stirred for 4 h at 0 oC. After completion of reaction (monitored by TLC), the reaction 
mixture was quenched by slow addition of saturated ammonium chloride solution (17 
ml) (Caution: exothermic reaction) at 0 oC over 30 min. After being stirred for 1 h, the 
mixture was filtered and the filtrate concentrated under reduced pressure. The crude 
product was partitioned between water and ethyl acetate. The organic layer was washed 
with brine, dried over anhydrous sodium sulphate and evaporated. The residue was 
chrmatographed on silica gel using ethyl acetate and hexane (1: 9 ratio) to afford the 
pure compound 36a  (5.4 g, 74%) as yellowish oil. 
 [α]D25 = -5.40 (C = 0.5, MeOH). 
IR (neat): 3454 (br, OH), 2930, 1375, 1214, 1064 cm-1. 
EIMS (relative intensity) m/z: 172 (M+, 5%), 157 (5%), 101 (40%), 83 (5%), 69 
(10%), 59 (35%), 43 (100%). 
O
O
OH
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1H NMR (CDCl3, 300 MHz): δ 5.09 – 5.75 (m, 1H), 5.16-5.06 (m, 2H), 3.99-3.83 (m, 
3H), 3.73-3.66 (m, 1H), 2.35-2.31 (m, 2H), 1.93 (br, s, 1H, -OH), 1.39 (s, 3H), 1.32 (s, 
3H). 
13C NMR (CDCl3, 75 MHz): δ 133.9, 118.0, 108.9, 77.9, 70.3, 65.1, 37.5, 26.3, 25.1.  
 
1-(2,2-Dimethyl-(1,3)dioxolan-4-yl)-butan-1-ol (43): 
 
 
 
 
        Procedure: To a solution of homo allylic alcohol 36a (11g, 63.9mmol) in distilled 
ethanol (70ml) at room temperature was added 5% Pd/C under the hydrogen 
atmosphere and the reaction mixture was stirred at roomtempareture for 4h, after 
completion of reaction (monitored by TLC), the reaction mixture was filtered through 
filterpaper and the filtrate was concentrated under reduced pressure. The product was 
chrmatographed on silica gel using ethyl acetate and hexane (1: 9 ratio) to afford the 
pure compound 43 (11.12g, 100%) as a yellowish oil. 
[α]D25 = - 16.1 (C = 0.5 DCM). 
LCMS (relative intensity) m/z: 197.23 (M+Na)+ 
1H NMR (CDCl3, 300 MHz): δ 3.98-3.81 (m, 3H), 3.72-3.67 (m, 1H), 2.28 (br, s, 1H, 
-OH), 1.62-1.44 (m, 2H), 1.40-1.25 (m, 8H), 0.94 (t, 3H). 
 
 
O
O
OH
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4-(1-(Methoxy-benzyloxy)-butyl)-2,2-dimethyl-(1,3)dioxolane (35): 
 
 
 
 
        Procedure: To a solution of alcohol 43 (9g, 51.7mmol), in anhydrous THF (50 ml) 
at 0oC was added NaH (1.4g, 62.0mmol) and the mixture was stirred at 
roomtemparature for 30 min. The resulting solution was again cooled to 0oC followed 
by the addition of 4-mthoxy benzyl bromide (12.3g, 60.0mmol). Then the reaction 
mixture was allowed to room temperature, after being stirred for 3h at room 
temperature, the excess of NaH was destroyed by the addition of saturated ammonium 
chloride solution. The solvent was removed under vaccum and residue partitioned 
between water and ethyl acetate. The organic layer was washed with water and brine 
and dried over anhydrous sodium sulphate and concentrated in vacuo and the crude 
residue was subjected to silica gel column chromatography using (0.5:9.5 ratio) of ethyl 
acetate and hexane to afford the required compound 35 (12.9g, 85%) as yellowish 
syrup.   
LCMS (relative intensity) m/z: 317.1 (M+Na)+ 
1H NMR (CDCl3, 200 MHz): δ 7.22 (d, 2H J = 8.4 Hz), 6.83 (d, 2H J = 8.4 Hz), 4.54 
(d, 2H, J = 2.3 Hz), 4.05 - 3.93 (m, 2H), 3.90-3.82 (m, 1H), 3.79 (s, 3H), 3.53 –3.45 (m, 
1H), 1.55 –1.43 (m, 4H), 1.41 (s, 3H), 1.34 (s, 3H), 0.93 (t, 3H). 
 
 
O
O
OPMB
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3-(4-Methoxy-benzylozy)-hex-1,2-diol (44): 
 
 
 
        Procedure: To a solution of acetonide 35 (6g, 20.4mmol) in THF was added 
aq.1N HCl at 0oC. The solution was allowed to warm to room temperature, stirred for 
6h, and recooled to 0oC. Solid sodium carbonate was then added by portion wise to 
neutralize the reaction mixture. The solvent was removed in vacuo and the residue 
partitioned between water and ethyl acetate. The organic layer was washed with 
aqueous sodium bi carbonate solution and brine and dried over anhydrous Na2SO4. The 
filtration and concentration fallowed by flash chromatography using ethyl acetate and 
hexane (3:7 ratio) afforded the required product 44 (4.8g, 95%) as yellowish liquid.  
[α]D25 = - 4.21 (C = 1, CHCl3). 
IR (neat): νmax: 3424, 2956, 2929, 1613, 1513, 1461, 1248, 1082, 1035, 820 cm-1. 
LCMS (relative intensity) m/z: 272.1(M+Na)+ 
1H NMR (CDCl3, 200 MHz): δ 7.18 (d, 2H, J = 8.4 Hz), 6.79 (d, 2H, J = 8.4 Hz), 
4.55-33 (m, 2H), 3.75 (s, 3H), 3.62 –3.50 (m, 3H), 3.48 –3.34 (m, 1H), 3.22 –2.4 (br, d, 
2H, -OH), 1.61-1.24 (m, 4H), 0.94- 0.86 (m, 3H). 
13C NMR (CDCl3, 50 MHz): δ 159.2, 130.2, 129.6, 129.4, 113.8, 80.7, 79.2, 72.5, 
64.1, 56.0, 18.6, 14.3, 14.2. 
 
 
OPMB
OH
OH
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1-(1-(Bis-triethylsilanyloxy-mrthyl)-butoxymethyl)-4-methoxy-benzene (45): 
 
 
 
 
        Procedure: To a stirred solution of diol 44 (4.6g, 18.2mmol) and imidazole (7.4g, 
109.5mmol) in dry DCM was added tri ethyl silyl chloride (7.3ml, 45.5mmol) by drop 
wise at 0oC under nitrogen atmosphere. The reaction mixture was stirred for 6 h at 0 oC 
to room temperature. After completion of reaction, monitored by TLC, then filtered off, 
washed with DCM and concentrate the organic layer. The crude product was diluted 
with water and extracted with ethyl acetate; combined organic layer was washed with 
brine solution and dried over anhydrous Na2SO4. The filtration and concentration 
fallowed by column chromatography provided the required compound 45 (7.4g, 85%) 
as a colorless liquid. 
[α]D25 = -9.17 (C = 0.5, CHCl3). 
LCMS (relative intensity) m/z: 433.3 (M+Na)+ 
1H NMR (CDCl3, 200 MHz): δ 7.19 (d, 2H, J = 8.4 Hz), 6.79 (d, 2H, J = 8.4 Hz), 4.53 
(t, 1H, J = 11.3 Hz), 4.40 (t, 1H, J = 11.3 Hz), 3.78 (s, 3H), 3.77–3.72 (m, 1H), 3.62 –
3.49 (m, 2H), 3.41 –3.36 (m, 1H), 1.58-1.21 (m, 4H), 0.98- 0.85 (m, 21H), 0.63-0.54 
(m, 12H). 
13C NMR (CDCl3, 50 MHz): δ 158.2, 131.4, 129.4, 113.6, 80.2, 75.5, 72.0, 64.5, 32.6, 
19.2, 6.7, 5.0, 4.3. 
OPMB
OTES
TESO
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5-(4-methoxy-benzyloxy)-4-triethylsilanyloxy- non-1-en-3-ol (34a):  
 
 
 
        Procedure: To a –78 oC solution of oxalyl chloride (4.24 ml, 49.1 mmol) in 
CH2Cl2 (40 ml) was added dropwise DMSO (6.9 ml, 98.2 mmol). After 15 min stirring 
the di-TES ether 45 (4.5g, 11.1mmol) in CH2Cl2 (20 ml) was added. The stirring was 
continued at –78 oC for 20 min followed by 20 min at –40 oC. The reaction was 
quenched at –78 oC by the addition of Et3N (23.4 ml, 167.3 mmol). The mixture was 
allowed to reach room temperature, diluted with CH2Cl2 and washed with ice-cold 
water and brine, dried over anhydrous Na2SO4 and concentrating the crude aldehyde, It 
was without further purification used for next reaction. The aldehyde was adeded in dry 
THF at 0 oC to freshly prepared grignard reagent vinyl magnesium bromide. After being 
stirring for 4h completion of reaction indicated by TLC, reaction quenched with 
saturated aqueous ammonium chloride solution. The reactiom mixture was partitioned 
between water and ethyl acetate. The organic layer was concentrated and product was 
purified by flash column chromatography provided required compound 34a as 
yellowish compound (3.2g) 74%in yield.  
[α]D
25  =  +18.0 (c 1.0, CHCl3)  
IR (neat): νmax: 3292, 2956, 2871, 1612, 1515, 1251, 1086, 1036 cm-1.  
MS-ESIMS: m/z 417 (M+Na)+; HRMS calcd for C22H38O4NaSi, 417.2437; found, 
417.2447. 
OPMB
OTES
OH
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1H NMR (300 MHz, CDCl3):  δ 7.20 (d, J = 8.3 Hz, 2H), 6.80 (d, J = 9.0 Hz, 2H), 
6.00–5.90 (m, 1H), 5.30 (dt, J = 17.3, 1.5 Hz, 1H), 5.18 (dt, J = 10.5, 1.5 Hz, 1H), 4.45 
(dd, J = 17.3, 10.5 Hz, 2H), 4.24 (t, J = 6.0 Hz, 1H), 3.80 (s, 3H), 3.74 (t, J = 5.2 Hz, 
1H), 3.50–3.42 (m, 1H), 2.20–2.18 (br s, OH, 1H), 1.60–1.30 (m, 4H) 1.00–0.80 (m, 
12H), 0.70– 0.50 (m, 6H).  
13C NMR (75 MHz, CDCl3): δ 144.7, 142.3, 130.0, 128.7, 128.2, 127.5, 126.2, 122.5, 
119.0, 114.8, 75.8, 66.6, 57.4, 45.7, 24.4.  
 
5-(4-Methoxy-benzyloxy)-octa-1-ene-3,4-diol (47):  
 
 
 
        Procedure: To a solution of compound 34a (3.0g, 7.6mmol) in dry THF and 0.5 
ml of 1N HCl was added at 0 oC. The resulting mixture was stir for 3h at room 
temperature. The complete conversion of the starting material was conformed by TLC. 
Then the reaction mixture was recooled to 0 oC. Solid sodium carbonate was then added 
by portion wise to neutralize the reaction mixture. The solvent was removed in vacuo 
and the residue partitioned between water and ethyl acetate. The organic layer was 
washed with aqueous sodium bi carbonate solution and brine and dried over anhydrous 
Na2SO4. The filtration was concentration fallowed by flash chromatography using ethyl 
acetate and hexane (4:6 ratio) afforded the required product 47 (1.8g, 92%) as white 
solid.  
IR (neat): νmax: 3293, 2924, 2868, 1614, 1513, 1458, 1250, 1085, 1036 cm-1. 
OH OPMB
OH
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MS-ESIMS: m/z 303.1 (M+Na)+. 
1H NMR (300 MHz, CDCl3):  δ 7.20 (d, J = 8.3 Hz, 2H), 6.80 (d, J = 9.0 Hz, 2H), 
6.00–5.85 (m, 1H), 5.35 – 5.15 (m, 2H), 4.50 – 4.30 (q, 2H), 4.16 (t, J = 6.0 Hz, 1H), 
3.78 (s, 3H), 3.63 (t, J = 5.2 Hz, 1H), 3.51–3.43 (m, 1H), 2.45 (br s, OH, 1H), 2.20 (br s, 
OH, 1H), 1.70–1.55 (m, 2H) 1.51–1.32 (m, 2H), 0.90 (t, 3H).  
 
4-(1-(4-Methxy benzyloxy)-butyl)-2,2-dimethyl-5-vinyl-(1,3)dioxolane (48):  
 
 
 
        Procedure: Pyridenium p- tolyl sulphonate was added to a stirred solution of diol 
47 (1.40g, 5.0mmol) in 2,2-dimethoxypropane. The reaction mixture stirred for 6 h at 
room temperature. After completion of reaction mixture was concentrated under 
reduced pressure. The crude product was purified on silica gel column chromatography 
using a mixture of ethyl acetate and hexane (1 : 9 ratio) to afford 48 (1.5g) 95% in yield.  
IR (neat): νmax: 3292, 2956, 2871, 1612, 1515, 1251, 1086, 1036 cm-1. 
MS-ESIMS: m/z 343.2 (M+Na)+. 
1H NMR (300 MHz, CDCl3):  δ 7.16 (d, J = 8.3 Hz, 2H), 6.80 (d, J = 9.0 Hz, 2H), 5.81 
– 5.98 (m, 1H), 5.37-5.15 (m, 2H), 4.62 (t, J = 6.2, Hz, 1H), 4.44 (d, J = 10.9 Hz, 1H), 
4.25 (d, J = 10.4 Hz, 1H), 4.11 (dd, J = 8.6, 6.2 Hz, 1H), 3.79 (s, 3H), 3.50–3.42 (m, 
1H), 1.73–1.59 (m, 2H), 1.57–1.40 (m, 5H) 1.35 (s, 3H), 0.96(m, 3H). 
 
 
OPMB
O
O
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1-(2,2-Dimethyl-5-vinyl-(1,3)dioxolan-4-yl)butan-1-ol (32):  
 
 
 
 
        Procedure: To a solution of compound 48 (1.2g, 3.7mmol) in DCM – water (19: 1 
ratio) and DDQ (1.0g, 4.4mmol) was added at 0 oC. The resulting mixture was stir for 
30 min. at room temperature. The complete conversion of the starting material was 
conformed by TLC. Then the reaction mixture was retooled to 0 oC. After being stirred 
for 1 h, solid sodium bi carbonate was then added by portion wise to neutralize the 
reaction mixture. Then the mixture was filtered and the filtrate was partitioned between 
water and DCM. The organic layer was washed with brine, dried over anhydrous 
sodium sulphate and evaporated. The residue was chromatographed on silica gel using 
ethyl acetate and hexane (3: 7 ratio) to afford the pure compound 32 (0.69g, 92%) as 
yellowish oil. 
[α]D
25  =  +7.50 (c =1.2, CH2Cl2).  
IR (neat): νmax: 3460, 2930, 1642, 1372, 1252, 1062 cm-1. 
LC–MS: m/z (%): 223 ( (M+Na)+, 10), 200 (M+, 5). 
1H NMR (200 MHz, CDCl3): δ 6.00 (ddd, J = 17.0, 10.2, 7.2 Hz, 1H), 5.34 (dd, J = 
17.0, 10.2 Hz, 2H), 4.58 (t, J = 7.2 Hz, 1H), 3.90 (t, J = 7.2 Hz, 1H), 3.65–3.55 (m, 1H) 
1.65–1.55 (m, 2H), 1.50–1.30 (m, 8H), 0.95 (t, J = 7.2 Hz, 3H). 
13C NMR (50 MHz, CDCl3): d 135.0, 119.0, 108.5, 80.5, 79.0, 69.5, 35.9, 28.9, 25.3, 
18.9,14.0.  
OH
O
O
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Hexenoic acid 1-(2,2-dimethyl-5-vinyl-(1,3)dioxolan-4yl)-butyl ester (33): 
 
 
 
 
        Procedure: To a stirred solution of hexenoic acid 136mg (1.2mmol), in dry THF 
(5ml), Et3N (1 eq) was added, at room temperature and stirred for 0.5 h. 2,4,6-
trichlorobenzoylchloride 354 mg (1.5 mmol) in dry THF (2ml) was added and stirred 
for 5 h at room temperature. Solvent was evaporated and the residue diluted with tolune 
(15 ml) then alcohol 32 (200mg, 1mmol) was added in toluene (3ml) and treated with 
DMAP (3 eq) in toluene (10 ml) over the period of 1 h using syrige pump, The resulting 
reaction mixture was stirred for 18h, after completion of reaction, toluene was 
concentrated under reduced pressure, added ethyl acetate (20 ml) to crude residue then 
reaction mixture was quenched with sat, NH4Cl solution. The organic layer was 
separated and washed with water, brine, dried over Na2SO4 and concentrated under 
reduced pressure. The crude product was purified by columnchromatogrphy to afforded 
33 (251mg, 85%).  
[α]D
25  =  +12.5 (c =1.0, CHCl3).  
LC–MS: m/z (%): 319.2 (M+Na)+ 
1H NMR (200 MHz, CDCl3): δ 5.85-5.67 (m, 2H), 5.31-5.16 (m, 2H), 5.03-4.95 (m, 
2H), 4.89-4.83 (m, 1H), 4.54 (t, J = 6.7 Hz, 1H), 4.13-4.09 (m, 1H) 2.28-2.18 (m, 2H), 
2.12–2.03 (m, 2H), 1.73-1.60 (m, 2H), 1.46-1.25 (m, 10H), 0.91(t, J = 7.2 Hz, 3H). 
 
O
O O
O
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2,2-Dimethyl-4-propyl-3a,4,7,8,9,11a-hexahydro-1,3,5-tioxa-cyclopentacyclodecen-
6-one (34a & 34b): 
 
 
 
 
                                  E-isomer                               Z-isomer 
        Procedure: Diolefin 33 (163 mg, 0.4 mmol) was dissolved in dry degassed CH2Cl2 
(10 mL) and added dropwise within 1h to a refluxing solution of ruthenium catalyst Ru-
I (65 mg, 0.08 mmol) in dry, degassed CH2Cl2 (390 ml). The reaction mixture was 
heated at reflux until consumption of the starting material (4-6 h, TLC monitoring). 
Solvent removal in vacuo and column chromatography of the residue on silica gel 
(hexanes-EtOAc, 9:1) provided first E-34a (85 mg, 57%) and then Z-34b (26 mg, 
18%). When the same reaction was performed in the presence of ruthenium catalyst Ru-
II (reaction time, 12 h), lactone Z-34b was obtained as the sole stereoisomer in 72% 
yield as pale yellow oil.  
LC–MS: m/z (%): 291.3 (M+Na)+ 
Data for E-isomer:  
1H NMR (200 MHz, CDCl3): δ 5.61 (br, s, 2H), 4.87 (td, J = 9.8, 2.2 Hz, 1H), 4.71-
4.22 (m, 1H), 4.57 (d, J = 4.5 1H), 3.84 (dd, J = 10.5, 4.5 Hz, 1H), 2.37-2.20 (m, 4H) 
2.00-1.89 (m, 2H), 1.73-1.69 (m, 2H), 1.53 (s, 3H), 1.35-1.25 (m, 5H), 0.91(t, J = 7.2 
Hz, 3H). 
Data for Z-isomer: 
O
O
O
O
O
O
O
O
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1H NMR (200 MHz, CDCl3): δ 5.46 –5.31 (m, 2H), 4.94-4.89 (m, 1H), 4.68-4.61 (m, 
1H), 4.17 (dd, J = 9.8, 6.0 1H), 2.35-2.10(m, 4H) 1.98-1.76 (m, 3H), 1.73-1.56 (m, 1H), 
1.47 (s, 3H), 1.35 (s, 3H), 0.94(t, J = 7.2 Hz, 3H). 
 
Herbarumin I (1) :  
 
 
 
        Procedure: A solution of compound E-34a (50mg, 0.186 mmol) in THF (5ml) and 
1N aq. HCl (0.25ml) is stirred at 50 oC for 8h until TLC shows complete conversion. 
The reaction mixture is diluted with Et2O before it is neutralized with aq. NaOH. The 
organic layer is dried over Na2SO4 and evaporated and the residue is purified by flash 
chromatography.  
[α]D25 = +12.0 (c 0.5, EtOH).  
IR (neat): νmax: 3431, 2925, 2854, 1718, 1460, 1316, 1203, 1154, 1058 cm-1. 
LC–MS: m/z (%):  251 (M+Na)+;  
HRMS calcd for C12H20O4Na, 251.1259; found, 251.1269.  
1H NMR (300 MHz, CDCl3): δ 5.57 (d, J = 15.6 Hz, 1H), 5.50 (m, 1H), 4.87 (td, J = 
9.4, 2.4 Hz, 1H), 4.35 (br s, 1H), 3.41 (d, J = 9.4 Hz, 1H), 2.43 (br s, OH, 1H), 2.22–
2.33 (m, 2H), 2.07–1.80 (m, 3H), 1.48– 1.70 (m, 3H), 1.30–1.20 (m, 3H), 0.92 (t, J = 
7.3 Hz, 3H).   
13C NMR (75 MHz, CDCl3): 176.0, 130.6, 124.9, 73.7, 73.4, 70.2, 34.4, 33.7, 33.4, 
24.7, 18.0, 13.8. 
O
OH
OH
O
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Stereoselective synthesis of Leiocarpin A starting from commercially 
available D-mannitol: 
Introduction 
        The family Annonaceae has been reviewed from the point of view of the frequent 
presence of isoquinoline alkaloids, and more recently on the basis of the restrictive 
existence of a very active class of natural products, the acetogenins, which are 
inhibitors of the mitochondrial respiratory chain complex I.1 However, this family also 
produces a wide range of compounds belonging to various phytochemical groups: for 
example, terpenoid compounds co-occur with isoquinoline alkaloids in some genera, 
while a group of secondary metabolites commonly named styryllactones have been 
reported mainly within the genus Goniothalamus. More than twenty number of 
bioactive styryl-lactones, with six different basic skeletons, have been isolated from 
Goniothalamus species.  The first styryl-lactone, the styryl-pyrone goniothalamin 1, 
found within the family Annonaceae was isolated from several species of 
Goniothalamus.2         
 In this chapter various methods for the synthesis of Leiocarpin-A and related styryl 
lactones are reviewed in the past work and several facial approaches for the synthesis of 
Leiocarpin-A was presented in this chapter. 
CLASSIFICATION OF STYRYL-LACTONES 
Styryl-pyrones 
        The first member of this class, goniothalamin, has been isolated from barks, roots 
and the whole plant material of G. andersonii, G. fulvus, G. giganteus, G. macrophyllus, 
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G. malayanus, G. scortechinii, G. sesquipedalis, G. tapis, G. uvaroides and G. amuyon, 
G. arvensis.5 This compound can be considered as a biogenetic precursor of the other 
groups of styryl-lactones. Because of the number of identified compounds and of the 
species that contain them, styrylpyrones represent to date the most important group of 
styryl-lactones. The most significant structural differences occur in the degree of 
oxidation of their aliphatic chain and in the saturation of the pyrone moiety. These 
characteristics permit the group to be classified under four types: 
 1)    7,8-olefinic styrylpyrones (C7=C8) or goniothalamin type; 
 2)    7,8-epoxidic styrylpyrones or goniothalamin oxide type; 
3)     7, 8- dioxygenated styrylpyrones or goniodiol type; and  
4)     Saturated styryl-pyrones or garvensintriol type.. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                      Chapter II, Section A  
 64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Structure & Name Plantname
1
O
O
(+) Goniothalamin
O
O
O
O
O
OH
OH
 Goniothalamin oxide
7-epi-goniodiol
2
3
O
O
OH
OH
O
O
OAc
OH
(+) Goniodiol
7-Acetyl-goniodiol
4
5
Goniothalamus andersonii
Goniothalamus macrophyllus
and Goniothalamus sesquipedalis
Goniothalamus leiocarpus
Goniothalamus giganteus and
Gonithalamus sequipedalis 
Goniothalamus amuyon
Table 1: Various styryl pyrones and its isolated plants
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Furano pyrones  
        The first such compound of this group was initially identified from Polyalthi,4 and 
named altholactone. Eight years later it was also isolated from the bark of Goniothalamus 
S.No Structure & Name Plantname
6
O
O
OH OH
OH
O
O
OH
OH
OH
 Goniotriol (7)
7
8
O
O
OH
OH
6-epi- Goniodiol
9
Goniothalamus Arvensis
Table 1 continued.......
O
O
OAc
OAc
Goniodiol diacetate (6)
Goniothalamus amuyon
Goniothalamus amuyon
Garvensintriol (8)
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giganteus,5a and reported under the different trivial name of goniothalenol. Altholactone 
10 and all furanopyrones are biogenetically related to styryl-pyrones. 
        The furano-pyrone skeleton represents the second most abundant class of styryl-
lactones in Goniothalamus. A number of these compounds, including the main 
styryllactone of the genus, are characterized by the presence of an α, β-unsaturated δ-
lactone moiety (type 5: altholactone type). However, there are three different 
stereochemistries based on the relative configurations at the 2 and the 3 positions. The 
configuration of the C-3 chiral centre was initially established from coupling constant 
values in the 1H-NMR and demonstrated by crystallographic analysis. 
 
 
 
 
 
 
 
 
Figure 2 
Furano-furones 
        Only two styryl-lactones with this skeleton have been described. Both were 
isolated from the stem bark of Goniothalamus giganteus,6 and they differ only with 
respect to their stereochemistry at C-8. Because highly oxygenated lactones may have 
significant potential as anti-tumour agents, these compounds have been the subject of 
O
O O
OH
O
O O
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O O
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O
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numerous enantioselective syntheses from carbohydrates. The absolute configuration of 
natural goniofuranone 15 was confirmed on the basis of an unambiguous synthesis of 
its enantiomer from D-glycero- D-gulo-heptono-g-lactone.7 Later it was reported that  
 
 
 
 
 
 
Figure 3: 
the absolute configurations of goniofuranone 15, and 8-Epi-goniofuranone 16 coincide 
with those of their suggested biogenetic precursors,8 and analogues of goniofufurone 
have been synthesized from D-glucose as the starting material. 
Pyrano-pyrones 
        Among the styryl-lactones isolated from G. giganteus, goniopypyrone stands out 
as exhibiting very high, non-selective activity against human tumour cell lines. This 
compound, together with 2,5-deoxygoniopypyrone 18 and leiocarpin-A 19, are 
examples of pyrano-pyrone styryllactones. The structure and relative configuration of 
goniopypyrone 17 were initially suggested by comparison of the 1H-NMR spectral data 
with that of altholactone 10, and were confirmed by X-ray crystallographic data which 
also indicated the existence of an intramolecular hydrogen bond between 5-OH and 7-
OH.  
 
O
OH
H
H
OH
Ph
H
OO
(+)-Goniofufurone
O
OH
H
H
OH
Ph
H
OO
8-Epi-goniofufurone
15 16
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Figure 4: 
Butenolides 
        The two known butenolide compounds, Goniobutanolide-A 20, and 
Goniobutanolide-B 21, were originally isolated from G. giganteus, but recently both 
metabolites have been obtained from the bark of G. borneensis.9 The structural 
elucidation was supported by comparison of the NMR spectral data with those of 
acetylmelodorinol, a closely related compound previously identified from Melodorum 
fruticosum bark (Annonaceae) the structure of which was proven by X-ray 
crystallography.10  
 
 
 
 
Figure 5: 
 
BIOACTIVITY OF STYRYL-LACTONES: 
        The styryl-lactones make up an interesting group from the pharmacological point 
of view. Styryl-lactones, despite their restricted occurrence in the plant kingdom, are 
Goniopypyrone 2,5-Deoxygoniopypyrone Leiocarpin-A
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reported to possess cytotoxic, anti-tumour, pesticidal, teratogenic and embryotoxic 
activities.14 Significant anti-tumour and cytotoxic activities associated with styryl-
lactones of Goniothalamus have promoted a detailed chemical investigation of the 
different styryl-lactones. Goniothalamin 1, the first styryl-lactone isolated, showed 
strong embryotoxicity, teratogenicity and toxicity in both the brine shrimp lethality 
assay and human epidermoid carcinoma of the nasopharynx (9-KB) cell line assays. 
The cytotoxic effect of Goniothalamin was evaluated on different cell lines, both 
cancerous (Hela, human cervical carcinoma; PANC-1, pancreas carcinoma; HGC-27, 
gastric carcinoma; and MCF-7, breast carcinoma) and non-cancerous (3T3, mouse 
fibroblast), reflecting a non-selective mode of action. Nevertheless, the cytotoxicity 
appears to be more effective on dividing cells.15 
        The styryl-pyrone 7-acetyl-goniodiol 5 was demonstrated to have significant anti-
tumour activity in the murine lymphocytic leukaemia (P-388) in vivo system as well as 
cytotoxicity against a cell culture 9-KB.16 Goniodiol 4 was found to be a selective 
cytotoxic agent against several human tumour cell lines, particularly human lung 
carcinoma A-549.16a 
        It is noteworthy that goniofufurone 15 showed significant cytotoxic activities 
against several human tumour cell lines, while 8-epi-goniofufurone 16 proved to be less 
active.17 With respect to the pyrano-pyrone group, goniopypyrone 17 is one of the most 
active styryl-lactones of the Goniothalamus genus with similar cytotoxic activity 
(DE50 of ca. 0.67 mg/mL) against human breast carcinoma (MCF-7), human lung 
carcinoma (A-549) and human colon adenocarcinoma (HT-29).  
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        The bioactivities of the styryllactones of Goniothalamus lead us to ask whether the 
cytotoxicity towards different human carcinoma cell-lines could be explained, as for 
Annonaceous acetogenins, by an action on the mitochondrial respiratory chain.  
Previous synthetic approaches of Liocarpin A and structures related 
to Leiocarpin A: 
Guo-Qiang Lin approach for the synthesis of Leiocarpin-A: 18 
        Guo-Qiang Lin and coworkers synthesis starts from Sharpless epoxidation of 
cinnamyl alcohol 22 followed by swern oxidation of the resulting epoxy alcohol 23, 
followed by Wittig methylenation provided the vinyl epoxide 24. As shown in previous 
report that the palladium-catalyzed cross-coupling of allylic cyclic carbonate 25 with 
vinyltributylstannane  afforded the diene 27. Asymmetric epoxidation of compound 28  
 
 
 
 
 
 
 
 
 
Scheme 1 
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by using m-CPBA threo epoxide was major, where as the erythro epoxide 29 became 
the main product when using TBHP/VO(acac)2. Epoxide 29 was lactonized by 
treatment of 30% HClO4 in methanol to give 6-epi-goniodiol 9 in 71% yield which was 
treated with DBU afforded leiocarpin A 19 (scheme 1). 
Motoo Tori  approach for the synthesis of 6-epi-goniodiol:19 
        Mooto group reports (+)-Goniodiol, a potent and selective cytotoxic, and (-)-6-epi-
goniodiol as well as their enantiomers, have been synthesized starting from cinnamyl 
alcohol 22, the key steps of the synthesis were Sharpless asymmetric epoxidation of 
cinnamyl alcohol fallowed by TBDPS protection of primary alcohol and then ring  
 
 
 
 
 
 
 
 
 
 
Scheme 2 
opening of epoxide from benzylic position provided diol 30. Which was protected with 
diacetonide and the deprotection of TBDPS in the presence of TBAF gave primary 
alcohol 31.  The alcohol on oxidation with Dress-Martin periodinone fallowed by 
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allylation with allylmagnesium bromide provided mixture of diastereomers 32a, and 
32b, A mixture of alcohols was treated with acryloyl chloride to give acrylates 33a, 
373b respectively. After separation with column chromatography, required acrylate was 
ring closed using Grubs first generation catalyst and fallowed by deprotection of 
acetonide group provided (-)-6-epi-goniodiol 9 (scheme 2).  
Jean-Michel Vate1e  approach for the synthesis of 9-deoxygoniopypyrone: 20 
    Jean-Michel Vate1e et al reported 9-deoxygoniopypyrone from (R)-Mandalic acid. 
The compound ester 35 was prepared by known steps, which was diastereoselective 
catalytic asymmetric cis hydroxylation with AD-mix gave diol. After diacetonide 
protection of diol. Ester 36 was reduced to alcohol 37, which was transformed to 
Triflate 38, the coupling reaction between Triflate and sulfone provided product 39.  
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Then treatment of sulfone ester by TFA led to lactone 40. Which by explore to an 
excess of DBU furnished 2,5-deoxygoniopypyrone 18.   
Steven V. Ley  approach for the synthesis of goniodiol: 21 
        This group report a new synthesis of goniodiol by using commercially available S-
(2)-glycidol 41, which of primary alcohol protected with TBDPS fallowed by 
subsequent opening of epoxide by the addition of but-3-enylmagnesium bromide 
fallowed by reductive ozonolysis of this material afforded lactol 42. Alkylation of lactol  
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with a-bromo-N-methyl-N-methoxyacetamide in the presence of KHMDS afforded cis 
anomerically-linked amide. Subsequent treatment with phenylmagnesium bromide led 
directly to the phenyl ketone 43. Treatment of this ketone Et3N fallowed by 
trimethylsilyl triflate afforded trans hydroxy ketone 44, 45. The required ketone was 
diastereoselective reduction of using sodium borohydride fallowed by diacetonide 
protection of diol afforded 46 and deprotection of primary hydroxyl group with TBAF 
fallowed by oxidation under swern oxidation conditions then converted to lactone 48 
23,24.  Introduction of the α, β -unsaturation was achieved via a-selenation followed by 
oxidative elimination with 30%H2O2 fallowed by acetonide deprotection gave the 
natural product goniodiol 4 (scheme 4).   
Prasad approach for the synthesis of 9- deoxygoniopypyrone:24 
        Prasad group reported a stereoselective syntheses of the bio-active styryllactones 
goniodiol and 9- deoxygoniopypyrone from D-(-)-tartaric acid.  Tartaric acid derived di 
amide treated with phenyl magnesium bromide followed by sodium K-selekride gave 
benzylic alcohol 50, then protected with TBSCl , imidazole in DCM followed by 
Buterylmagnesium bromide afforded keto compound 52, which was  reduced with 
NaBH4 to provide alcohol 53, which on subsequent reaction formed xanthate 54 and it 
was deoxyzenated  by using  Bu3SnH afforded 55. Then deprotection of TBS and 
diacetonide gave triol 57, the desired lactone was formed in a two step sequence i.e by 
the treatment of alkene under ozonylysis conditions formed lactol which was oxidized 
with Ag2CO3 afforded deoxygoniopypyrone was γ-Hydroxybutyramide 5025 derived 
from the dimethylamide 49. Which was protected with TBSCl fallowed by the 
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treatment with 4-butynylmagnesiumbromide 51 gave keto compound 52. The keto 
compound was lactone 58, the diol protected with MOMCl then treatment of lactone in 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5 
the presence of LHMDS, phenyl selenyl bromide then 30%H2O2 provided α, β –
unsaturated lactone 60, deprotection of MOM with FeCl3.6H2O  and the treatment of 
this goniodiol 61 with DBU gave 9-deoxygonioypyranone 18 (Sheme 5).  
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Miyoji Hanaoka approach for the synthesis of 9- deoxygoniopypyrone: 26 
        Miyoji Hanaoka group has reported from compound 6227 which was used as an 
intermediate to the synthesis of 9-Deoxygoniopypyrone. Pentinolide 65 was achieved 
under acidic or basic conditions for butinolide 62. and then free hydroxyl group of 65 
was acylated fallowed by reduction with Zn-Hg, sat. HCl in ether furnish 
dehydroxylated product 67. The double bond Isomerization of the γ,β unsaturated 
lactone structure of to the corresponding α,β one was easily achieved by DBU treatment  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6 
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at room temperature. After conversion of α, β lactone 68 then TBS was removed by 
TBAF provided 69, the required hydroxyl group was inverted under mitsunobu 
conditions gave 70, which was further transforms to provided 9-deoxygoniopypyrone 
18 (Scheme 6). 
 
Present work: 
Isolation and biological activity of Leiocarpin A: 
        Leiocarin A 19 was isolated from the ethonolic extraction of stem bark from the 
seeds of Goniothalamus leiocarpus (Annonaceae family). Chaoming Li 28 group 
isolated four new styryllactone, named leiocarpin A (19), 7- epi goniodiol (3), 
leiocarpin B (71), leiocarpin C (72). Their structures were elucidating by mean of 
spectral. The relative configuration of 19, 3 and 22 were determined by X-ray 
crystallographic analysis.  
 
 
 
 
 
Figure 6 
The leiocarpin A (19) was isolated as crystal, mp 132-134 oC, [α] D24 -98.4 oC (c = 0.60 
in CHCl3). In IR spectrum indicated in the presence of 1720 cm-1 and hydroxyl (3360 
cm-1) group. 1H and 13C NMR spectra 29 showed that 19 had a phenyl (δ 7.25-7.43 ppm,  
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5H, m), four oxymethines (δ 65.6, 72.2, 73.9 and 76.3 ppm) and two methelenes (δ 
29.5, 36.5 ppm). These spectral data suggest 19 were a styrylactone. The 
 same molecular formula C13H14O4 as 9-deoxygoniopypyrone (18) was given by 
measurements of EIMS at m/z 234 and HREIMS at 234.0890 (calcd 234.0892). Which 
was same as that 18 by analysis the 1H, 13C, COLOC and MS spectra of 18. The spectra 
of 1H-1H COSY, 1H-13C COSY supported the structure. However, the obvious 
distinction in [α]D values (-98o for 19 and +12o for 18).                                                                                                                                                  
        The compounds 71 and 72 were showed selective activities in the test of trypan 
blue dye exclusion method. Under different concentration of 100, 10, 1, 0.1, 0.01 µg/ml, 
the inhibition against HL-60 cells of compound 71 were 100, 100, 55, 20, and 45. IC50 
aginest Bel 7404 (heptocarcinoma), Bcap32 (Brest Cancer) Hela of were 0.79>100, 30 
µg/ml against HL-60, K-562, U937 (Lukamia).    
        A retro synthetic analysis for leiocarpin A is pictorially presented in scheme                            
1. the foremost disconnection involved the application of  ring-deformation transform 
on pyran ring to provide 6-epi goniodiol (A). This synthetic direction constitute of the 
6-epi goniodiol. The construction of pyrone ring is acroylylation followed by ring 
closing metathesis which from alcohol (B). The synthesis of benzylic alcohol (B) build 
up from protected homo allylic alcohol (C) including diastereoselective phenylation 
reactions. Homo allylic alcohol from (R)-2,3-O-isopropylidineglyceraldehyde (D) 
which was from commercially available D-mannitol (73).     
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Scheme 7 
        In direct reciprocation of retrosynthetic analysis, we commanced our synthesis 
from D-mannitol 73. The cheap and commercially easy availability high enantiomeric 
purity and equivalence of double unit of C3-chiral building block because of C2 
symmetry were the strong incentives to start from D-mannitol. The foremost step was 
the conversion of D-mannitol into 1,2:5,6-di-O-isopropylidine-D-mannitol 74 using 2,2-
dimethoxy propane and cat. PTSA in dry DMSO for 8h as shown in scheme. The 
treatment of diacetonide D-mannitol 74 with NaIO4, and sat. NaHCO3 in DCM at 0 oC  
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 for 8h afforded the (R)-2,3-O-isopropylidineglyceraldehyde 75 in quantitative yield.29 
In the 1H NMR spectrum of 75 the characteristic aldehyde proton resonated at δ 9.65 
ppm and two methyl protons appeared as two signals at δ 1.40 and 1.45 ppm. 
 
 
 
 
Scheme 9 
        The next endeavor was the stereoselective allyl addition to the aldehyde 75. 
Accordingly, the compound 75 was treated with allyl bromide, in presence of activated 
zinc dust and saturated NH4Cl for 4h, which gave the mixture of diastereomers 76a and 
76b in the ratio of the 95:5 (anti : syn) (scheme). The diastereomers were separated by 
column chromatography and the required isomer was obtained in 74% yield. The 
reaction was called as barbier type reaction; this stereoselective barbier reaction 
installed the single chiral center of the target compound with appropriate 
stereochemistry. In the proton NMR, appearance of allylic protons peaks at δ 5.89 –5.75 
for olefinic one proton and another multiplet at δ 5.16 – 5.06 for two protons, attributed 
inylic group. The alcohol of 76a protected using 4-methoxy benzyl bromide and NaH  
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in dry THF at 0 oC to room temperature for 4h afforded 77 in 85% yield (Scheme). The 
newly introduced protons corresponding to pmb group in 1H NMR of 77 resonated at δ 
3.70 as singlet for methoxy group, δ 4.54 as doublet for benzylic protons and two 
doublets at δ 7.25 andδ 6.88 for aromatic protons. while rest of the protons appeared at 
the expected chemical shifts, thus conforming the product.  
        Acetonide deprotection in compound 77 on reaction with 1N HCl in THF at room 
temperature for 6h (scheme) afforded diol 78 in 95% yield. In the 1H NMR of the diol 
expected disappearance of isopropylide protection was observed. 
        The diol compound 78 was silylated using TESCl in the presence of immidazole in 
DCM at 0 oC to room temperature for 3h provided di TES compound 79 in 85% yield.  
 
 
 
 
Scheme 11 
        The newly introduced protons corresponding to TES group in 1H NMR of 79 
resonated at δ 1.01 – 0.89 as multiplet and as δ 0.67 – 0.57 multiplet, and also ESIMS 
of 79 (M++Na) peak was observed at 503.3 giving further conformation of the 
product.Selective oxidation of terminal TES protected alcohol under swern conditions30 
furnished aldehyde 80 which was without further purification subsequent phenylation, 
with phenyl magnesium bromide in THF at 0 oC to roomtemperature afforded to the  
corresponding benzylic alcohols as mixture of 81a and 81b anti: syn ( 9: 1 ) in 76%  
OPMB
OH
OH
OPMB
TESO
OTES
OPMB
OHC
OTES
TESCl, immidazole
DCM, rt
Oxalyl Chloride, dry DMSO
Et3N, -78 oC
78 79 80
 
                                                                                                      Chapter II, Section A  
 82 
 
 
 
 
Scheme 12 
overall yield for two steps. These diastereomers were separated by column 
chromatography. The major diastereoisomer 81a had the required stereochemistry at C-
3, which was conformed by 1H NMR. The 1H NMR of 81a characteristic benzylic   
 
 
 
 
Scheme 13 
proton resonated at δ 4.64 (J= 8.0 Hz) as doublet, and olefinic protons at δ 5.89-5.72 
(m, 1H), 5.12-4.94 (m, 2H), thus, conformed the product. Further LC-MS spectrum 
shows (M++23 ) peak at 465.3. 
        The benzylic alcohol was protected with TESCl in the presence of immdazole, in 
DCM at 0 oC, for 3h gave compound 82, conformation its LC-MS spectum shows 
(M++23 )  peak at 579.3, which on oxidative deprotection of PMB group gave alcohol, 
proton NMR of compound 83 where the disappearance of characteristic benzylic and O-
Me proton was conformed the product. LC-MS spectrum has shows  (M++23) peak at 
439.2 for further conformation of no 83. 
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Scheme 14 
        The alcohol was acryloylated with acryloyl chloride in presence of Et3N, DCM 
gave compound 84 the characteristic newly introduced olefinic protons observed at δ 
6.40 (d, J= 15.1, 1H), 6.12-6.02 (m, 1H), 5.47- 5.42 (m, 1H). Which on treatment with 
(20 mol%) Grubbs first generation catalyst under reflux for 8 in dry DCM gave 
protected 6-epigoniodiol 85, the characteristic α, β-unsaturated olefinic protons 
observed in the 1H NMR spectrum δ 6.91-6.84 as multiplet and δ 5.94 (dd, J=9.8, 2.2 
Hz, 1H) gave the conformation of product 85.  
 
 
 
 
Scheme 15 
 
        Finally deprotection of TES groups of 85 in the presence of TBAF in THF, first 
deprotection TES group fallowed by cyclization by oxa micheal addition reaction 
insitively gave the target liocarpin A all the date were matched with naturally isolated 
liocarpin A (19).28 
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Conclusion:  
        we have described a simple, convenient and efficient approach for the Leiocarpin 
A 19 involving a sequence of reactions starting from (R)-2,3-O-isopropylidine 
glyceraldehyde. This approach offers high stereoselectivity and readily available 
starting material at low cost and simple experimental conditions, which makes it a 
useful and attractive process for the total synthesis of Leiocarpin A 19. 
 
 
 
 
 
 
 
 
 
S.No Group/ref Reported optical rotation 
1 Guo-Qiang Lin (isolation)
(Heterocycle 1999, pp2969)
2 Guo-Qiang Lin (synthetic)
(Tetrahedron letters 2004, 8111)
3 Our group
- 98.41 ( c = 0.6 CHCl3)
- 97.6 ( c = 0.5 CHCl3)
- 94.9 ( c = 0.4 CHCl3)
Table : Comparision of optical rotations:
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Experimental section: 
Synthesis of mannitol diacetonide (74): 
 
 
 
 
Procedure: To a mixture of D-mannitol 73 (10.0 g, 54.94 mmol) and PTSA catalylitic 
amount (5 mg) in dry DMSO (15 ml), was added 2,2-dimethoxypropane (14.2 ml) at 0 
oC under nitrogen atmosphere. The resulting reaction mixture was gradually warmed to 
ambient temperature and stirr for 8 h. the complete conversion of the starting material 
was conformed by TLC. Then the reaction mixture was partitioned water and ethyl 
acetate. The combined organic layer was washed with brine, dried over anhydrous 
Na2SO4 and concentrated under reduced pressure to obtain the crude product which was 
purified by column chromatography on elution with a mixture of ethyl acetate and 
hexane (4 : 6 ratio) to obtain the pure product 74 (7.9 g, 55%) as a white solid.  
IR ( neat ): 3330, 2987, 2935, 1372, 1214, 1068 cm-1 
EIMS ( relative intensity ) m/z: 248 (M+-14), 190 (3%), 102 (45%), 73 (15%), 59 
(43%), 43 (100). 
1H NMR ( CDCl3, 300 MHz): δ 4.10 (m, 4H), 3,94 (q, 2H), 3.68 (t, 2H, J = 4.8 Hz), 
2.71 (br, 2H, -OH), 1.40 (s, 6H), 1.34 (s, 6H). 
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Synthesis of ( R )-2,3-O-Isopropylideneglyceraldehyde (75): 
 
 
 
Procedure: To a stirred solution of D-mannitol diacetonide 74 (7.0 g, 2.0 mmol) in 
DCM, was added 3.0 ml of saturated sodium bicarbonate solution at 0 oC and then 
added sodium metaperiodate (11.7 g, 54.6 mmol) portion wise over 15 min. the reaction 
mixture was stirred for 8 h at ambient temperature. After completion of reaction, the 
reaction mixture was filtered and concentrated under reduced pressure to afford the 
crude product 75 ( 6.95 g, 99%). 
1H NMR ( CDCl3, 300 MHz): δ 9.70 (s, 1H), 4.35 (m, 1H), 4.10 (m, 2H), 1.45 (s, 3H), 
1.40 (s, 3H). 
1-(2,2-Dimethyl-[1,3]dioxolan-4-yl)-but-3-en-1-ol (76a):  
 
 
 
 
Procedure: To a mixture of activated zinc dust in (5.5g, 84.6mmol) 30ml of dry THF 
under nitrogen atmosphere, was added a solution of (R)-glyceraldehyde 75 (5.5g, 
42.3mmol) in 25ml THF at 0oC followed by allyl bromide (7.15ml, 84.6mmol) drop 
wise over 10min. The reaction mixture was stirred for 4h at 0oC. After completion of 
the reaction (monitored by TLC), the reaction mixture was quenched by addition of 
saturated aqueous ammonium chloride solution (17ml) at 0oC over 30min. After being 
O
O
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stirred for 1h, the reaction mixture was filtered and the filtrate was concentrated under 
vacuum. The crude product was partitioned between water and ethyl acetate. The 
organic layer was washed with brine, dried over anhydrous Na2SO4 and evaporated. The 
residue was further purified by column chromatography to afford the pure compound 
76a (8.3g, 92%) as yellowish oil.   
[α]D
25
 = + 5.58 (c = 0.5, MeOH);  
IR (neat): max: 3454 (br, OH), 2986, 1375, 1214, 1064 cm–1;  
1H NMR (200 MHz, CDCl3):  5.90-5.70 (m, 1H), 5.20-5.00 (m, 2H), 4.00-3.90 (m, 
3H), 3.75-3.65 (m, 1H), 2.40-2.20 (m, 2H), 1.40-1.30 (d, 6H);  
13C NMR (50 MHz, CDCl3): 134, 118, 109, 88, 71, 65, 38, 27, 25; EIMS: m/z (%): 172 
(M+, 5), 157 (10), 141 (13), 101 (70), 59 (35), 43 (100).  
 
3-(4-Methoxy-benzyloxy)-hex-5-ene-1,2-diol (78):  
 
 
 
 
Procedure: To a solution of acetonide 77 (6g, 20.5mmol) in THF was added 1N HCl at 
0oC. The solution was allowed to warm to room temperature, stirred for 6h, and 
recooled to 0oC. Solid sodium carbonate was then added by portion wise to neutralize 
the reaction mixture. The solvent was removed in vacuo and the residue partitioned 
between water and ethyl acetate. The organic layer was washed with aqueous sodium bi 
carbonate solution and brine and dried over anhydrous Na2SO4. The filtration and 
OH
OH
OPMB
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concentration fallowed by flash chromatography using ethyl acetate and hexane (3:7 
ratio) afforded the required product 78 (4.9g, 95%) as yellowish liquid Pale yellow oil.  
[α]D
25= + 8.20 (CHCl3);  
IR (neat): νmax: 3410, 2931, 1612, 1513, 1462, 1301, 1248, 1078, 1034, 821cm-1;  
1H NMR (200 MHz, CDCl3): δ 7.18 (d, J = 8.3 Hz, 2H), 6.81 (d, J = 8.3 Hz, 2H), 5.90-
5.76 (m, 1H), 5.14-5.05 (m, 2H), 4.58-3.35 (m, 2H), 3.77 (s, 3H), 3.65-3.41 (m, 4H), 
2.69 (br, s, 2H, -OH), 2.39-2.27 (m, 2H). 
LC-MS: m/z (%): 275.1 (M+Na)+(100%) 
 
1-(1-(1,2-Bis-triethylsilanyloxy-ethyl)-but-3-enyloxymethyl)-4-methoxy-benzene 
(79):  
 
 
 
Procedure: To a stirred solution of diol 78 (4.6g, 18.2mmol) and immidazole (7.4g, 
109.5mmol) in dry DCM was added tri ethyl silyl chloride (7.3ml, 45.5mmol) by drop 
wise at 0oC under nitrogen atmosphere. The reaction mixture was stirred for 6 h at 0 oC 
to room temperature. After completion of reaction, monitored by TLC, then filtered off, 
washed with DCM and concentrate the organic layer. The crude product was diluted 
with water and extracted with ethyl acetate; combined organic layer was washed with 
brine solution and dried over anhydrous Na2SO4. The filtration and concentration 
fallowed by column chromatography provided the required compound 79 (7.6g, 88%) 
as a colorless liquid.  
TESO
OTES
OPMB
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[α]D
2 = - 6.08 (c = 0.5, CHCl3).  
IR (neat): νmax: 2954, 2878, 1613, 1513, 1461, 1246, 1087, 1009, 739cm-1. 
1H NMR (300 MHz, CDCl3): δ 7.18 (d, J = 8.3 Hz, 2H), 6.78 (d, J = 8.3 Hz, 2H), 5.89-
5.76 (m, 1H), 5.08-4.98 (m, 2H), 4.46 (q, J = 17.3, 11.3 Hz 2H), 3.77 (s, 3H), 3.75-3.72 
(m, 1H), 3.64-3.59 (m, 1H), 3.52-3.37 (m, 2H),  2.34-2.24 (m, 2H), 0.97-0.92 (m, 18H), 
0.63-0.54 (m, 12H).   
LC-MS:m/z (%): 503.3 (M+Na)+(100%) 
 
3-(4-methoxy-benzyloxy)-1-pheny-4-triethylsilanyloxy-hex-5-en-1-ol (81a): 
 
 
 
Procedure: A solution of oxalyl chloride (2.5 ml, 29.2 mmol) in 10ml DCM was added 
drop wise to dimethyl sulfoxide  (4.1ml, 58.3mmol) in 20ml DCM at –78 oC. After 15 
min, compound 79 (3.5g, 7.2 mmol) in 10ml DCM was added and stirring were 
continued for 40 min at –78 oC followed by 20 min –40 oC. Tri ethylamine (12.0ml, 
88.0 mmol) was added at –78 oC and the reaction was allowed to reach rt. The mixture 
was diluted with water, extracted with DCM and the organic layer was separated, 
washed with brine and dried over anhydrous sodium sulphate. This crude aldehyde was 
added to phenyl magnesium bromide in THF at 0 oC. After stirring of 3h at 0 oC to 
room temaparature, completion of reaction (monitored by TLC) quenched with 
saturated NH4Cl solution at 0 oC, then the reaction mixture was concentrated. The crude 
product was extracted with ether, the organic layer was washed with water, brine and 
OPMBOH
OTES
 
                                                                                                      Chapter II, Section A  
 90 
dried over anhydrous Na2SO4. The filtration and concentrated followed by column 
chromatography provided pure compound 81a 76% (2.6g) in over all yield. Pale yellow 
oil.  
[α]D
25
 = - 9.10 (c = 0.4, CHCl3);  
IR (neat): max: 3452, 2924, 2877, 1708, 1639, 1613, 1513, 1459, 1246, 1085, 1040, 
738, 701 cm-1. 
 1H NMR (300 MHz, CDCl3):  7.37-7.18 (m, 5H), 7.12 (d, J = 8.30 Hz, 2H), 6.77 (d, 
J = 8.30 Hz, 2H), 5.86-5.73 (m, 1H), 5.07-4.97 (m, 2H), 4.65 (dd, J = 6.79, 2.26 Hz, 
1H), 4.36 (q, J = 10.57 Hz,  2H), 3.94-3.91 (dd, J = 6.79, 2.26 Hz, 1H), 3.78 (s, 3H), 
3.51-3.46 (m, 1H), 2.37 (t, J = 6.79 Hz, 2H), 0.83 (t, J = 8.30 Hz, 9H) 0.45-0.35 (m, 
6H).  
13C NMR (75 MHz, CDCl3):  142.9, 129.3, 127.7, 127.6, 127.3, 115.9, 113.4, 79.1, 
76.6, 76.2, 70.9, 34.0, 6.9, 4.8. 
LCMS: m/z (%): 465.3 (M+Na)+.  
 
Compound (82):  
 
 
 
Procedure: To a stirred solution of alcohol 81a (4.6g, 10.4mmol) and immidazole 
(2.8g, 41.6mmol) in 20ml dry DCM was added tri ethyl silyl chloride (3.5g, 22.9mmol) 
in 10ml dry DCM by drop wise at 0oC under nitrogen atmosphere. The reaction mixture 
was stirred for 4 h at 0 oC to room temperature. After completion of reaction, monitored 
OPMBOTES
OTES
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by TLC, then filtered off, washed with DCM and concentrate the organic layer. The 
crude product was diluted with water and extracted with ethyl acetate; combined 
organic layer was washed with brine solution and dried over anhydrous Na2SO4. The 
filtration and concentration fallowed by column chromatography provided the required 
compound 82 in 85%(4.8g) in yield as Yellowish oil.  
[α]D
25 = + 4.80 (c = 1.2, CHCl3).  
IR (neat): νmax: 2954, 2878, 1612, 1513, 1459, 1245, 1089, 1008, 737cm-1.  
1H NMR (300 MHz, CDCl3): δ7.31-7.19 (m, 5H), 7.16 (d, J = 8.3 Hz, 2H), 6.78 (d, J = 
8.3 Hz, 2H), 5.91-5.76 (m, 1H), 5.08-4.96 (m, 2H), 4.47-4.44 (m, 2H), 4.32 (d, J = 11.3 
Hz, 1H), 3.90 (m, 1H), 3.79 (s, 3H), 3.66-3.60 (m, 1H), 2.40-2.29 (m, 2H), 0.81 (t, J = 
8.3 Hz, 9H), 0.75 (t, J = 8.3 Hz, 9H); 0.48-028 (m, 12H).  
13C NMR (75 MHz, CDCl3): δ 128.8, 127.2, 127.1, 126.8, 115.4, 112.9, 78.6, 76.1, 
75.7, 70.4, 33.5, 6.4, 4.3. 
LC-MS:m/z (%): 579.3 (M+Na)+(100%). 
 
1-phenyl-1,2-bis-triethylsilanyloxy-hex-5-en-3-ol (83):  
 
 
 
 
Procedure: To a stirred solution of 82 (3.8g, 6.8mmol) in DCM: H2O (19:1) was added 
DDQ (1.8g, 8.1mmol) portions wise at 0 oC. The reaction mixture was stirred for 30 
min. after completion of reaction was monitored by TLC was added solid NaHCO3. 
OHOTES
OTES
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Then the reaction mixture filtered, the crude mixture wash with water, brine. The 
solvent was removed in vacuo then the residue partitioned between water and DCM. 
The organic layer was washed with water, brine and dried over anhydrous Na2SO4. The 
filtration and concentration fallowed by flash chromatography using ethyl acetate and 
hexane (2:8 ratio) afforded the required alcohol 83 ( 2.7g, 90% in yield) as yellowish 
oil.  
[α]D
25 = +12.0 CHCl3). 
IR (neat): νmax: 3432, 2923, 2853, 1638, 1459, 1238, 1063, 1007, 736 cm-1. 
1H NMR (200 MHz, CDCl3): δ7.32-7.23 (m, 5H), 5.92-5.72 (m, 1H), 5.21-5.08 (m, 
2H), 4.59 (d, J = 6.6 Hz, 1H), 3.81-3.74 (m, 1H), 3.70-3.71 (m, 1H), 2.23-2.02 (m, 2H), 
0.89-0.78 (m, 18H), 0.50-0.29 (m, 12H).  
LC-MS: m/z (%): 459.2 (M+Na)+(100%). 
 
Acrylic acid 1-(2-phenyl-1,2-bis-triethylsilanyloxy-ethyl)-but-3-enyl ester (84):  
 
 
 
 
Procedure: To a solution of alcohol 83 (2.2g, 5.0 mmol.) in10ml dry DCM was added 
Et3N (2.0 ml, 15.0 mmol) drop wise at 0 oC over 15 min. . After stirring of 30 min. at 
same temperature then acryloyl chloride (0.45ml, 5.5mmol) in 5ml dry DCM was added 
drop wise to it at same temperature and the reaction mixture was stirred at 0 oC to room 
temperature for 6h. After completion of reaction, being monitored by TLC, the reaction 
OOTES
OTES
O
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mixture was terminated by sat. NaHCO3 solution at 0 oC., fallowed by diluted with 
DCM. The organic layer was washed with water and brine. The solution was dried and 
concentrated under reduced pressure. The product was purified by column 
chromatography afforded the required product 84 (2.2g) 92% in yield as yellow oil.  
1H NMR (200 MHz, CDCl3): δ7.31-7.15 (m, 5H), 6.38 (dd, J = 17.3, 2.2 Hz, 1H), 6.08 
(dd, J = 17.3, 10.5 Hz, 1H), 5.82-5.74 (m, 2H), 5.47-5.42 (m, 1H), 5.07-4.95 (m, 2H), 
4.41 (d, J = 8.3 Hz, 1H), 3.89 (m, 1H), 2.54-2.41 (m, 2H), 0.85 (t, J = 8.3 Hz, 9H), 0.76 
(t, J = 8.3 Hz, 9H), 0.49-0.41 (m, 6H), 0.30-0.20 (m, 6H).   
 
6-(2-phenyl-1,2bis tri ethyl silanyloxy-ethyl-5,6-dihydro-pyran-2-one (86):  
 
 
 
 
Procedure: Diolefin 15 (1.8g, 3.6mmol) was dissolved in dry DCM  (20 mL) and added 
dropwise within1 h to a refluxing solution of ruthenium catalyst Ru-I (630mg, 0.72 
mmol) in dry, degassed DCM (780 mL). The reaction mixture was heated at reflux until 
consumption of the starting material (10 h, TLC monitoring). Solvent removal in vacuo 
and column chromatography of the residue on silica gel (hexanes-EtOAc, 9:1) provided 
lactone 6 (1.6g) in 85% yield. Pale yellow oil. 
[α]D
25
 = +20.00  (c = 0.5, CHCl3).  
IR (neat): max: 3445, 2923, 2853, 1738, 1633, 1461, 1482,1244, 1085, 737 cm-1. 
OOTES
OTES
O
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1H NMR (200 MHz, CDCl3):  7.29-7.23 (m, 5H), 6.91-6.84 (m, 1H), 5.95 (dd, J = 
9.82, 2.26 Hz, 1H), 4.63 (m, 1H), 4.51 (d, J = 6.04 Hz, 1H), 4.06 (dd, J = 6.79, 2.26 Hz, 
1H) 2.79-2.68 (m, 1H), 2.35-2.25 (m, 1H), 0.81 (m, 18H), 0.48-0.39 (m, 12H). 
13C NMR (50 MHz, CDCl3):  163.4, 144.9, 144.5, 127.1, 127.0, 126.4, 119.9, 76.9, 
76.6, 28.8, 5.9, 3.9. 
LC-MS: m/z (%): 485.2 (M+Na)+.  
 
Leiocarpin A (19):  
 
 
 
Procedure: To a stirred solution of 6 (200mg, 0.43mmol) in THF was added TBAF 
(1.2ml) 1.0M solution in THF at 0 oC. The reaction mixture was stirred for 8h at 0 oC to 
roomtemparature. After completion of reaction was monitored by TLC. The solvent was 
removed in vacuo then the residue partitioned between water and DCM. The organic 
layer was washed with water, brine and dried over anhydrous Na2SO4. The filtration 
and concentration fallowed by flash chromatography using ethyl acetate and hexane 
(4:6 ratio) afforded the target final compound 5 ( 87mg) 86% in yield. Colorless solid. 
[α] D
25
 = -94.91 (c = 0.4, CHCl3). 
IR (KBr): max: 3437, 2924, 2854, 1716, 1631, 1459, 1379, 1274, 1080, 758 cm-1.  
O
O
O
H
HOH
H
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1H NMR (300 MHz, CDCl3):  7.44-7.27 (m, 5H), 4.89 (brs, 1H), 4.44 (m, 1H), 4.39 
(d, J = 9.82 Hz, 1H), 3.52 (dd, J = 9.82, 3.02 Hz, 1H), 2.96 (d, J = 18.88 Hz, 1H), 2.86 
(dd, J = 18.88, 5.28 Hz, 1H), 2.22 (brs, 2H). 
13C NMR (75 MHz, CDCl3): 168.8, 137.7, 128.7, 128.6, 127.3, 77.1, 74.4, 72.5, 65.8, 
36.5, 22.6. 
LC-MS: m/z: 257.1 (M+Na)+. 
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Phosphomolybic acid catalyzed synthesis of tetrahydro pyrano and 
furano quinolines: 
Introduction 
        Pyrano- and furanoquinoline derivatives are an important class of natural products 
and exhibit a wide spectrum of biological activities such as antiallergic, anti-
inflammatory, antipyretic, analgesic, antiplatelet, psychotropic and estrogenic activity.1 
Many biologically active alkaloids like Simulenoline 1, Huajiaosimuline 2, 
Zanthodioline 3, Flindersine 4, Teclealbine 5 and Flindersiamine 6 contain 
pyranoquinoline and furanoquinoline moiety (figure 2). 1d-e,2 Hence, the synthesis of 
pyranoquinoline and furanoquinoline derivatives is of much current importance.  
Diels-Alder reaction: 
        The Diels-Alder3 reaction is an organic chemical reaction or cycloaddition reaction 
between a conjugated diene and a substituted alkene (commonly termed the dienophile), 
to form a substituted cylohexene system. Diels and his student Alder first documented 
the novel reaction in 1928 for which they were awarded the Nobel Prize in chemistry in 
1950 for their work on the eponymous reaction.  
 
 
 
Scheme 1 
Aza-diels alder reaction: 
+
R or hv R
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Aza Diels-Alder reaction is a cycloaddition reaction between azabutadiene with an 
electron-rich alkene to form tetrahydro pyridine and tetrahydro quinoline moiety. 
Which is one of the efficient methods for the preparation of the tetrahydroquinoline 
derivatives.4  
 
 
 
 
 
Scheme 2 
        These aza Diels-Alder reaction are normal aza-Diels-Alder reactions of electron 
rich aza dien  with electron deficient alkene and inverse electron demand aza diels alder 
reaction of aza dien  with an electron rich alkene.  
 
 
Scheme 3 
General mechanism for tetrahydroquinoline synthesis: 
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        In this section some literature pertaing to the Aza-Diels-Alder reaction have been 
reviewed.  
        Generally the pyranoquinoline and furanoquinoline derivatives are prepared by 
aza-Diels-Alder reactions of imines (derived from various aromatic amines and 
aromatic aldehydes) with different dienophiles like 3,4-dihydro-2H-pyran and 2,3-
dihydrofuran in the presence of different acid catalysts. However, many of these 
reactions cannot be carried out in a one-pot operation with a carbonyl compound, amine 
and enol ether because the amines and water that exist during imine formation can 
decompose or deactivate the Lewis acids.  
        Min-Dai and coworkers 5 reported the aza-Diels-Alder reaction 2-amono phenol in 
combination of substituted benzaldehyde and electron rich cyclic alkenes were under 
controlled microwave in presence of catalytic amount of CF3COOH to afforded 
corresponding tetrahydro quinolines.  
 
 
 
 
 
Scheme 5 
       
Makioka and coworkers 6 reported Ytterbium Triflate has been utilized as an efficient 
catalyst for cycloaddition reaction of CF3-N-arylaldimines with electron rich enol ethers 
to afforded tetrahydro quinoline derivatives (scheme 6). 
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Scheme 6 
        Yadav and coworkers 7 reports  Ionic liqids are found to catalyze efficiently the 
three component-coupling reactions of aldehydes, amines and cyclic enol ethers such as 
3,4-dihydro-2H-pyran and 2,3-dihydrofuran under mild and convenient condition to 
afforded corresponding tetrahydro pyrano and furano quinolines(Scheme 7). The same 
reaction performed by Yadav group by lithium perchlorate di ethyl ether as catalyst. 
 
        
 
Scheme 7 
        Perumal and coworkers 8 reported Gadalonium (III) chloride catalyzed synthesis of 
tetrahydro pyrano and furano quinolines in the one pot reaction of aldehydes and 
amines and dihydropyran or dihydrofuran to afforded in high yields under mild 
conditions. (Scheme 8) 
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        Kametani and coworker 9 reported Indium chloride catalyzed cycloaddition of 
aldimines with various enolethers to afforded the corresponding tetrahydroquinoline 
derivatives (in Scheme 7 &8). 
        Spellar and coworkers 10 reported intramolecular cycloaddition reactions used 
anilines or substituted anilines (secondary amines) with functionalized aldehyde enol 
ether in the presence of triflouroacetic acid to provided highly functionalized 
tetrahydroquinolines (Scheme 9).  
 
 
 
 
Scheme 9 
        Takahiko Akiyama and coworkers 11 reports enantioselective aza Diels-Alder 
reactions by using chiral phosphoric acid derived from chiral BINOL and demonstrated 
its catalytic activity as chiral Bronsted acid catalyst (scheme 10). 
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        Batey and coworkers 12 reported Ln(OTf)3 catalyzed cycloaddition reactions of 
cyclopentadiene with in situ generated N-arylimines containing enolizable protons is 
described. This three component reaction generates highly fuctionalized C-2 alphatic 
substituted tetrahydroquinilines (scheme 11). 
 
 
 
Scheme 11 
        Ahmad Kamal and coworker 13 reported the synthesis of tetrahydroquinoline by the 
reaction of aryl azides with 2,3-dihydro-2H-furan and 3,4-dihydro-2H-pyrans in the 
presence of Clhorotrymethyl silane-sodium iodide (TMSCl-NaI) affords this derivatives 
(scheme 12). 
 
 
 
 
 
 
 
Scheme 12 
        Guang wang and co worker 14 highly efficient method for the synthesis of 1,2,3,4-
tetrahydroquinoline derivatives via a molecular iodine catalyzed domino reaction of 
anilines with cyclic enol ethers, such as 2,3-dihydrofuran and 3,4-dihydro-2H-pyran, is 
described. The reaction may proceed through an aza-Diels–Alder process between an in 
situ generated 2-azadiene and another equivalent of cyclic enol (scheme 13). 
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Scheme 13 
        The same reaction has developed by various methods.  In this Yadav15 coworkers 
reported Montmorillonite-clay as catalyst,   Lakshmikantham16a,coworker reported 
polyaniline supported Indium trichloride as reusable catalyst,  Zang16b, Chen 16c , Shinde 
16d coworkers ZrOCl2 has been extensively studied in the cycloaddition reaction of 
anilines with various enol ethers to afforded to corresponding tetrahydroquinoline 
derivatives (scheme 12 & 13). 
        Wei Yu and coworkers 17 reported Cycloaddition of N-arylimines with N-
vinylpyrrolidin-2-one or N-methyl-N-vinylacetamide was efficiently initiated by cerium 
(IV) ammonium nitrate (CAN), and produced stereoselectively the corresponding 2,4-
cis-4-amido-N-yl tetrahydroquinoline derivatives in good yields (scheme 14). 
 
 
 
 
 
Scheme 14 
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Proposed mechanism: 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
        Longmin Wu and coworkers 18 reported an efficient aza-Diels–Alder reaction of 
N-arylimines with N-vinylpyrrolidinone was achieved using nitrosonium 
tetrafluoroborate as a cation radical initiator, giving cis-4-(2-oxopyrrolidin-1-
yl)tetrahydroquinolines (scheme 14) 
        Yadav and coworker 19 reported 2-Azadienes derived in situ from arylamines and 
(R)-(+)-citronellal/3-methylcitronellal undergo intramolecular [4+2] hetero- Diels–
Alder reactions in the air and moisture stable ionic liquid [bmim]BF4 in the absence of 
any acid catalyst to afford 1,2,3,4,4a,9,9a,10-octahydroacridine derivatives in high to 
quantitative yields (scheme 15). 
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Scheme 15 
        Thus more than the stoichiometric amounts of the Lewis acids are required because 
the acids are trapped by nitrogen of both reactant and product.1 Furthermore, most of 
the imines are hygroscopic, unstable at high temperatures, and difficult to purify by 
distillation or column chromatography. Subsequently, one-pot procedures have been 
developed for this transformation using many acid catalysts referred above. Even 
though these procedures do not require the isolation of unstable imines prior to the 
reactions, but metal triflates are not easily available, expensive and afford  
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the mixture of products with unsatisfactory yields. Therefore, the development of 
simple, convenient, efficient, economic and environmentally benign approaches for 
single step synthesis of pyrano-and furanoquinoline derivatives is still desirable. 
        In recent years, in view of the emerging importance to more environmental 
awareness in chemical and pharmaceutical industries, development of environmentally 
benign organic reactions have become a crucial and demanding research area in modern 
organic chemical research.20 Due to environmental awareness, chemists are devoted 
toward ‘green chemistry’ which by definition is to design, development, and 
implementation of chemical products and processes to reduce or eliminate the use and 
generation of substances hazardous to human health and the environment.  
        Heteropolyacids (HPAs) are environmentally friendly and economically feasible 
solid acids owing to their high catalytic activities and reactivities, ease of handling, 
allow cleaner reactions in comparison to conventional catalysts, non-toxicity and 
experimental simplicity and hence regarded as green catalysts.21 Also heteropolyacids 
are promising redox and bifuntional catalysts in homogeneous as well as in 
heterogeneous conditions.22 Among the heteropolyacids, phosphomolybdic acid (PMA, 
F.W: H3PMo12O40) is one of the less expensive commercially available catalyst. Hence 
in recent years organic chemists are very much interested to explore its important 
catalytic properties.  
        Vazquez23 and co-workers reported the dehydration of alcohols in liquid phase by 
recyclable silica-supported phosphomolybdic acid (PMA-SiO2). Especially, the 
dehydration of 1,2-diphenylethanol (Scheme 16), 1-(3,4-dimethoxyphenyl)-2-
phenylethanol (Scheme 17) and cholesterol was studied (Scheme 18).  
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Scheme 16 
 
Scheme 17 
 
Scheme 18 
        Romanelli24 and co-worker reported the tetrahydropyranylation of phenols by 
recyclable silica-supported phosphomolybdic acid (PMA-SiO2) (Scheme 19). 
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        Pizzio25 and coworkers reported aromatic Friedel-Crafts C-alkylation of aromatic 
compounds with benzyl alcohol or benzyl chloride (Scheme 20), cyclohexene or 
cyclohexanol (Scheme 21) by recyclable silica-supported phosphomolybdic acid (PMA-
SiO2).  
 
Scheme 20 
 
Scheme 21 
        Kishore Kumar26 and co-workers reported the aziridination of olefins catalyzed by 
phosphomolybdic acid in the presence of inexpensive Chloramine-T as a nitrogen 
source as a nitrogen source (Scheme 22). 
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        Smitha27 and co-workers reported phosphomolybdic acid catalyzed three-
component reaction of aldehydes, carbamate and allyltrimethyl silane to yield the 
corresponding protected homoallylic amines in good yields (Scheme 23). 
 
Scheme 23 
        Kishore Kumar28 and co-workers reported recyclable silica-supported 
phosphomolybdic acid (PMA-SiO2) catalyzed regioselective ring opening of activated 
aziridines with alcohols, azide, cyanide and bromide, at ambient temperature to afford 
the corresponding β-amino derivatives in good yields (Scheme 24). 
 
Scheme 24 
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(DHF) in the presence of 1 mol% of phosphomolybdic acid in acetonitrile afforded the 
corresponding furanoquinolines 3 and 4 in 92% yield (Scheme 25).  
   
 
 
Scheme 25 
        In a similar manner, treatment of anilines 1 and benzaldehydes 2 with 3,4-dihydro-
2H-pyran (DHP) in the presence of 1 mol% of phosphomolybdic acid in acetonitrile 
afforded the corresponding pyranoquinolines 5 and 6 in 90% yield (Scheme 26).  
        
 
 
 
Scheme 26 
Results and discussions 
        Several aldimines (formed in situ from aromatic aldehydes and anilines in 
acetonitrile) reacted smoothly with 2,3-dihydrofuran and 3,4-dihydro-2H-pyran to 
afford the corresponding furano- and pyranoquinolines (Table 1) in good to excellent 
yields. It is considered from synthetic point of view that imines, generated in situ from 
aldehydes and amines, immediately react with dihydrofuran or dihydropyran to afford 
furano- and pyranoquinolines in a one-pot way without the need of preformation of the 
imines. In most of the cases the product was obtained as the mixture of cis- and trans- 
isomers favoring the trans- isomer.  
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        The product was conformed by 1H NMR, Mass and IR spectroscopy comparison 
with previous reports29. The trans- isomer charesteric proton of 5g at  4.75 as doublet ( 
J = 10.8 Hz) in 1H NMR, similarly cis- isomer characteristic proton of 6g at 5.30 as 
doublet ( J = 5.6 Hz) in 1H NMR. The coupling constant between protons H-3 and H-4 
in the isomer 6g is J(3, 4) = 5.6 Hz is significantly smaller and typical for a gauche 
conformation. This orientation is present in both conformers of the configuration having 
cis orientation of the pyran ring and phenyl group. In the isomer 5g the J(3, 4) 10.8 Hz 
is relevant and indicative of the antireciprocal orientation of protons H-2 and H-3. This 
orientation is only possible when the pyran ring and phenyl group are on opposite sides 
of the quinoline ring of 5g. The 1H-HCOSY analysis confirms this structural assignment 
for 5g, a strong reciprocal interaction is found between H-3 and H-4, a weak one 
between protons H-3 and H-2, but none between protons H-4 and H-2, all in accord 
with a trans configuration 31. 
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Possible transition states: 
 
 
 
 
 
 
 
 
 
Figure 3 
In the mass spectrometry molecular ion peak at 299 and a strong stretching band at 
3325 cm-1 in IR spectra gave further conformation of the products. 
        In all the cases similarly the products were obtained in good yields with high 
diastereoselectivity. The diastereomers could be easily separated by column 
chromatography on silicagel. In the absence of the catalyst, the reaction did not yield 
any product even after a long reaction time (12-24 h). Among various solvents such as 
chloroform, dichloromethane, benzene, toluene and acteonitrile used for this reaction, 
acetonitrile appears to give the best results in terms of yields and diastereoselectivities. 
This method is equally effective for both electron-rich as well as electron deficient 
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substitution like CH3, -OMe. In case halo substituted aldehydes with simple anilines, 
less reactive and low yields compared to other electron donating substituents. In case 
both aldehydes and anilines substituted with election donating groups like methyl or 
methoxy groups less reactive and high reaction times and low yields were observed 
compared to halo substituted aryl imines, in this ortho methyl substituted aniline more 
reactive than para substituted aniline. In overall reactions halo substituted imines more 
reactive and high yields and less reactive times. This method offers several advantages 
such as higher yields, shorter reaction times, high trans-selectivity, cleaner reaction 
profiles, simple experimental and work-up procedures. All the products were 
characterized by 1H NMR, 13C NMR, IR and mass spectroscopic data and also by 
comparision with authentic samples. 7,8,9,11,12,29. 
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Entry 
Product Time(h) Yield(%) Producttrans:cistrans cis
a
N
H
O
H
H
N
H
O
H
H
3.5 92 90:10
N
H
O
H
H
OMe
N
H
O
H
H
OMe
R Ar
H
4-OMe C6H4
C6H5
Hb 4.0 90 87:13
c H 4-FC6H4
N
H
O
H
H
F
N
H
O
H
H
F
3.0 89 85:15
d 4-Me 4-Cl-C6H4
N
H
O
H
H
Cl
N
H
O
H
H
Cl
3.5 85 78:22
e 4-OMe H
N
H
O
H
H
MeO
N
H
O
H
H
MeO
4.5 75 88:12
f 4-OMe 4-FC6H5
N
H
O
H
H
MeO
F
N
H
O
H
H
MeO
F
4.0 95 88:12
C6H5
N
H
H
H
O
N
H
H
H
O
3.0 90 90:10
g H
h H 4-Cl-C6H4
3.5 87 85:15
N
H
H
H
O
Cl
N
H
H
H
O
Cl
Table 1: Phosphomolybdic acid catalyzed pyrano-furano quinolines
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Entry 
Product Time(h) Yield(%) Producttrans:cistrans cis
i
N
H
H
H
O
F
N
H
H
H
O
F
3.5 89 88:12
N
H
H
H
O
N
H
H
H
O
R Ar
H
j 5.0 83 83:17
k 4-MeOC6H4 N
H
H
H
OMe
O
N
H
H
H
OMe
O
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l 
4-Me 
4-Cl-C6H4
N
H
H
H
O
N
H
H
H
O
4.5 81 82:18
m
N
H
H
H
O
MeO
N
H
H
H
MeO
O
4.0 85 78:22
n 4-F
N
H
H
H
F
O
N
H
H
H
F
O
3.5 87 85:15
C6H5
N
H
H
H
O
N
H
H
H
O
6.0 90 73:27
o
p 4-F-C6H4 4.0 89 75:25
N
H
H
H
O
F
N
H
H
H
O
F
Table 1:continued....................
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Conclusion      
        In conclusion, we describe a simple, mild and efficient protocol for the synthesis of 
trans-fused furano- and pyranoquinolines via three-component one-pot aza-Diels-Alder 
reaction of aldehydes, amines and cyclic enol ethers using 1 mol% of commercially 
available cheap phosphomolybdic acid (PMA) as catalyst. This protocol offers several 
advantages like mild reaction conditions, high yields, greater trans-selectivity, shorter 
reaction times, cleaner reaction profiles, simple experimental and work-up procedures, 
thus making the process as environmentally friendly for the synthesis of biologically 
important furano- and pyranoquinolines. 
 
Experimental Section  
General methods 
Melting points were recorded on Buchi R-535 apparatus and are uncorrected. IR 
spectra were recorded on a Perkin-Elmer FT-IR 240-c spectrophotometer using KBr 
optics. 1H NMR and 13C spectra were recorded on Gemini-200 MHz, Bruker Avance 
300 M Hz and Unity-400 M Hz spectrometer in CDCl3 using TMS as internal standard. 
Mass spectra were recorded on a Finnigan MAT 1020 mass spectrometer operating at 
70 eV. Column chromatography was performed using E.Merck 60-120, mesh silica gel. 
All the solvents were distilled, dried and stored under nitrogen prior to use. 
 
General procedure for the synthesis of furano- and pyranoquinolines catalyzed by 
phophomolybdic acid.  
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        A mixture of an aromatic aldehyde (1.0 mmol), aryl amine (1.0 mmol), 2,3-
dihydrofuran or 3,4-dihydro-2H-pyran (2.0 mmol) and phosphomolybdic acid (PMA) 
(18 mg, 1 mol%) in acetonitrile (10 ml) was stirred at ambient temperature for an 
appropriate time (Table 1). The progress of the reaction was monitored by TLC. After 
completion of the reaction, as indicated by TLC, the solvent was evaporated in vacuo 
and the crude product was purified by column chromatography over silica gel first elute 
cis isomer and then trans isomer to the corresponding pure furano- and 
pyranoquinolines. All products were characterized by 1H NMR, 13C NMR, IR and mass 
spectroscopic data and also by comparison with authentic samples. The spectroscopic 
data of products were identical with the data reported in the literature 7,8,9,11,12,29. 
Spectral data the products:  
trans-4-Phenyl-2,3,3a,4,5,9b-hexahydro-furo[3,2-c]quinoline (3a): Viscous oil, IR 
(KBr): max: 3329, 2952, 1610, 1055 cm-1; 1H NMR (200 MHz, CDCl3):  1.72 (m, 
1H), 2.00 (m, 1H), 2.45 (m, 1H), 3.85 (m, 3H), 4.10 (m, 1H), 4.60 (d, J = 5.2 Hz, 1H), 
6.64 (d, J = 8.2 Hz, 1H), 6.80 (td, J = 7.9, 0.9 Hz, 1H,), 7.18 (td, J = 7.9, 0.9 Hz, 1H), 
7.24-7.46 (m, 6H). 13C NMR (50 MHz, CDCl3):  145.5, 141.6, 131.0, 128.9, 128.6, 
128.2, 128.0, 120.0, 118.0, 114.4, 76.0, 65.2, 57.4, 47.4, 43.3, 28.6. EIMS m/z: 251 M+, 
206. 
cis-4-Phenyl-2,3,3a,4,5,9b-hexahydro-furo[3,2-c]quinoline (4a):  white solid, m.p. 
93-95 oC; IR (KBr): max: 3350, 2975, 2855, 1612, 1485, 1072 cm-1, 1H NMR (200 
MHz, CDCl3):  1.55 (m, 1H), 2.25 (m, 1H), 2.75 (m, 1H), 3.82 (m, 3H), 4.70 (d, J = 
2.9 Hz, 1H), 5.25 (d, J = 8.2 Hz, 1H), 6.60 (d, J = 8.2 Hz, 1H), 6.80 (d, J = 8.2 Hz, 1H), 
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7.05 (t, J = 8.2 Hz, 1H), 7.35-7.55 (m, 6H). 13C NMR (50 MHz, CDCl3):  144.7, 
142.3, 130.0, 128.7, 128.2, 127.5, 126.2, 122.5, 119.0, 114.8, 75.8, 66.6, 57.4, 45.7, 
24.4. EIMS m/z: 251 M+, 206, 174, 130, 91. Anal. calcd for C17H17NO (251.32): C, 
81.24; H, 6.82; N, 5.57. Found: C, 81.27; H, 6.85; N, 5.60. 
cis-4-(4-Methoxy-phenyl)-2,3,3a,4,5,9b-hexahydro-furo[3,2-c]quinoline (4b):  Pale 
yellow solid, m.p. 155-156 oC; IR (KBr): max: 3340, 2992, 2868, 1607, 1520, 1135 cm-
1, 1H NMR (200 MHz, CDCl3):  1.58 (m, 1H), 2.20 (m, 1H), 2.70 (m, 1H), 3.70-3.80 
(m, 3H), 3.85 (s, 3H), 4.62 (d, J = 2.2 Hz, 1H), 5.22 (d, J = 8.0 Hz, 1H), 6.54 (d, J = 8.0 
Hz, 1H), 6.78 (d, J = 8.0 Hz, 1H), 6.90 (t, J = 8.0, 1H), 7.05 (d, J = 8.0 Hz, 2H), 7.40 
(m, 3H). EIMS  m/z: 281 M+, 252, 236, 224, 167, 155, 141, 121, 91, 69, 43. Anal. calcd 
for C18H19NO (281.35): C, 76.84; H, 6.81; N, 4.98. Found: C, 76.87; H, 6.86; N, 4.99. 
cis-4-(4-Fluoro-phenyl)-2,3,3a,4,5,9b-hexahydro-furo[3,2-c]quinoline (4c):  White 
solid, m.p. 173-174 oC; IR (KBr): max: 3315, 2975, 2880, 1607, 1508, 1225, 1155, 
1060 cm-1, 1H NMR (200 MHz, CDCl3):  1.50 (m, 1H), 2.10-2.15 (m, 1H), 2.60-2.80 
(m, 1H), 3.65-3.80 (m, 3H), 4.65 (d, J = 2.4 Hz, 1H), 5.20 (d, J = 7.9 Hz, 1H), 6.52 (d, 
J = 7.9 Hz, 1H), 6.78 (d, J = 7.9 Hz, 1H), 7.05 (m, 3H), 7.30 (m, 1H), 7.40 (m, 2H). 
EIMS  m/z: 269 M+, 240, 224, 198, 174, 130, 117, 77, 39. Anal. calcd for C17H16FNO 
(269.31): C, 75.82; H, 5.99; F, 7.05, N, 5.20. Found: C, 75.84; H, 6.00; F, 7.09, N, 5.24. 
cis-4-(4-Chloro-phenyl)-8-methyl-2,3,3a,4,5,9b-hexahydro-furo[3,2-c]quinoline 
(4d):  White solid, m.p. 147-148 oC; IR (KBr): max: 3345, 2990, 2879, 1610, 1495, 
1145, 1030 cm-1, 1H NMR (200 MHz, CDCl3):  1.50 (m, 1H), 2.20 (m, 1H), 2.35 (s, 
3H), 2.64 (m, 1H), 3.60 (brs, NH, 1H), 3.72 (m, 1H), 3.80 (m, 1H), 4.60 (d, J = 2.2 Hz, 
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1H), 5.20 (d, J = 8.0 Hz, 1H), 6.50 (d, J = 8.0 Hz, 1H), 6.85 (dd, J = 8.0, 2.2 Hz, 1H), 
7.10 (d, J = 2.2 Hz, 1H), 7.35 (d, J = 8.0 Hz, 2H), 7.40 (d, J = 8.0 Hz, 2H). EIMS  m/z: 
299 M+, 254, 188, 160, 144, 115, 77. Anal. calcd for C18H18NClO (299.79): C, 72.11; 
H, 6.05; N, 4.67, Cl, 11.83. Found: C, 72.15; H, 6.10; N, 4.69, Cl, 11.90. 
trans-8-Methoxyl-4-phenyl-2,3,3a,4,5,9b-hexahydro-furo[3,2-c]quinoline (3e):  Pale 
yellow solid, m.p. 94-95 oC; IR (KBr): max: 3290, 2989, 1609, 1027 cm-1, 1H NMR 
(200 MHz, CDCl3):  1.20 (m, 1H), 1.70 (m, 1H), 2.00 (m, 1H), 2.40 (brs, NH, 1H), 
3.87-3.73 (m, 2H), 3.78 (s, 3H), 4.05 (m, 1H), 4.62 (d, J = 5.2 Hz, 1H), 6.60 (d, J = 8.2 
Hz, 1H), 6.80 (dd, J = 8.2, 2.7 Hz, 1H), 7.00 (d, J = 2.7 Hz, 1H), 7.45-7.38 (m, 5H). 
EIMS  m/z: 282 M+1, 220.  
cis-8-Methoxyl-4-phenyl-2,3,3a,4,5,9b-hexahydro-furo[3,2-c]quinoline (4e):  Pale 
yellow solid, m.p. 131-132 oC; IR (KBr): max: 3305, 2975, 2875, 1605, 1510, 1225, 
1057 cm-1, 1H NMR (200 MHz, CDCl3):  1.55 (m, 1H), 2.20 (m, 1H), 2.75 (m, 1H), 
3.65-3.85 (m, 3H), 3.78 (s, 3H), 4.62 (d, J = 2.8 Hz, 1H), 5.22 (d, J = 8.0 Hz, 1H), 6.50 
(d, J = 8.4 Hz, 1H), 6.74 (dd, J = 8.4, 2.8 Hz, 1H), 6.94 (d, J = 2.8 Hz, 1H), 7.25-7.45 
(m, 5H). 13C NMR (50 MHz, CDCl3):  153.0, 142.5, 139.0, 128.5, 127.4, 126.5, 123.5, 
116.3, 115.8, 76.7, 66.6, 57.9, 55.7, 45.7, 24.5. EIMS  m/z: 281 M+, 236, 206, 160, 141, 
115, 91, 41. Anal. calcd for C18H19NO2 (281.35): C, 76.84; H, 6.81; N, 4.98. Found: C, 
76.86; H, 6.83; N, 4.99. 
cis-4-(4-Fluoro-phenyl)-8-methoxy-2,3,3a,4,5,9b-hexahydro-furo[3,2-c]quinoline 
(4f):  White solid, m.p. 136-137 oC; IR (KBr): max: 3014, 1660, 1575, 1503, 1220, 
1035 cm-1, 1H NMR (200 MHz, CDCl3):  1.35-1.55 (m, 1H), 2.10-2.25 (m, 1H), 2.60-
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2.75 (m, 1H), 3.60-3.80 (m, 3H), 3.76 (s, 3H), 4.62 (d, J = 2.7 Hz, 1H), 5.20 (d, J = 7.9 
Hz, 1H), 6.45 (d, J = 8.4 Hz, 1H), 6.68 (dd, J = 8.4, 2.7 Hz, 1H), 6.92 (d, J = 2.7 Hz, 
1H), 7.00-7.10 (m, 2H). EIMS m/z: 299 M+, 272, 255, 205, 150, 109, 77, 43. Anal. 
calcd for C18H18FNO2 (299.34): C, 72.22; H, 6.06; F, 6.35; N, 4. 68. Found: C, 72.25; 
H, 6.09; F, 6.38; N, 4.72. 
trans-5-Phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline (5g): Pale 
yellow oil; IR (KBr): max: 3325, 2940, 2864, 1605, 1480, 1080 cm-1, 1H NMR (200 
MHz, CDCl3):  1.25-1.60 (m, 3H), 1.80-1.90 (m, 1H), 2.00-2.10 (m, 1H), 3.75 (dt, J = 
11.5, 2.5 Hz, 1H), 4.00-4.10 (m, 2H), 4.40 (d, J = 2.5 Hz, 1H), 4.75 (d, J = 10.8 Hz, 
1H), 6.50 (d, J = 8.0 Hz, 1H), 6.70 (t, J = 7.5 Hz, 1H), 7.10 (t, J = 7.5 Hz, 1H), 7.25 (d, 
J = 8.0 Hz, 1H), 7.45-7.55 (m, 5H). 13C NMR (50 MHz, CDCl3):  144.5, 142.2, 130.9, 
129.5, 128.5, 127.9, 127.7, 120.5, 117.2, 114.2, 74.5, 69.2, 55.0, 39.2, 24.2, 22.2. EIMS  
m/z: 299 M+, 272, 255, 205, 150, 109, 77, 43. Anal. calcd for C18H19NO (265.35): C, 
81.48; H, 7.22; N, 5.28. Found: C, 81.51; H, 7.24; N, 5.34. 
cis-5-Phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline (6g): White solid 
m.p. 128-129 oC; IR (KBr): max: 3340, 2970, 2850, 1610, 1490, 1090 cm-1, 1H NMR 
(200 MHz, CDCl3):  1.25 (m, 1H), 1.50-1.70 (m, 3H), 2.15-2.20 (m, 1H), 3.40 (dt, J = 
11.3, 2.4 Hz, 1H), 3.55 (dd, J = 11.3, 2.4 Hz, 1H), 3.80 (brs, NH, 1H), 4.70 (d, J = 2.7 
Hz, 1H), 5.30 (d, J = 5.6 Hz, 1H), 6.55 (d, J = 8.0 Hz, 1H), 6.78 (t, J = 8.0 Hz, 1H), 
7.05 (t, J = 7.8 Hz, 1H), 7.25-7.45 (m, 6H). 13C NMR (50 MHz, CDCl3):  145.2, 
141.2, 128.2, 128.0, 127.7, 127.5, 126.9, 120.4, 118.0, 114.4, 72.8, 60.7, 59.3, 39.0, 
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25.7, 18.2. EIMS m/z: 265 M+, 234, 220, 194, 129, 117, 91, 77. Anal. calcd for 
C18H19NO (265.35): C, 81.48; H, 7.22; N, 5.28. Found: C, C, 81.50; H, 7.24; N, 5.30. 
trans-5-(4-Chloro-phenyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline 
(5h): White solid m.p. 122-123 oC; IR (KBr): max: 3351, 2945, 2865, 1628, 1470, 1055 
cm-1, 1H NMR (200 MHz, CDCl3):  1.25-1.50 (m, 2H), 1.60-1.70 (m, 1H), 1.80-1.90 
(m, 1H), 2.00-2.10 (m, 1H), 3.70 (dt, J = 11.5, 2.5 Hz, 1H), 3.95 (brs, NH, 1H), 4.05-
4.10 (m, 1H), 4.35 (d, J = 2.7 Hz, 1H), 4.70 (d, J = 10.8 Hz, 1H), 6.50 (d, J = 8.2 Hz, 
1H), 6.70 (t, J = 8.0 Hz, 1H), 7.10 (t, J = 8.0 Hz, 1H), 7.10 (t, J = 8.0 Hz, 1H), 7.20 (d, 
J = 8.2 Hz, 1H), 7.30-7.40 (m 4H).  
cis-5-(4-Chloro-phenyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline(6h):  
White solid m.p. 169-170 oC; IR (KBr): max: 3354, 2950, 2875, 1630, 1473, 1053 cm-1, 
1H NMR (200 MHz, CDCl3):  1.23-1.38 (m, 1H), 1.40-1.60 (m, 3H), 2.10-2.20 (m, 
1H), 3.45 (dt, J = 11.5, 2.5 Hz, 1H), 3.60 (dd, J = 11.5, 2.5 Hz, 1H), 3.80 (brs, NH, 
1H), 4.70 (d, J = 2.8 Hz, 1H), 5.30 (d, J = 5.7 Hz, 1H), 6.60 (d, J = 8.2 Hz, 1H), 6.80 (t, 
J = 7.9 Hz, 1H), 7.10 (t, J = 7.9 Hz, 1H), 7.30-7.45 (m, 5H). EIMS  m/z: 299 M+, 268, 
240, 229, 188, 156, 130, 115, 77. 
trans-5-(4-Fluoro-phenyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline 
(5i): White solid m.p. 143-144 oC; IR (KBr): max: 3327, 2950, 2870, 1610, 1495, 1250, 
1090 cm-1, 1H NMR (200 MHz, CDCl3):  1.30-1.35 (m, 1H), 1.40-1.45 (m, 1H), 1.60-
1.70 (m, 1H), 1.75-1.85 (m, 1H), 2.05 (m, 1H), 3.70 (dt, J = 11.5, 2.5 Hz, 1H), 3.95 
(brs, NH, 1H), 4.10 (d, J = 2.5 Hz, 1H), 4.35 (d, J = 2.7 Hz, 1H), 4.70 (d, J = 10.8 Hz, 
1H), 6.48 (d, J = 8.0 Hz, 1H), 6.68 (dd, J = 8.0, 2.5 Hz, 1H), 7.05 (m, 3H), 7.18 (m, 
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1H), 7.38 (m, 2H). Anal. calcd for C18H18FNO (283.34): C, 76.30; H, 6.40; F, 6.71, N, 
4.94. Found: C, 76.35; H, 6.42; F, 6.74, N, 4.97. 
cis-5-(4-Fluoro-phenyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline (6i):  
White solid m.p. 174-175 oC; IR (KBr): max: 3325, 2945, 2860, 1607, 1490, 1250, 
1080 cm-1, 1H NMR (200 MHz, CDCl3):  1.30 (m, 1H), 1.45-1.60 (m, 3H), 2.12 (m, 
1H), 3.40 (dt, J = 11.5, 2.5 Hz, 1H), 3.56 (dd, J = 11.5, 2.5 Hz, 1H), 3.75 (brs, NH, 
1H), 4.65 (d, J = 2.7 Hz, 1H), 5.28 (d, J = 5.7 Hz, 1H), 6.52 (d, J = 8.0 Hz, 1H), 6.75 
(dd, J = 8.0, 2.5 Hz, 1H), 7.05 (m, 3H), 7.40 (m, 3H). EIMS  m/z: 283 M+, 239, 225, 
198, 150, 148, 91. Anal. calcd for C18H18FNO (283.34): C, 76.30; H, 6.40; F, 6.71, N, 
4.94. Found: C, 76.33; H, 6.44; F, 6.72, N, 4.96. 
trans-9-Methyl-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline (5j):  
Pale yellow oil; IR (KBr): max: 3350, 2957, 2865, 1611, 1499, 1040 cm-1, 1H NMR 
(200 MHz, CDCl3):  1.30-1.40 (m, 1H), 1.45-1.50 (m, 1H), 1.60-1.70 (m, 1H), 1.80-
1.95 (m, 1H), 2.05-2.15 (m, 4H), 3.70 (dt, J = 11.5, 2.4 Hz, 1H), 3.90 (brs, NH, 1H), 
4.15 (dd, J = 11.5, 2.4 Hz, 1H), 4.35 (d, J = 2.8 Hz, 1H), 4.65 (d, J = 10.5 Hz, 1H), 6.40 
(d, J = 8.0 Hz, 1H), 6.95 (dd, J = 8.0, 1.2 Hz, 1H), 7.00 (d, J = 1.2 Hz, 1H), 7.30-7.45 
(m, 5H).  
cis-9-Methyl-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline (6j):  
White solid m.p. 129-130 oC; IR (KBr): max: 3345, 2970, 2845, 1610, 1505, 1038 cm-1, 
1H NMR (200 MHz, CDCl3):  1.15-1.25 (m, 1H), 1.32-1.60 (m, 3H), 2.05-2.15 (m, 
4H), 3.35 (dt, J = 11.4, 2.7 Hz, 1H), 3.50 (dd, J = 11.4, 2.7 Hz, 1H), 3.55 (brs, NH, 
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1H), 4.60 (d, J = 2.7 Hz, 1H), 5.25 (d, J = 5.6 Hz, 1H), 6.50 (d, J = 8.0 Hz, 1H), 6.85 
(d, J = 8.0 Hz, 1H), 7.25-7.40 (m, 6H). EIMS  m/z: 279 M+, 219, 158, 144, 105, 91.  
trans-5-(4-Methoxy-phenyl)-9-methyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-  
c]quinoline (5k):  White solid; IR (KBr): max: 3447, 2921, 2851, 1618, 1509, 1249, 
1035 cm-1, 1H NMR (200 MHz, CDCl3):  1.35-1.45 (m, 1H), 1.45-1.50 (m, 1H), 1.60-
1.70 (m, 1H), 1.85-1.90 (m, 1H), 2.00 (m, 1H), 2.25 (s, 3H), 3.70 (dt, J = 11.4, 2.4 Hz, 
1H), 3.90 (s, 3H), 4.10 (d, J = 2.4 Hz, 1H), 4.32 (d, J = 2.4 Hz, 1H), 4.62 (d, J = 10.8 
Hz, 1H), 6.49 (d, J = 8.2 Hz, 1H), 6.88 (m, 3H), 7.00 (m, 1H), 7.32 (m, 2H). EIMS  m/z: 
309 M+, 265, 250, 207, 202, 158, 71, 57. Anal. calcd for C20H23NO2 (309.40): C, 77.64; 
H, 7.49; N, 4.53. Found: C, 77.67; H, 7.52; N, 4.55. 
trans-7-Methyl-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline (5l):  
White solid m.p. 130-131 oC; IR (KBr): max: 3340, 2975, 2840, 1615, 1505, 1085 cm-1, 
1H NMR (200 MHz, CDCl3):  1.25-1.35 (m, 3H), 1.60-1.65 (m, 1H), 1.80-1.85 (m, 
1H), 2.10 (s, 3H), 3.70 (dt, J = 11.4, 2.4 Hz, 1H), 3.90 (brs, NH, 1H), 4.10 (m, 2H), 
4.40 (d, J = 2.7 Hz, 1H), 4.78 (d, J = 10.5 Hz, 1H), 6.64 (t, J = 8.0 Hz, 1H), 7.00 (dd, J 
= 8.0, 1.0 Hz, 1H), 7.10 (dd, J = 8.0, 1.0 Hz, 1H), 7.30-7.40 (m, 3H), 7.45 (m, 2H). 
EIMS (EI, 70 eV): m/z: 299 M+, 272, 255, 205, 150, 109, 77, 43. Anal. calcd for 
C19H21NO (279.38): C, 81.68; H, 7.58; N, 5.01. Found: C, 81.73; H, 7.62; N, 5.03. 
cis-7-Methyl-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline (6l):  
White solid m.p. 142-143 oC; IR (KBr): max: 3345, 2970, 2845, 1610, 1510, 1030 cm-1, 
1H NMR (200 MHz, CDCl3):  1.25 (m, 1H), 1.35-1.50 (m, 4H), 2.10 (s, 3H), 3.34 (dt, 
J = 11.3, 2.4 Hz, 1H), 3.55 (brs, NH, 1H), 4.62 (d, J = 2.4 Hz, 1H), 5.30 (d, J = 5.2 Hz, 
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1H), 6.70 (t, J = 7.8 Hz, 1H), 6.90 (dd, J = 7.0, 0.8 Hz, 1H), 7.20-7.40 (m, 6H). EIMS 
m/z: 279 M+, 260, 220, 184, 155, 144, 104, 91, 65. Anal. calcd for C19H21NO (279.38): 
C, 81.68; H, 7.58; N, 5.01. Found: C, 81.70; H, 7.61; N, 5.02. 
trans-9-Methoxy-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline 
(5m): Brown solid m.p. 98-99 oC; IR (KBr): max: 3325, 2965, 2865, 1605, 1515, 1070 
cm-1, 1H NMR (200 MHz, CDCl3):  1.25 (m, 1H), 1.40 (m, 1H), 1.60 (m, 1H), 1.70 
(m, 1H), 2.00 (m, 1H), 3.50 (m, 1H), 3.60 (s, 3H), 4.00 (m, 2H), 4.30 (d, J = 2.7 Hz, 
1H), 4.55 (d, J = 10.5 Hz, 1H), 6.38 (d, J = 8.1 Hz, 1H), 6.60 (dd, J = 8.0, 2.7 Hz, 1H), 
6.65 (d, J = 2.7 Hz, 1H), 7.20-7.30 (m, 5H). Anal. calcd for C19H21NO2 (295.38): C, 
77.26; H, 7.17; N, 4.74. Found: C, C, 77.29; H, 7.22; N, 4.77. 
cis-9-Methoxy-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline 
(6m):  White solid m.p. 145-146 oC; IR (KBr): max: 3340, 2970, 2855, 1610, 1520, 
1065 cm-1, 1H NMR (200 MHz, CDCl3):  1.30-1.60 (m, 4H), 2.15 (m, 1H), 3.42 (m, 
1H), 3.58 (m, 1H), 3.60 (brs, NH, 1H), 3.80 (s, 3H), 4.62 (d, J = 2.1 Hz, 1H), 5.25 (d, J 
= 5.2 Hz, 1H), 6.70 (dd, J = 8.2, 2.7 Hz, 1H), 7.00 (d, J = 2.7 Hz, 1H), 7.30-7.45 (m, 
5H). EIMS m/z: 295 M+, 237, 225, 160, 91. Anal. calcd for C19H21NO2 (295.38): C, 
77.26; H, 7.17; N, 4.74. Found: C, C, 77.28; H, 7.20; N, 4.79. 
trans-9-Fluoro-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline (5n):  
Pale brown oil; IR (KBr): max: 3325, 2945, 2870, 1605, 1495, 1250, 1080 cm-1, 1H 
NMR (200 MHz, CDCl3):  1.35 (m, 1H), 1.50 (m, 1H), 1.55-1.65 (m, 1H), 1.75-1.90 
(m, 1H), 2.10 (m, 1H), 3.68 (dt, J = 11.5, 2.8 Hz, 1H), 3.90 (brs, NH, 1H), 4.10 (d, J = 
2.8 Hz, 1H), 4.32 (d, J = 2.8 Hz, 1H), 4.65 (d, J = 10.8 Hz, 1H), 6.45 (d, J = 8.2 Hz, 
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1H), 6.80 (dd, J = 8.2, 2.8 Hz, 1H), 6.95 (d, J = 2.8 Hz, 1H), 7.30-7.40 (m, 5H). Anal. 
calcd for C18H18FNO (283.34): C, 76.30; H, 6.40; F, 6.76; N, 4.94. Found: C, 76.33; H, 
6.43; F, 6.79; N, 4.96. 
cis-9-Fluoro-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline (6n):  
White solid, m.p. 174-175 oC; IR (KBr): max: 3326, 2943, 2865, 1610, 1498, 1250, 
1090 cm-1, 1H NMR (200 MHz, CDCl3):  1.30 (m, 1H), 1.35-1.60 (m, 3H), 2.10 (m, 
1H), 3.40 (dt, J = 11.5, 2.5 Hz, 1H), 3.68 (brs, NH, 1H), 4.60 (d, J = 2.7 Hz, 1H), 5.20 
(d, J = 5.7 Hz, 1H), 6.44 (dd, J = 8.2 Hz, 1H), 6.78 (dd, J = 8.2, 2.7 Hz, 1H), 7.10 (d, J 
= 2.7 Hz, 1H), 7.25-7.40 (m, 5H). EIMS  m/z: 283 M+, 239, 225, 198, 150, 148, 91. 
Anal. calcd for C18H18FNO (283.34): C, 76.30; H, 6.40; F, 6.76; N, 4.94. Found: C, 
76.35; H, 6.43; F, 6.78; N, 4.97. 
trans-12-Phenyl-2,3,4a,11,12,12a-hexahydro-1H-4-oxa-11-aza-chrysene (5o):  Pale 
yellow solid, m.p. 144-145 oC; IR (KBr): max: 3378, 2945, 2870, 1665, 1575, 1468, 
1080 cm-1, 1H NMR (200 MHz, CDCl3):  1.38 (m, 1H), 1.55 (m, 1H), 1.68 (m, 1H), 
1.80 (m, 1H), 2.20 (m, 1H), 3.75 (dt, J = 11.8, 2.8 Hz, 1H), 4.10 (d, J = 2.8 Hz, 1H), 
4.45 (d, J = 2.8 Hz, 1H), 4.70 (brs, NH, 1H), 4.80 (d, J = 10.8 Hz, 1H), 7.20-7.25 (m, 
2H), 7.30-7.45 (m, 4H), 7.50 (m, 3H), 7.70 (m, 2H). Anal. calcd for C22H21NO 
(315.41): C, 83.78; H, 6.71; N, 4.44. Found: C, 76.82; H, 6.75; N, 4.47. 
trans-12-(4-Fluoro-phenyl)-2,3,4a,11,12,12a-hexahydro-1H-4-oxa-11-aza-chrysene 
(5p):  Brown solid, m.p. 179-181 oC; IR (KBr): max: 3378, 2947, 2870, 1668, 1575, 
1468, 1081 cm-1, 1H NMR (200 MHz, CDCl3):  1.30-1.45 (m, 2H), 1.60-1.80 (m, 2H), 
2.10 (m, 1H), 3.75 (dt, J = 11.5, 2.7 Hz, 1H), 4.10 (d, J = 2.7 Hz, 1H), 4.452 (d, J = 2.7 
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Hz, 1H), 4.65 (brs, NH, 1H), 4.80 (d, J = 10.8 Hz, 1H), 7.05-7.15 (m, 2H), 7.20-7.40 
(m, 4H), 7.45-7.50 (m, 2H), 7.70-7.80 (m, 2H). Anal. calcd for C22H20FNO (333.40): C, 
79.26; H, 6.05; F, 5.70, N, 4.20. Found: C, 79.28; H, 6.10; F, 5.74, N, 4.22. 
cis-12-(4-Fluoro-phenyl)-2,3,4a,11,12,12a-hexahydro-1H-4-oxa-11-aza-chrysene 
(6p):  Brown solid, m.p. 138-140 oC; IR (KBr): max: 3370, 2945, 2860, 1665, 1570, 
1465, 1080 cm-1, 1H NMR (200 MHz, CDCl3):  1.20-1.35 (m, 2H), 2.10 (m, 1H), 3.25 
(dt, J = 11.5, 2.5 Hz, 1H), 3.50 (dd, J = 11.5, 2.5 Hz, 1H), 4.00 (brs, NH, 1H), 4.70 (d, J 
= 2.7 Hz, 1H), 5.40 (d, J = 5.7 Hz, 1H), 7.00 (m, 2H), 7.20 (m, 1H), 7.35 (m, 2H), 7.40-
7.50 (m, 3H). 7.65 (m, 2H). Anal. calcd for C22H20FNO (333.40): C, 79.26; H, 6.05; F, 
5.70, N, 4.20. Found: C, 79.30; H, 6.09; F, 5.76, N, 4.24. 
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Ring opening of epoxide with amines with NbCl5 as a Lewis acid  
INTRODUCTION 
        The β-amino alcohols are versatile intermediates and major functional groups for 
the synthesis of various biologically active natural and synthetic products, synthetic 
amino acids, β-blockers, insecticidal agents, chiral auxiliaries, and oxazolines, which 
have been widely explored as protecting groups.1 
 
 
 
Figure 1 
        The β-amino alcohols play a vital role in both organic and medicinal chemistry. 
The β-amino-α-hydroxy ethyl group present in many natural products is responsible for 
some of their remarkable physiological activities.2 The importance of enantiomerically 
pure β-amino alcohols can also be seen in β-blockers, antidepressants etc.3 
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        β – Adregnergic bloking agents are of great significance a pharmaceutical agents 
and are highly effective antagonists in the treatment of cardiovascular disease, cardiac 
failure, asthama, anxiety and obesity.4 According to dictionary of drugs,5 majority of β-
blockers sush as Isoprenaline (1), Terbutaline (2), Salbutamol (3) etc. are related 
chemically to the aryl ethanolamine structure of nor-adrenaline(4) (figure. 2). 
β - Adrenergic blocking agents 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 
        β-Adrenergic blocking agents have additional properties that may contribute to 
antiarrythmic activity including membrane stabilizing activity.6 some common β – 
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Adregeneric blocking drugs such as metoprolo (5) Atenolo1 (6), Nifinalol (7), Sotalol 
(8)  Propanolo (9) Pindolol (8), and represented here (figure 3).  
        Other pharmaceutically useful amino alcohols are Vesamical (11) and its 
analogues (12),7 sphingosine (13)8 etc. Vesamical its analogues are useful as drug in 
vitro acetyl choline storage.  Sphingosine acts as intra cellular second messengermany 
biological processes. 
 
 
 
 
 
 
 
Figure 4 
        β-amino alcohols are used not only in medicinal chemistry but also asymmetric 
synthesis9 as chiral auxilaries and ligands. S-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-  
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ol borane complex (14) and evan auxilaries (15) were used for asymmetric reduction of 
aldehydes, ketones and aldol reaction respectively (figure 5). 
        Synthetic steps from a trans-epoxy cinnamate to the phenylisoserine is used in the 
synthesis of the side chain of Taxol.10 
 
 
Scheme 1 
        One of the straightforward synthetic procedure for the preparation of β-amino 
alcohols involving the ring opening of epoxides with amines.11 The reactivities of 2,3-
epoxy alcohols have been stidied extensively with various nucliophiles. 12 However, the 
utility of these reactions is dependent on the regioselectivity at C-2 andC-3.13 Only few 
direct and practical approaches to the ring opening of substituted epoxides using amines 
as nucliophiles have been reported.14 
 
Previous approcheses: 
        The introduction of a new and efficient method for this transformation under more 
convenient and general conditions is still in demand. Niobium pentachloride is well 
known in the literature as a mild and efficient catalyst for various organic 
transformations.19   
        M. Yamamoto et al19e reported, a  -tri alkylstannylmethyl- β-keto ester is 
homologated to the corresponding γ- keto ester in good yield. (Scheme 2) 
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Scheme 2 
        Y. Sudo et al 19f has demonstrated an efficient and selective methodology for C—
O bond cleavage promoted by Niobium pentachloride via chelation due to its strong 
oxophility and these observations should offer new insights into niobium chemistry. 
Further investigation on a possible application in organic synthesis is underway. 
(Scheme 3) 
 
 
 
 
Scheme 3 
        K. Suziki et al 19g reports combination of staoichiometric BF3.OEt2 and catalytic 
niobium pentachloride efficiently promotes the reaction of sec-phosphines to carbonyl  
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compounds with a concomitant oxygen transfer. This protocol offers a good synthetic 
route to various sort phosphine oxides in good to exelent yields. (scheme 4) 
        Srinivas Hotha et al19h a practical methodology for the synthesis of 2,3-dideoxy 
glycopyranosides in a stereoselective manner using a catalytic quantity of NbCl5 under 
microwave irradiation conditions. Our current endeavors are devoted to the 
incorporation of this protocol into our diversity oriented synthesis pathway development 
programs using glycals as starting templates (scheme 5). 
 
 
 
 
Scheme 5 
        C. K. Z. Andrade et al19i The nucliophilic addition of several nucliophiles 
(allyltrimethylsilane, silyl enol ether from acetophenone, indole and N-sulphonylindole) 
to the enantiopure cyclic N-acyliminium ion derived from malic acid, promoted by  
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Scheme 6 
 
niobium pentachloride is described. The products were obtained in good yields and in 
variable diastereoselectivities depending on the steric bulkness of the nucliophiles and 
the best results were obtained with the addition of indoles (scheme 6)  
        C. K. Z. Andrade et al19j Niobium chloride promoted the addition of allylstannanes 
or crotylstannanes to aromatic and aliphatic aldehydes. Excellent syn 
diastereoselectivity was obtained in the addition of E-cinnamylstannane to 
benzaldehyde (49:1). In the addition of allylstannane to racemic 2-
phenylpropionaldehyde, syn diastereoselection  
 
 
 
 
Scheme 7 
 
(Cram–anti-Cram=3:1) was observed. The same level of diastereoselection was 
achieved in the reaction between crotylstannane and benzaldehyde (scheme 7). 
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        Aurelio Ortiz19k group were reports a chiral auxiliary 1,3-oxazolidinethione that 
was utilized in the asymmetric intramolecular sulfur transfer reactions to the N-enoyl 
oxazolidinethiones using NbCl5 as promoting reagent, further more this Lewis acid is 
easy to handle and makes it possible to follow the course of the reaction (scheme 8). 
 
 
 
Scheme 8 
        Shigeru Arai et al19l repored NbCl5-AgCl4-catalysed friedal- crafts acylation and 
Sakurai-Hosomi reaction aetals with excellent chemical yields under quite mild 
conditions. These reaction systems allow using of 1 and 0.5 mol% each. 
 
 
 
Scheme 9 
        J.S.Yadav et al19b Niobium(V) chloride a useful and novel catalyst for selective 
acetylation of a wide range of alcohol functional groups such as primary, secondary, 
tertiary, benzylic and Phenolic (scheme 10).  
 
 
Scheme 10 
        M.G. Constantino et al 19p report a new and efficiant 2-step synthesis of 3-hydroxy 
chromone is described. Commercially available chromone is converted to the 
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corresponding epoxide which is rearranged with niobium pentachloride to 3-
hydroxychromone in  61% overall yield (scheme 11). 
 
 
 
Scheme 11 
        Kohei fuchibe et al19m report a variety of  , , ,-trifluorotoluenes could be 
reduced by the combined use of 5 mol % of Niobium(V) chloride and lithium aluminum 
hydride. The corresponding toluenes were obtained in good yields. Both complete and 
partial reduction of bis(trifluoromethyl)benzene derivative was also demonstrated 
(scheme 12). 
 
 
 
Scheme 12 
        Kohei fuchibe et al19n have developed a novel low-valent niobium- mediated 
synthetic method of indenes starting from o-alkenes-  , , -trifluorotoluenes via 
intramolecular coupling reaction of the CF3 group and the alkene C–H bond (scheme 
13). 
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Scheme 13 
        R. Wang et al19n report concise, high-yielding three-component Mannich reaction 
has been described. This approach could make a valuable contribution to the existing 
processes in the field of β-amino ketones synthesis (scheme 14). 
 
 
 
Scheme 14 
 
Present work : 
        The β-amino alcohols are versatile intermediates and major functional groups for 
the synthesis of various biologically active natural and synthetic products, synthetic 
amino acids, β-blockers, insecticidal agents, chiral auxiliaries, and oxazolines , which 
have been widely explored as protecting groups.15 Because of remarkable synthetic 
demand, the development of an efficient and environmentally friendly method for the 
regioselective ring opening of epoxides constitutes an active area of investigation in 
organic synthesis. One of the most straightforward synthetic approaches for the 
preparation of β-amino alcohols involves heating an epoxide with an excess of amines 
at elevated temperatures. Because some functional groups may be susceptible to high 
temperature, and also to control the regioselectivity, A variety of activators or 
promoters such as metal amides, metal triflates, transition-metal halides,16 microwaves, 
and ionic liquids17 have been developed to perform the epoxide ring-opening reactions 
with amines under mild reaction conditions. 18 
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        As part of our ongoing program into develop various new synthetic 
methodologies,20 herein we report our results on regioselective ring opening of various 
oxiranes with aromatic amines using a catalytic amount (10 mol%) of niobium 
pentachloride under mild reaction conditions. In a typical experiment, styrene oxide 1 (2 
mmol) and aniline 2 (2 mmol) were stirred in the presence of niobium pentachloride 
(0.2 mmol) at room temperature in dichloromethane to obtain the corresponding β -
amino alcohol 3a in 95% yield (scheme 14). The reaction was completed within 1 h, 
and the epoxide opening takes place in a regioselective manner preferentially at the 
benzylic position. Only a single product was obtained in all the styrene oxide reactions, 
and the structure of the product was confirmed by its 1H NMR spectrum. In a similar 
manner, glycidyl aryl ethers and aliphatic alkyl oxiranes reacted smoothly with aryl 
amines to afford the corresponding β amino alcohols (4i–4p) in very good yields with 
high regioselectivity. The epoxide opening takes place in a regioselective manner 
preferentially at the terminal opening. In these reactions also, only a single product was  
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obtained, and the structure of the product was confirmed by its 1H NMR spectrum. 
Furthermore, a cycloalkyl epoxide such as cyclohexene oxide reacted smoothly with 
different substituted aromatic amines to afford the corresponding b-amino alcohols (5e–
5h) in excellent yields with high regioselectivity (Scheme 15).  
 
The stereochemistry of the ring-opening products (Scheme 15) was found to be trans 
from the coupling constants. In the case of epichlorohydrin (Table 1, entries i–l) the 
ring-opening reaction proceeds very well, with one product of β -amino alcohols but no 
side products. The four different epoxides underwent ring opening with various 
substituted aromatic amines to afford the corresponding β -amino alcohols in very good 
to excellent yields. We noticed that the present reaction in the absence of NbCl5 could 
not progress. All the products were characterized by 1H NMR, IR, and mass 
spectroscopic data. This method does not require any anhydrous solvents or stringent 
reaction conditions. No precautions need to be taken to exclude moisture from the 
reaction medium. The reactions are clean and highly regioselective, affording high 
yields of products in a short reaction time of 1–4 h. The scope and the generality of this 
process are illustrated with respect to various epoxides and different substituted 
anilines. The advantages of niobium pentachloride are its simplicity in handling and the 
easy workup procedure for the isolation of products. In conclusion, the present 
methodology describes a simple, convenient, and efficient procedure for the 
regioselective ring opening of epoxides with a variety of aromatic amines using a 
catalytic (10 mol%) amount of niobium pentachloride. The notable features of this 
procedure are mild reaction conditions, excellent regioselectivity, cleaner reaction 
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profiles, improved yields, enhanced reaction rates, and simplicity of operation, which 
makes it a useful and attractive process for the synthesis of β -amino alcohols of 
biological and synthetic importance. 
 
GENERAL PROCEDURE 
Melting points were recorded on Buchi R-535 apparatus and are uncorrected. IR spectra 
were recorded on a Perkin-Elmer FT-IR spectrophotometer. 1H NMR spectra were 
recorded on Gemini-200 and Avance 300 spectrometer in CDCl3 using TMS as internal 
standard. Mass spectra were recorded on a Finnigan MAT 1020 mass spectrometer 
operating at 70 eV. All the products’ physical and spectroscopic data were compared 
with those reported in the literature. Niobium pentachloride (0.2 mmol) was added to a 
mixture of epoxide (2 mmol) and aniline (2 mmol) in dichloromethane (DCM, 10 mL). 
The resulting mixture was stirred at room temperature for a specified period  (Table 1). 
The progress of the reaction was monitored by thin-layer chromatography (TLC). After 
complete conversion of the starting material, the reaction mixture was diluted by adding 
dichloromethane (20 mL). The mixture was washed with water (2 x 20 mL) followed by 
brine solution. The organic layer was dried over Na2SO4 and concentrated under 
reduced pressure to obtain the crude products, which were purified by column 
chromatography (silica gel 60–120 mesh) while eluting with ethyl acetate–petroleum 
ether (3: 7). 
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Experimental section 
Spectral Data of the Selected Products:  
2-Pheny-2-phenylamino-ethanol (3a): colorless oil; IR (neat): max 3397, 3328, 2926, 
2873, 1602, 1503, 1452, 1431, 1354, 1317, 1228, 1108, 1067, 1028,  752, 698 cm-1; 1H 
NMR (300 M Hz, CDCl3): 7.34 - 7.21 (m, 5H); 7.06 (t, J = 7.0 Hz, 2H), 6.62 (t, J = 
7.0 Hz, 1H), 6.49 (d, J = 7.0 Hz, 2H), 4.41 (dd, J = 11.0, 6.5 Hz, 1H), 3.89 (dd, J = 
10.8, 6.6 Hz, 1H),3.72 (dd, J = 10.8, 6.6 Hz, 1H),; EIMS(relative intensity): m/z (%) 
213 (m+ 10), 204 (12), 182 (100), 104 (31), 91 (95), 77 (35).  
2-(2,4-Dichloro=phenylamino)-2-phenyl-ethanol (3b): pale yellow solid; mp: 76-
78oC. 1H NMR (300 M Hz, CDCl3):  3.72 (dd, J = 10.8, 6.6Hz, 1H), 3.94 (dd, J = 10.8, 
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4.4 Hz, 1H), 4.40 (dd, J = 10.8, 6.8 Hz, 1H), 6.32 (dd, J = 8.6, 4.2 Hz, 1H), 6.60 (t, J = 
7.4 Hz, 1H), 7.20 (d, J = 11.8 Hz, 1H), 7.40 (m, 5H). ESI-MS (m/z): 283.16 (M++1).  
2-(2-Methoxy-phenylamino)-2-phenyl-ethanol (3c): White solid, mp: 74-76oC, 1H 
NMR (300 MHz, CDCl3):  2.38 (s, 3H),  3.75 (dd, J = 8.6, 4.2 Hz, 1H), 3.96 (m, 1H), 
4.48 (dd, J = 10.6, 6.8 Hz), 3.64 (d, J = 8.6 Hz, 1H), 6.62-6.54 (m, 2H), 6.70 (d, J = 8.6 
Hz, 1H), 7.38-7.20 (m, 5H). ESI-MS: 244.30(M++1) 
2-(3-Chloro-2-methylphenylamino)-2-phenylethanol (3d): Brownish oil, IR (neat): 
max 3412, 3326, 3068, 2942, 2851, 1605, 1554, 1436, 1372, 1251, 1128, 1049, 1018, 
936, 847, 752 cm-1; 1H NMR (300 MHz, CDCl3):  2.35 (s, 3H), 3.70–3.80 (m, 1H), 
4.40–4.50 (m, 1H), 4.95 (t, J = 6.5 Hz,1H,), 6.18 (d, J = 6.5 Hz, 1H,), 6.65–6.80 (m,1H) 
7.25–7.40 (m, 6H); EIMS m/z (%) 261 (m+ 10), 230 (88), 156 (18), 125 (100), 103 (31), 
91 (95), 77 (35), 61 (42), 57 (70), 43 (55). Calcd. for C15H16ClNO: C, 68.83; H, 6.16; N, 
5.35. Found: C, 68.81; H, 6.13; N, 5.32.  
2-(3-Nitro-phenylamino)-2-phenyl-ethanol (3e): Brownish oil; IR (KBr): max 3402,  
2928, 2856, 1621, 1582, 1346, 1261, 1066, 853, 734; cm-1; 1H NMR (300 MHz, 
CDCl3): 1.88–2.00 (br, OH), 3.68-3.80 (m, 1H), 3.90-4.00 (m, 1H), 4.44-4.52 (m, 1H), 
4.96-5.10 (m, 1H), 6.70 (d, J = 6.5 Hz, 1H), 7.15 (t, J = 7.5 Hz, 1H), 7.22-7.40 (m, 5H) 
7.50-7.40 (d, J = 6.5 Hz, 1H); EIMS m/z (%) 258, (m+ 2), 227 (100), 181 (46), 77 (5).  
2-(3-Nitro-phenyamino)-cyclohexanol (6f): Brown colored solid, mp 71–72 oC; IR 
(KBr): max 3394,  2928, 2856, 1738, 1622, 1582, 1528, 1453, 1347, 1132, 1067, 949, 
854, 735; cm-1; 1H NMR (300 MHz, CDCl3):  0.81–0.95 (m, 1H), 1.22–1.45 (m, 3H), 
1.70–1.85 (m, 2H), 2.04–2.20 (m, 2H), 2.85 (brs, NH), 3.20 (ddd, 1H, J = 4.2, 9.5 & 
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11.0 Hz), 3.40 (ddd, J = 4.0, 10.0 & 11.0 Hz, 1H), 6.95 (d, J = 6.5 Hz, 2H), 7.30 (t, J = 
7.5 Hz, 1H), 7.55 (t, J = 7.5 Hz, 1H); EIMS m/z (%) 237, (m+ 62), 221 (26), 194 
(10),178 (96), 152 (32), 139 (15), 121 (18), 118 (40), 92 (51), 57 (41), 41(100).  
2-(2-Methoxy-phenylamino)-cyclohexanol (6g): Whight  solid, mp 56–57 oC ; IR 
(KBr): max 3380,  3063, 3000, 2933, 2858, 1601, 1511, 1457, 1431, 1401, 1343, 1302, 
1224, 1177, 1141, 1118, 1068, 1030, 936, 850, 738; 1H NMR (300 MHz, CDCl3):  
0.98–1.18 (m, 1H), 1.25–1.41 (m, 3H), 1.70–1.80 (m, 2H), 2.05–2.20 (m, 2H), 2.75 
(brs, NH), 3.10 (ddd, 1H, J = 4.1, 9.2 & 11.0 Hz), 3.40 (ddd, J = 4.1, 92.0 & 11.0 Hz, 
1H), 3.85 (s, 3H), 6.60 – 6.85 (m, 4H), EIMS m/z (%) 221, (m+ 90), 162 (100), 136 
(25), 123 (90), 108 (82), 80 (81), 53(41). 
1-trans-2-(2-Chloro-3-methylphenylamino)-cyclohexanol (6h): Light colored solid, 
mp 49–508C; IR (KBr): max 3408, 3374, 3061, 2935, 2861, 1603, 1585, 1506, 1456, 
1429, 1389, 1346, 1312, 1267, 1214, 1163, 1131,1097, 1059, 946, 913, 854, 763, 748 
cm-1; 1H NMR (CDCl3):  0.94–1.15 (m, 1H), 1.23–1.40 (m, 3H), 1.68–1.79 (m, 2H), 
2.02–2.20 (m, 2H), 2.40 (s, 3H), 2.85 (brs, NH), 3.15 (ddd, 1H, J = 4.0, 9.0 & 11.0 Hz), 
3.38 (ddd, 1H, J = 4.0, 10.0 & 10.0 Hz), 6.50 (d, 1H, J = 6.5 Hz), 6.75 (d, 1H, J = 6.5 
Hz), 7.05 (t, 1H, J = 6.5 Hz); EIMS: m/z (%) 241 (m+ 30), 204 (12), 189 (10), 127 
(100), 114 (56), 90 (39), 75 (31), 65 (11), 51 (32). Calcd. for C13H18ClNO: C, 65.13; H, 
7.57; N, 5.84. Found: C, 65.10; H, 7.55; N, 5.81.  
2-(4-chloro-phenylamino)-cyclohexanol (6i) : white solid, mp 61–52oC; IR (KBr): 
max 3394, 3276, 3081, 2961, 2846, 1739, 1608, 1526, 1452, 1381, 1232, 1112, 1073, 
952, 847, 753 cm-1; 1H NMR (CDCl3):  0.98–1.08 (m, 1H), 1.29–1.41 (m, 3H), 1.70–
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1.85 (m, 2H), 2.08–2.20 (m, 2H), 2.90 (brs, NH), 3.10 (ddd, 1H, J = 4.2, 9.5 & 11.0 
Hz), 3.30 (ddd, 1H, J = 4.0, 10.0 & 10.0 Hz), 6.68-6.78 (m, 2H), 7.10-7.20 (m, 2H); 
EIMS: m/z (%) 227 (m+ 30), 191 (25), 167 (51), 114 (19), 96 (21), 77 (100), 56 (31). 
2-(4-nitrophenyamino)cyclohexanol (6j): broen solid, mp 71–72 oC; IR (KBr): max 
3394, 2928, 2856, 1749, 1622, 1528, 1453, 1347, 1262, 1133, 1067, 949, 854, 815, 735 
cm-1; 1H NMR (CDCl3):  0.80–0.95 (m, 1H), 1.22–1.45 (m, 3H), 1.70–1.85 (m, 2H), 
2.08–2.20 (m, 2H), 3.20 (ddd, 1H, J = 4.2, 9.5 & 11.0 Hz), 3.40 (ddd, 1H, J = 4.0, 10.0 
& 10.0 Hz), 3.80 (br, s, 1H), 6.95 (d, J = 7.5Hz, 2H), 7.55 (d, J = 7.5Hz, 2H); EIMS: 
m/z (%) 237 (m+ 79), 221 (26), 194 (10), 178 (96), 152 (32), 139 (15), 121 (18), 118 
(40), 106 (14), 92 (51), 65 (66) 57 (66), 41 (100). 
1-Chloro-3-phenylamino-propan-2-ol (4k): colourless oil, IR (KBr) max: 3404, 3396, 
3062, 2952, 2836, 1602, 1583, 1505, 1456, 1404, 1318, 1259, 1247, 1102, 1090, 912, 
847, 753; 1H NMR (200 MHz, CDCl3):  2.85 (brs, NH), 3.18 – 3.41 (m, 2H), 3.60 – 
3.70 (m, 2H), 3.98 – 4.10 (m, 1H), 6.55 – 6.65 (m, 3H), 7.10 -7.20 (m, 2H). EIMS m/z 
(%): 185, (m+ 20), 168 (26), 106 (100), 77 (41), 51(21). 
1-Chloro-3-(3-chloro-2-methylphenyl)-aminopropan-2-ol (4l): Browncolored syrup, 
IR (neat) max: 3403, 3386, 3072, 2941, 2837, 1605, 1518, 1461, 1404, 1346, 1286, 
1231, 1203, 1172, 1134, 1108, 1031, 917, 846, 748 cm-1; 1H NMR (CDCl3):  2.28 (s, 
3H), 2.45 (brs, 1H), 3.25 (q, J = 6.5 Hz,1H), 3.42 (dd, 1H, J = 4.0 & 9.5 Hz), 3.65–3.75 
(m, 2H), 4.00 (brs, 1H), 4.15 (brs, 1H), 6.53 (d,  J = 7.0 Hz, 1H), 6.80 (d, J =7.0 Hz, 
1H), 7.05 (t, J =7.0 Hz, 1H); EIMS m/z (%): 234 (m+ 10), 232 (15), 156 (41), 154 (100), 
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125 (15), 117 (10), 89 (20), 77 (12), 51 (10), 43 (12). Calcd. for C10H13Cl2NO: C, 
51.30; H, 5.60; N, 5.98. Found C, 51.27; H, 5.56; N, 5.95.  
1-Chloro-3-(2-methoxy-phenylamino)-propan-2-ol (4m): colourless oil, IR (KBr) 
max: 3389, 3067, 2936, 2839, 1602, 1513, 1458, 1344, 1295, 1251, 1223, 1177, 1132, 
1102, 1026,743; 1H NMR (200 MHz, CDCl3):  3.10 – 3.20 (m, 1H), 3.25 – 3.34 (m, 
1H), 3.50 – 3.60 (m, 2H), 3.78 (s, 3H), 3.90- 4.00 (m, 1H), 6.50 – 6.75 (m, 3H), 6.80 –
6.85 (m, 1H). EIMS m/z (%): 215, (m+ 20), 136 (100), 121 (60), 120 (56), 77 (10), 
65(10). 
1-Phenyloxy-3-phenylamino-propan-2-ol (4n): colourless oil; IR (neat) max: 3408, 
3061, 3056, 2926, 2872, 1602, 1562, 1517, 1491, 1362, 1243, 1123, 1039, 947, 861, 
742 cm-1; 1H NMR (300 CDCl3):  3.15 (dd, J = 7.5 , 12.0 Hz, 1H), 3.36(dd, J = 4.5 , 
12.0 Hz, 1H), 3.50–3.60 (m, 2H), 4.02–4.35 (m, 1H), 6.55–6.70 (m, 3H), 7.15–7.35 (m, 
7H); EIMS m/z (%): 243 (m+ , 18 ), 150 (23), 137 (32), 106 (100), 93 (14), 77 (41), 51 
(31).  
1-(2,4-Dichloro-phenylamino)-3-phenyloxy-propan-2-ol (4o): colourless oil; IR 
(neat) max:  3397, 3061, 3047, 2961, 2851, 1631, 1604, 1501, 1487, 1342, 1213, 1143, 
1019, 951, 841, 748 cm-1; 1H NMR (300 CDCl3):  3.18 (dd, J = 6.0 , 11.0 Hz, 1H), 
3.32 (dd, J = 4.0, 11.0 Hz, 1H), 3.52–3.63 (m, 2H), 4.05–4.30 (m, 1H), 6.65 (d, J = 7.0 
Hz, 1H), 7.10 (d, J = 7.0 Hz, 1H), 7.30 (s, 1H); EIMS m/z (%): 312 (m+, 18 ), 275 (10), 
219 (23), 175 (18), 163 (12), 146 (31), 134 (21), 109 (100), 90 (24), 74 (36), 49 (24). 
1-Phenoxy-3-(3-chloro-2-methylphenyl)-aminopropan-2-ol (4p): Lightyellow oil; IR 
(neat) max: 3403, 3371, 3065, 2943, 2849, 1636, 1606, 1541, 1508, 1431, 1362, 1308, 
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1256, 1137, 1046, 1012, 937, 851, 749 cm-1; 1H NMR (CDCl3):  2.37 (s, 3H), 3.18 (dd, 
J = 5.5 & 10.5 Hz, 1H), 3.32 (dd, J = 5.5 & 10.5 Hz, 1H), 3.45–3.58 (m, 2H), 3.90–3.97 
(m, 1H), 6.20 (d, J = 7.0 Hz, 1H), 6.70–6.85 (m, 1H) 7.30–7.40 (m, 6H); EIMS m/z 
(%): 291 (m+ , 21), 256 (18), 154 (21), 137 (100), 119 (56), 104 (11), 93 (15), 77 (25), 
61 (412), 57 (37), 43 (51). Calcd. for C16H18ClNO2: C, 65.86; H, 6.22; N, 4.80. Found 
C, 65.84; H, 6.19; N, 4.78. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                         Chapter III, Section B, synthesis of amino alcohols 
 153
REFERENCES: 
1) a) Ager, D. J.; Prakash, I.; Schaad, D. Chem. Rev., 1996, 96, 835.  
 b)Auvin-Guette, C.;  Rebuffat, S.; Prigent, Y.; Bodo, B. J. Am. Chem. Soc. ,     
1992, 114, 2170.  
c) Corey, E. J.; bakshi, R. K; Shibata, S.; Chen, C. P.; Singh, V. K. J. Am. Chem. 
Soc.,1987, 109, 7925. 
2) Odmann, L.; Gilman,s, A. “ The phormoclogical basis of therapeutics” 6 th Ed.. 
Eda acmillan, New York, 1980. 
3) a) Ariens, E. J.; Soudijn, W.; Timmermans, P. B. M. W. Eds.  “Stereochemistryy 
and biological activiy” Blackwell Scienttific Publications, Amsterdam, 1982. 
            b) Ariens, E. J. Med. Res. Rev., 1986, 6, 451.  
            c)Wainer, L.; Drayer, D. E. Eds. “Drug Stereochemistry” Marcel Dekker, 
Newyork, 1988. 
4) a) Hieble, J.P.; bondinell, W. E.; Ruffolo, J. R, J. R. J. Med. Chem., 1995, 28, 
3415. b) Corey, E. J.; Link. J. O. J. Org. Chem., 1991, 56, 442. 
5) Elks, J; Ganellin, C. R. “ Dictionary of drugs” Chapman and Hall; London, 
1990. 
6) Ruffelo, R. R. Jr.; Bondwell, W.; Hieble, J. P. J. Med. Chem., 1995, 38, 3681. 
7) Roger, G. A.; Parsons, S. M.; Anderson, D. L.; Nilsson, L. M.; Bahr, B. A.; 
Kornreich, A. D.; Koufman, R.; Jacobs, R. S.; Kirtman, B. J. Med. Chem., 1989, 
32, 1217. 
8) Cater, H. E.; Glick, F. J.; Norris, W. P.; Phillips, G. E., J. Biol. Chem., 1947, 
170, 285. 
 
                                                         Chapter III, Section B, synthesis of amino alcohols 
 154
9) a) Itsuno, S.;  Ito, K. J. Org. Chem., 1984, 555. b) Kolo H. C.; Van 
Nieeuweenhze, M. S.; Sharpless, K. B. Chem. Rev., 1994, 94, 2483. 
10) Adger, B. M.; Barkley, J. V.; Bergeron, S.; Cappi, M. W. J. Chem. Soc., Perkin 
Trans. 1, 1997, 3501. 
11) a) Chang, B. L.; Ganesan, A. Bioorg. Med. Chem. Lett., 1997, 7, 1511.  b) Van 
de Weghe, P.; Collin, J. Tetrahedron Lett., 1995, 36, 1649. c) Chakraborti, A. 
K.; Kondaskar, A. Tetrahedron Lett., 2003, 44, 8315. d) Zhao, P-Q.; Xu, L. 
Synlett 2004, 846. e) Sekar, G.; Kamble, R. M.; Singh, V. K. Tetrahedron 
asymmetry 1999, 10, 3663.  f) Martinez, L. E.; Leighton, J. L.; Carsten, D. H..; 
Jacobsen, E. N. J. Am. Chem. Soc., 1995, 117, 5897.  g) Larrow, J. F.; Schaus, S. 
E.; Jacobsen, E. N. J. Am. Chem. Soc. 1996, 118, 7420. 
12) Hanson, R. M. Chem. Rev., 1991, 91, 437. 
13) a) Sasaki, M.; Tanino, K.; Hirai, A.; Miyashita, M. Org. Lett., 2003, 5, 1789 and 
references therein. b) Tomata Y.; Sasaki, M.; Tanino, K.; Miyashita, M. 
Tetrahedron Lett 2003, 44, 8975. c) Liu, Z.; Yang, D.; Wu, L. Tetrahedron Lett. 
2004, 45, 1565. d) Islas-Gonzalez, G.; Puigjaner, C.; Vidal-Ferram, A.; Moyana, 
A.; Riera, A.; Pericas, M. A. Tetrahedron Lett. 2004, 45, 6337.   
14) Chini, M.; Crotti, P.; Gardelli, C.; Macchia, F. J. Org. Chem., 1994, 59, 4131. 
15) (a) Corey, E. J.; Cheng, X.-M. The Logic of Chemical Synthesis; John Wiley: 
New York, 1989; (b) Kino, T.; Halanaka, H.; Hashimoto, M.; Nishiyama, M.; 
Goto, T.; Okuhara, M.; Kohsaka, M.; Aoki, H.; Imanaka, H. J. Antibiot. 1987, 
40, 1249; (c) Bose, D. S.; Narsaiah, A. V. Bioorg Med. Chem. 2005, 3, 627; (d) 
 
                                                         Chapter III, Section B, synthesis of amino alcohols 
 155
Erhardt, P. W.; Woo, C. M.; Anderson, W. G.; Gorczynski, R. J. J. Med. Chem. 
1982, 25, 1408. 
16) (a) Yamamoto, Y.; Asao, N.; Meguro, M.; Tsukade, N.; Nemoto, H.; Adayari, 
N.; Wilson, J. G.; Nakamura, H. J. Chem. Soc., Chem. Commun. 1993, 1201; (b) 
Pachon, L. D.; Gamez, P.; Van Bessel, J. J. M.; Reedijk, J. Tetrahedron Lett. 
2003, 44, 6025; (c) Chakraborthi, A. K.; Kondaskar, A. Tetrahedron Lett. 2003, 
44, 8315; (d) Ollevier, T.; Guillaume, L. C. Tetrahedron Lett. 2004, 45, 49; (e) 
Curini, M.; Epifano, F.; Marcotullio, M. C.; Rosati, O. Eur. J. Org. Chem. 2001, 
4149; (f) Khodaei, M. M.; Khosropour, A. R.; Ghozati, K. Tetrahedron Lett. 
2004, 45, 3525. 
17) (a) Gupta, R.; Paul, S.; Gupta, A. K.; Kachroo, P. L.; Dandia, A. Ind. J. Chem. 
1997, 36B, 281; (b) Yadav, J. S.; Reddy, B. V. S.; Basak, A. K.; Narsaiah, A. V. 
Tetrahedron Lett. 2003, 44, 1047; (c) Yadav, J. S.; Reddy, B. V. S.; Sadashiv, 
K.; Harikishan, K.; Narsaiah, A. V. J. Mol. Catal. A. 2004, 220, 153. 
18) (a) Whitesel, J. K.; Felman, S. W. J. Org. Chem. 1980, 45, 755; (b) Yamada, J.; 
Yomoto, Y.; Yamamoto, Y. Tetrahedron Lett. 1989, 30, 4255. (c) Ramesh 
kumar, S., Leelavathi, P. Can. J. Chem. 2007, 85, 37. 
19) (a) Constantino, M. G.; Lacerda, V., Jr.; De Silva, G. V. S. Molecules 2002, 7, 
456; (b) Yadav, J. S.; Narsaiah, A. V.; Reddy, B. V. S.; Basak, A. K.; Nagaiah, 
K. J. Mol. Catal. A. 2005, 230, 107; (c) Nagaiah, K.; Reddy, B. V. S.; Sreenu, 
D.; Narsaiah, A. V. Arkivoc 2005, 3, 192; (d) Carlos, K. Z.; Andrade, N. R.; 
Azevedo, G. R.; Aliver, A. Synthesis 2002, 928; (e) Srinivas, H.; Ashish, T. 
Tetrahedron Lett. 2005, 46, 4555; (f) Makoto Yamamoto, Misako Nakazava, 
 
                                                         Chapter III, Section B, synthesis of amino alcohols 
 156
Keiki Kishikawa and Shigeo Kohmoto. Chem. Comm. 1996, 2353; (g) Y. Sudo, 
S. Arai and A. Nishida Eur. J. Org. Chem. 2006, 752-758; (h) Srinivas H.; 
Ashish T. Tetrahedron Lett. 2005, 4555-4558; (i) Carlos Kleber Z. Andrade, 
Rafael O. Rochaa, Dennis Russowskyb and Marla N. Godoy J. Braz. Chem. 
Soc., Vol. 16, No. 3B, 2005, 535-539; (j) Carlos Kleber Z. Andrade, Neucirio R. 
Azevedo. Tetrahedron Lett. 2001 6473-6476; (k) Aurelio Ortiza, L. Ouintero, H. 
Hernandez, S. Maldonado, G. Mendoza, S. Berne. Tetrahedron Lett. 2003, 
1129-1132; (l) Shigeru A.; Yukinori S.; Atsushi Nishida. Tetrahedron 2005, 
4639-4642; (m) Kohei F.; Yoshitaka, O.; Ken, M and Takahiko, A. Org.Lett. 
2007, 1497-1499; (n) Kohei F.; Ken, M and Takahiko, A. Chem.Lett.2007, 24-
25; (o) Rui Wang, Bo-gang Li,; Tai-kun Huang,; Lin Shi and Xiao-xia Lu. 
Tetrahedron Lett. 2007, 2071-2073; (p) Constantino, M. G.; Lacerda Junior, V.; 
Jose da siva, G. V. J. Heterocycl. Chem. , 2003, 40, 369-371. 
20) (a) Narsaiah, A. V.; Nagaiah, K. Adv. Synth. Catal. 2004, 346, 1271; (b) 
Narsaiah, A. V.; Basak, A. K.; Nagaiah, K. Synthesis 2004, 8, 1253; (c) 
Narsaiah, A. V.; Nagaiah, K. Synthesis 2003, 12, 1881; (d) Narsaiah, A. V.; 
Nagaiah, K. Ind. J. Chem. Sect. B. 2004, 11, 2478; (e) Narsaiah, A. V.; Nagaiah, 
K. Synth. Commun. 2003, 21, 3825. 
 
 
 
 
 
 
                                                                                                     Chapter III, Section B 
 157
Niobium (V) chloride catalyzed tetrahydropyranylation of alcohols. 
Introduction 
        During endeavors of the total synthesis of biologically active natural products, 
which involves the protection and deprotection of a variety of functional groups. 
Among the various functional groups, hydroxy is very familiar and its protection as 
tetrahydropyranyl ether (THP) is a common and widely used transformation in organic 
synthesis.1 The tetrahydropyran derivatives are attractive for the reason that they are 
less expensive, easily deprotected and stable under variety of reaction conditions such 
as strongly basic media, metal hydrides, metal triflates, Grignard reagents, acylating 
agents, oxidative reagents and alkylating agents.2 THP groups are also the protective 
groups of choice in peptide, nucleotide, carbohydrate and steroid chemistry.3  
 
 
 
Scheme 1 
General Mechanism for tetrahydropyranylation of alcohols: 
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        In this section described for the tetrahydropyranilation of alcohols are reviewed in 
the past work and several facial approaches for tetra hydro pyranylation.  
 
Previous approaches for the tetrahydropyranylation of alcohols: 
        A variety of Bronsted as well as Lewis acid catalysts, resins and heteropoly acids 
are used for tetrahydropyranylation of hydroxy functions. 
       Menjer and co-workers 4 reported poly (4-vinyl pyridinium-p-tolylsulphonate as a 
heterogeneous polymer catalized tetrahydropyranylation of aromatic and aliphatic 
alcohols with high yields. The reactivity of alcohols to the formation of THP-ethers is 
primary alcohols is better than secondary alcohols than tertiary alcohol. 
 
 
 
 
 
Scheme 1 
        Bongini and coworkers 5 reported tetrahydropyranylation of alcohols in DCM by 
using Amberlist-H-15 as catalyst and also reported deprotection of THP group by using 
this catalyst in methonolic solution of THP-Ether provided to alcohol. 
 
 
 
 
Scheme 2 
OH
+
O
O OCatalyst
Benzene
Catalyst = Poly (4-vinyl pyridinium p-tolyl sulphonate)
OH
+
O
O OAmberlyst-H-15, DCM
Amberlyst-H-15, Methanol
 
                                                                                                     Chapter III, Section B 
 159
        Olah and coworker 6 reported tetrahydropyranylation of aromatic and aliphatic 
alcohols by using Iodo trimethyl silane as a catalyst with dihydropyran in DCM with 
high yields. 
 
 
 
 
Scheme 3 
        Many of report from various groups: Orlivic and co-workers 7 reported with K-10 
monmorillonite as catalyst, Miyashita and co-workers 8 reported with PPTS 
(pyridinium-P-tolylsulphonate), as a mild and efficient catalyst for 
tetrahydropyranylation of alcohol, (scheme 2).  
        Karimi and co-workers9 reported with lithium triflate in dichloroethane, Afonso10 
and co-workers reported Ionic liquid as a recycle media for the tetrahydropyranylation 
of alcohols, Varma and co-workers 11 reported microwave assisted dialkyl imidazolium 
terachloroaluminate and it application of tetrahydropyranylation of aromatic and 
aliphatic alcohols under solvent free conditions Chavez12 and coworkers reported 
trtrahydropyranylation of alcohol with sulfuric acid on silica.  (scheme1). 
        Mineno 13 reports indium triflate catalyzed tetrahydropyranylation of alcohols in 
DCM and deprotection of THP-ethers in methanol, Molnar and coworkers 14 reported 
mild and efficient method of  hetero poly acid  catalyzed protection and deprotection of 
THP-ethers, Salehi and co-workers 15 reported ZrCl4 catalyzed tetrahydropyranylation 
OH
+
O
O
(CH3)3SiI
DCM
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of alcohols in DCM and detetrahydropyranylation of  methanolic solution of THP-
ethers (scheme 2). 
Present work: 
        However, many of these methods have drawbacks such as harsh acidic conditions, 
long reaction times, expensive catalyst, the lack of generality, reflux conditions, 
formation of polymeric by-products of the dihydropyran and isomerization. In addition, 
stoichiometric amounts of reagents or even in excess are sometime required to effect 
complete conversion of the substrate. Niobium (V) chloride is a well-known mild Lewis 
acid catalyst useful for effecting a variety of transformations. 
 
 
 
 
Scheme 4 
 
        As part of our continuing interest in the development of new synthetic 
methodologies,16-18 we wish to report the Lewis acid efficiency of niobium(V) chloride 
for the tetrahydropyranylation of various alcohols and phenols. Reactions were carried 
out in dichloromethane. In a typical experimental procedure, a variety of alcohols 1 
(primary, secondary, benzylic, allylic and phenolic) were treated with 3,4-dihydro-2H-
pyran 2 (DHP, 1.2 equiv.), and niobium (V) chloride (10 mol%) in DCM to obtain the 
corresponding THP-ethers. The products were characterized by 1H NMR, MASS, IR 
spectroscopy.  
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Proposed mechanism for the tetrahydropyranylation of alcohols: 
 
 
 
 
 
 
 
 
 
         
Figure 1 
 
        The treatment of benzyl alcohol 1b (1.0 equiv.) with dihydropyran 2 (1.2 equiv.) in 
presence of Niobium pent chloride (10 mol %) in DCM afforded corresponding THP-
benzyl ether 3b. The characterization of product was in the 1H NMR a characteristic 
signals observed at δ 4.90-4.86 as multiplate for THP acetal and another benzylic 
alcohol signal was observed at  δ 4.44 as doublet, the molecular ion signal at 192 in 
mass spectrum and the data compared with previous reports4 to conform the product. 
The functional compound conjugated ester, alcohols like Baylis-Hillman adduct 1d, 1h 
afforded their corresponding products with out any disturbing of other functional 
groups. 1H NMR of 1d the characteristic acetal signal observed at δ 5.58 as singlet and 
olefin protons observed at δ 6.08, and δ 6.32 , in mass spectrometry molecular ion peak 
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observed at 290 which was conformed. In IR spectrum a signal observed at 1720 cm-1 
which was further conformation of ester group for product 3d. 
        In this report we investigated the substrate scope of diverse alcohols including 
those that contain variety of  sensitive functional groups like acetonide (entry q), esters 
(entries d and g), ether (entry 1) and carbamates (entries h and p) presents (Table 1, 2) 
our observation along with the optimized parameters for obtaining the best yields of 
tetrahydropyranyl derivatives. In all cases, the THP-protection took place efficiently 
and gave excellent yields without affecting the other protecting groups. The reactions 
are reasonably fast, 2-3 h, which holds well even with hindered alcohols like menthol 
(entry l) and borneol (entry n). The reaction conditions are mild enough not to induce 
any isomerization of double bonds or chiral centers during tetrahydropyranylation of 
allylic moities (entries d, h and s). The acid sensitive alcohol like Baylis-Hillman 
adduct (entry d) also underwent protection without formation of any side products. 
Another important feature of this method is that absolute anhydrous conditions are not 
required. 
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Entry Substrate reactiontime(h) producta yeildb
a
OH
MeO
OTHP
MeO
2.0 92
OTHPOH
OTHP
F
OTHP
COOEt
OH
COOEt
OH OTHP
OH
O
OH
EtO
O
OTHP
EtO
OH
NH
O
O
OTHP
NH
O
O
OH OTHP
O
OTHP
O
OH
OTHP
b
c
d
e
f
g
h
i
j
2.5
2.5
2.0
2.0
2.0
2.5
3.0
3.0
3.0
90
86
90
94
95
88
86
91
87
Table 1: Niobium (V) chloride promoted tetrahydropranylation of alcohols
OH
F
 
                                                                                                     Chapter III, Section B 
 164
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        In conclusion, the present method describes an efficient and practical method for 
the protection of a wide range of structurally varied alcohols and phenols as 
tetrahydropyranyl ethers using niobium (V) chloride as catalyst. The significant 
advantages of this methodology over previously reported methods are milder reaction 
Entry Substrate reactiontime(h) producta yeildb
2.0 91
3.0
3.0
3.0
2.5
2.0
3.0
89
89
85
86
89
90
89
OH OTHP
k
OH OTHPl
m
OH OTHP
n
OTHPOH
0 N
OH
Boc
N
OH
Boc
P
O
OBnPh
OH
O
O O
OBnPh
OTHP
O
O
2.5
q
OH OTHP
r
OH OTHP
Table 1: Continued.................
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temperatures (room temperature), shorter reaction times, higher substrate to catalyst 
ratios, better yields, easier work-up conditions and a greater tolerance of functional 
groups present on substrates. We envisage that this method will find practical 
application for the protection of alcohols in multistep organic synthesis. 
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Experimental Section: 
General Procedures.  
        All commercial reagents were used without purification. The reaction mixtures 
were stirred magnetically and monitored by TLC using 0.25 mom E-Merck silica gel 60 
F254 precoated glass plates, which were visualized with UV light. IR spectra were 
recorded on a Perkin Elmer FT-IR–240 oC spectrophotometer. 1H NMR spectra were 
recorded on Bruker Avance 300 MHz spectrometer and Unity 400 MHz spectrometer. 
Chemical shifts are given in ppm with respect to internal TMS, and J values are quoted 
in Hz. Mass spectra were recorded on a Finnigan Mat 1020 mass spectrometer operating 
at 70 eV. Niobium (V) chloride was purchased from Aldrich (99%) and used as such. 
General procedure for the tetrahydropyranylation of alcohols 
        To a solution of alcohol (5 mmol), and dihydropyran (6 mmol) in dichloromethane 
(10 ml) was added niobium (V) chloride (0.5 mmol) and the mixture stirred at room 
temperature. The reaction progress was monitored by thin layer chromatography 
(Table1). After the complete conversion of the starting material, the reaction mixture 
was diluted by adding dichloromethane (20 ml) and washed with water (2 x 20 ml) 
followed by brine. The organic layer was dried over anhydrous Na2SO4 and 
concentrated under reduced pressure to obtain the crude products, which were purified 
by column chromatography by eluting with a mixture of ethyl acetate and n-hexane. 
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Spectral data for selected compounds 
2-(4Methoxy-phenoxy)-tetrahydro-pyran (2a): Colourless oil; 1H NMR (CDCl3): δ 
1.60-2.08 (m, 6H), 3.61 (m, 1H), 3.79 (s, 3H), 3.96 (m, 1H), 5.32 (br. s, 1H), 6.82-7.04 
(m, 4H). 
2-benzyloxy-tetrahydro-pyran (2b): Colourless oil; I.R (neat): νmax 3057, 2974, 2846, 
1608, 1528, 1421, 1379, 1256, 1171, 1129, 1068, 983,  cm-1H NMR (CDCl3): δ 1.20-
1.42 (m, 6H), 3.52-3.59 (m, 1H), 3.84-3.92 (m, 1H), 4.44 (d, J = 11.0 Hz, 1H), 4.86-
4.90 (m. 2H), 7.22-7.38 (m, 5H). EIMS m/z (%): 192 (M+, 5), 146(15), 108 (23), 101 
(56), 91 (100), 41 (37). 
2-(4-flouro-phenoxy)-tetrahydro-pyran (2c): Colourless oil; 1H NMR (CDCl3): δ 
1.70-1.50 (m, 3H), 1.86-1.78 (m, 2H), 2.04-1.92 (m, 1H), 3.58-3.50 (m, 1H), 3.80-3.88 
(m, 1H), 5.30-5.25 (m. 1H), 7.00-6.85 (m, 4H). EIMS m/z (%): 196(M+, 4), 112 (28), 
85(100), 67 (30), 57 (64), 41 (70). 
2-[Phenyl,tetrahydropyran-2yloxy]methyl-2-propen-1-oate (2d). Colourless oil; I.R 
(neat): νmax 3057, 2973, 2849, 1720, 1605, 1538, 1423, 1379, 1256, 1169, 1123, 1072, 
983, 857, 741 cm-1; 1H NMR (CDCl3): δ 1.23 (t, 3H, J = 6.0 Hz), 1.55-1.65 (m, 4H), 
1.70-1.90 (m, 2H), 3.40-3.90 (m, 2H), 4.15 (q, 2H, J = 6.0 Hz), 4.50 (s, 1H), 5.58 (s, 
1H), 6.08 (s, 1H), 6.32 (s, 1H), 7.30-7.40 (m, 5H); EIMS m/z (%): 290 (M+, 12), 244 
(15), 206 (23), 189 (56), 143 (10), 115 (82), 105 (18), 85 (100), 67 (10), 57 (28), 41 
(37); Anal.Calcd for C17H22O4 C, 70.32; H, 7.64 Found: C, 70.29; H, 7.68. 
2-(Diphenylmethoxy)tetrahydropyran (2e). Colourless oil; I.R (neat): νmax 3058, 
2939, 2869, 1490, 1448, 1379, 1200, 1118, 1077, 976, 762, 742, 700 cm-1; 1H NMR 
(CDCl3): δ 1.40-2.00 (m, 6H), 3.42-3.54 (m, 1H), 3.82-3.92 (m, 1H), 4.66 (t, 1H, J = 
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6.5 Hz), 5.80 (s, 1H), 7.14-7.40 (m, 10H); EIMS m/z (%): 268 (M+, 62), 184 (56), 167 
(21), 105 (72), 105 (18), 85 (100), 77 (10), 57 (28), 41 (37); Anal.Calcd for C18H22O4 C, 
80.56; H, 7.51 Found: C, 80.67; H, 7.51. 
2-(1-phenyl-ethoxy)tetrahydro-pyran (2f): Colourless oil; I.R (neat): νmax 3048, 
2976, 2842, 1604, 1532, 1418, 1381, 1261, 1170, 1119, cm-1; 1H NMR (CDCl3): δ1.45-
1.95 (m, 9H,), 3.38-4.05 (m, 2H), 4.43 (br. s, 1H), 4.90 (m, 1H), 7.26-7.44 (m, 5H). 
Ethyl 6-(tetrahydropyran-2-yloxy)hex-2-en-1-oate (2g). Colourless oil; I.R (neat): 
νmax 1728, 1598, 1522, 1447, 1368, 1207, 1126, 1064, 1012, 934, 821, 732 cm-1; 1H 
NMR (CDCl3): δ 1.20 (t, 3H, J = 6.5 Hz), 1.50-1.65 (m, 6H), 1.80-1.95 (m, 2H), 2.15-
2.24 (m, 2H), 3.40-3.70 (m, 4H), 4.15 (q, 2H, J = 6.5 Hz), 4.52 (s, 1H), 5.70 (d, 1H, J = 
14.0 Hz), 6.78-6.96 (m, 1H). EIMS m/z (%): 242 (M+, 18), 213 (12), 169 (10), 157 
(100), 128 (31), 85 (62), 59 (23), 41 (11); Anal.Calcd for C13H22O4 C, 64.44; H, 9.15 
Found: C, 64.42; H, 9.10. 
[N-tert-Butyloxycarbonyl]-4-methyl-1-(tetrahydropyran-2-yloxy)pentan-2-amine 
(2h). Light yellow oil; I.R (neat): νmax 3321, 1724, 1615, 1581, 1459, 1327, 1261, 1109, 
1028, 972, 861, 741 cm-1; 1H NMR (CDCl3): δ 0.96 (2s, 6H), 1.20-1.30 (m, 2H), 1.38 
(s, 9H), 1.50-1.65 (m, 5H), 1.72-1.85 (m, 2H), 3.40-3.60 (m, 5H), 4.40 (s, 1H), 4.65 (br 
s, 1H). EIMS m/z (%): 301 (M+, 21), 244 (15), 216 (12), 200 (10), 159 (42), 115 (100), 
97 (11), 85 (36), 56 (21), 42 (18); Anal.Calcd for C16H31NO4 C, 63.75; H, 10.37; N, 
4.65 Found: C, 63.70; H, 10.39; N, 4.71. 
2-Tetrahydropyran-2-yloxy]octane (2i). Colourless oil; I.R (neat): νmax 1605, 1535, 
1473, 1412, 1361, 1271, 1208, 1142, 1069, 1013, 918, 826, 732 cm-1; 1H NMR 
(CDCl3): δ 0.90 (t, 3H, J = 6.5 Hz), 1.08-1.12 (m, 2H), 1.20-1.26 (m, 2H), 1.30-1.40 (m, 
 
                                                                                                     Chapter III, Section B 
 169
7H), 1.50-1.60 (m, 6H), 1.65-1.80 (m, 2H), 3.40-3.50 (m, 1H), 3.60-3.70 (m, 1H), 3.82-
3.90 (m, 1H), 4.60-4.70 (m, 1H). EIMS m/z (%): 214 (M+, 12), 131 (25), 119 (5), 100 
(3), 85 (18), 69 (100); Anal.Calcd for C13H26O2 C, 72.84; H, 12.23 Found: C, 72.89; H, 
12.19. 
2-(2-n-Butoxyethoxy)tetrahydropyran (2j). Colourless oil; I.R (neat): νmax 1518, 
1453, 1361, 1208, 1172, 1064, 1026, 991, 817, 741 cm-1; 1H NMR (CDCl3) δ 0.90 (t, 
3H, J = 7.0 Hz), 1.30- 1.45 (m, 2H), 1.50-1.70 (m, 7H), 1.80-1.90 (m, 1H). 3.40-3.60 
(m, 6H), 3.75-3.88 (m, 2H), 4.60 (s, 1H); EIMS m/z (%): 202 (M+, 5), 101 (15), 85 
(100), 67 (13), 57 (63), 41 (38); Anal.Calcd for C11H22O3; C, 65.31; H, 10.96 Found: C, 
65.28; H, 10.99. 
2-Phenoxy-tetrahydro-pyran (2k): Colourless oil; I.R (neat): νmax 3063, 2942, 2872, 
1587, 1450, 1288, 1182, 1123, 1038, 921, 872, 810 cm-1; 1H NMR (CDCl3): δ1.58-1.72,  
(m, 3H,), 1.83-1.90 (m, 2H), 1.96-2.06 (M, 1H), 3.61 (m, 1H), 3.93 (m, 1H), 5.43 (m, 
1H), 6.95-7.09 (m, 3H); EIMS m/z (%): 184 (M+, 11), 85 (100). 
2-Menthyl-tetrahydro-pyran (2l): Colourless oil; I.R (neat): νmax 2949, 1452, 1374 
cm-1; 1H NMR (CDCl3): δ0.76-1.10 (m, 12H,), 1.20-1.83 (m, 10H), 2.05-2.37 (m, 2H), 
3.28-3.50 (m, 2H), 3.86-4.00 (m, 1H), 4.58-4.80 (m, 1H); Anal.Calcd for C15H28O2 C, 
74.95; H, 11.74 Found: C, 75.04; H, 11.91. 
2-{(1,7,7-Trimethyl)bicyclo[2,2,1]hept-2-yloxy)}tetrahydropyran (2m). Colourless 
oil. I.R (neat): νmax 1459, 13570, 1309, 1205, 1179, 1131, 1109 1068, 1034, 1016, 993, 
831, 753 cm-1; 1H NMR (CDCl3): δ 0.85 (s, 6H), 0.91 (s, 3H), 1.20-40 (m, 4H), 1.50-
1.65 (m, 6H), 1.80-1.90 (m, 1H), 2.00-2.10 (m, 2H), 3.40-3.50 (m, 1H), 3.70-3.90 (m, 
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2H), 4.55 (br s, 1H); EIMS m/z (%): 238 (M+, 12), 108 (10), 85 (100), 57 (20), 41 (30); 
Anal.Calcd for C15H26O2 C, 75.58; H, 10.99 Found: C, 75.52; H, 10.96. 
2-(Cyclohexyloxy)tetrahydro-pyran (2n): Colourless oil; I.R (neat): νmax 2932, 2855, 
1449, 1201, 1169, 1063, 998 cm-1; 1H NMR (CDCl3): δ1.10-2.00,  (m, 16H,), 3.43-3.52 
(m, 1H), 3.59 (m, 1H), 3.87 –3.95 (m, 2H), 4.70 (dd, J = 4.5, 3.0 Hz, 1H); Anal.Calcd 
for C11H20O2 C, 71.70; H, 10.94 Found: C, 71.79; H, 11.14. 
N-[tert-Butyloxylcarbonyl]-3-(tetrahydropyran-2-yloxy)piperidine (2o): Light 
yellowish oil; I.R (neat): νmax 3349, 1726, 1610, 1596, 1528, 1439, 1382, 1256, 1192, 
1121, 1063, 1008, 941, 829, 742 cm-1; 1H NMR (CDCl3): δ 1.38 (s, 9H), 1.56-1.66 (m, 
6H), 1.72-1.93 (m, 4H), 2.60-2.80 (m, 2H), 3.40-3.50 (m, 1H), 3.75-3.95 (m, 4H), 4.60 
(s, 1H). EIMS m/z (%): 285 (M+, 20), 228 (12), 200 (31), 143 (22), 99 (100), 81 (51), 43 
(33); Anal.Calcd for C15H27NO4 C, 63.13; H, 9.54; N, 4.91 Found: C, 63.10; H, 9.59; N, 
4.95. 
2,2-Dimethyl-5-[phenyl(tetrahydropyran-2-yloxy)methyl]tetrahydrofuro[2,3 
d][1,3]di-oxole (2p). Colourless oil; I.R (neat): νmax 3072, 2964, 2832, 1597, 1536, 
1471, 1347, 1290, 1223, 1169, 1043, 982, 837, 751 cm-1; 1H NMR (CDCl3): δ 1.25 (s, 
3H), 1.31 (s, 3H), 1.50-1.60 (m, 4H), 1.75-1.95 (m, 2H), 3.33 (br s, 1H), 3.60-3.95 (m, 
2H), 4.05-4.18 (m, 1H), 4.40-4.50 (m, 1H), 4.58 (s, 1H), 4.65 (s, 2H), 4.90-4.98 (m, 
1H), 5.98 (d, 1H, J = 4.5 Hz), 7.20-7.40 (m, 10H). EIMS m/z (%): 440 (M+,12), 355 
(21), 313 (15), 255 (27), 164 (52), 106 (100), 85 (61), 51 (35); HRMS (FAB) Calcd for 
C26H34O6 (M+) 442.2354 Found: 442.2348.  
2-(Naphthalen-1-yloxy)-tetrahydro-pyran (2q). Colourless oil; 1H NMR (CDCl3): δ 
1.60-2.30 (m, 6H), 3.52- 3.60 (m, 1H), 3.82-3.94 (m, 1H), 5.60 (s, 1H), 7.02-7.10 (m, 
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1H) 7.51 –7.30 (m, 5H), 7.80-7.72(m, 1H), 8.31-8.20 (m, 1H); EIMS m/z (%): 228 (M+, 
5), 144 (100), 106 (16), 115 (35), 85 (90), 67 (24), 57 (30), 4 (26). 
2-Phenyl-3-(tetrahydropyran-2-yloxy)-5-hexene (2r). Colourless oil; I.R (neat): νmax 
3057, 2982, 2834, 1592, 1523, 1461, 1312, 1247, 1168, 1042, 1013, 949, 861, 742 cm-1; 
1H NMR (CDCl3): δ 1.50-1.92 (m, 8H), 2.25-2.42(m, 2H), 2.51-2.60 (m, 2H), 2.65-2.75 
(m, 1H), 3.40- 3.50 (m, 1H), 3.60-3.78 (m, 1H), 3.85-3.95 (m, 1H), 4.65 (d, 1H, J = 5.0 
Hz), 5.00-5.10 (m, 2H), 5.70-5.90 (m, 1H), 7.10-7.25 (m, 5H). EIMS m/z (%): 260 (M+, 
5), 219 (15), 117 (25), 91 (65), 85 (100), 67 (14), 57 (20), 41 (26); Anal.Calcd for 
C17H24O2 C, 78.42; H, 9.29 Found: C, 78.47; H, 9.23. 
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